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Cationic liposome-mediated delivery of adeno-associated virus (AAV) based 
plasmid DNA has potential for efficient and safe delivery of DNA into a number 
of different cell types. The objective of this thesis was to develop techniques for 
transfecting adult somatic mammary epithelial cells with the aim of producing 
non-germline transgenic animals. Initially, chemical-mediated techniques were 
used to deliver plasmid DNA to mammary epithelial cells in vitro: this work was 
subsequently extended to in vivo studies. The research then focussed on cationic 
liposome-mediated delivery of AAV-based plasmid DNA to enhance transfection 
efficiency, and the molecular characteristics of AAV-based plasmid DNA as a 
vector for transfection and integration of DNA into the genome. 
Chemical-mediated procedures were used to deliver plasmid DNA to the mouse 
mammary epithelial cell line, HCl 1, and to primary bovine mammary cells in 
vitro. Four delivery vehicles were used; calcium phosphate co-precipitation, 
DOTAP, DMRIE-C and LipofectAMINE. The highest transfection efficiency 
resulted from using LipofectAMINE, although this efficiency was relatively low, 
with only 2.1 % of cells found to express ~-galactosidase. 
To establish the efficacy of chemical-mediated delivery of plasmid DNA in vivo 
and to investigate an intramammary route of delivery, lactating rats were 
transfected in vivo with plasmid DNA complexed with LipofectAMINE. These 
complexes were delivered by infusion through the mammary teat canal or by 
direct injection into the gland. The ensuing level of transfection was extremely 
low, with only a very small number of rat mammary epithelial cells found to 
express ~-galactosidase. These results indicated that alternative transfection 
procedures were required. 
Inverted terminal repeats (ITRs) of AAV have previously been shown to enhance 
transfection efficiency, and these were included in a plasmid construct flanking a 
~-galactosidase reporter gene. LipofectAMINE was used to deliver this DNA to 
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HC 11 cells, however, the efficiency of transient transfection was only increased 
by a modest 1.4-fold. 
To evaluate the effect of AA V ITRs on plasmid DNA integration, a DNA 
construct containing a neomycin resistance gene flanked by ITRs was transfected 
into HCll cells. Additionally, this construct was co-transfected with an AAV 
Rep protein expression construct, which is required for site-specific integration in 
human cells. Neither the inclusion of ITRs, or expression of the rep gene affected 
the frequency of integration of the neomycin gene. 
In humans a specific advantage of using AA V is site-specific integration of the 
virus into a locus on human chromosome 19, known as AAVSl. Southern blot 
analyses were used to ascertain whether a similar site is present in mouse and 
other species. No clear cut evidence was found for such a site. 
Further Southern blot analysis of clonal lines derived from mouse HCll cells that 
were co-transfected with a neomycin resistance gene, and an AA V rep gene 
construct, suggested that the site of integration was random. A novel PCR 
technique was utilised to amplify the site of integration. This enabled sequence 
data to be obtained for two HCll clones. The site of integration for one of the 
clones was identified within exon 16 of Mus musculus DNA coding for the DNA 
dependent protein kinase catalytic subunit. The site of integration for the second 
clone was an unknown region of the mouse genome. An interesting characteristic 
of both clones was the presence of mouse B 1 repeat sequences in close proximity 
to the sites of integration. 
These studies demonstrate that AA V-based plasmid DNA can enhance the 
transfection efficiency in mouse mammary epithelial cells, and they contribute 
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1.1 General introduction 
Traditionally, transgenic farm animals, such as sheep and cattle, have been 
produced by germ line gene transfer. The goal of genetic modifications of this 
kind is normally to alter a specific physiological process, which may in tum lead 
to enhancement of animal productive efficiency, to the generation of a new value 
added product, or they may be used for the evaluation of gene promoters. The 
mammary gland is a particularly attractive target tissue for this type of gene 
transfer. The introduction and expression of foreign genes in the mammary gland 
of large mammals such as cows can be used to modify milk composition, or to 
produce novel proteins in milk. Unfortunately, progress in the production of germ 
line transgenic farm animals has been hindered by high costs, mainly due to the 
associated long time frames required for gestation and maturation through 
puberty. An alternative approach to alleviate these inherent problems is to 
produce transgenic tissues by gene transfer to somatic cells. 
Gene transfer to somatic cells is a technology that holds many promises for gene 
therapy and considerable emphasis has been placed on developing efficient 
techniques for the in vivo treatment of human genetic disorders. To date the 
majority of gene transfer technologies tested in phase one human gene therapy 
clinical trials have involved viral vectors. However, a multitude of techniques 
have been explored, all with the common goal of designing the ultimate vector for 
delivery of foreign DNA to somatic cells of the particular target tissue. These 
technologies can be directly transferred to the agricultural industry for the 
production of somatic transgenic farm animals. 
This chapter discusses current methodologies used for gene transfer to somatic 
cells. In particular, focus has been placed on delivery of foreign DNA to 
mammary epithelial cells, as it is the objective of this thesis. Also, 
liposome-mediated delivery of adeno-associated virus based plasmid DNA is 
featured extensively, as this was the method that formed the basis of work in this 
thesis. 
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1.2 Gene transfer to somatic cells 
Gene transfer can be defined as the transfer, and subsequent expression of foreign 
genes, into cells. Vectors are the vehicles used to carry this genetic material into 
the target cells. A challenge exists to develop the perfect vector for gene transfer. 
Several features are considered essential for such a vector, depending on the 
application for which they are designed. In general the following attributes are 
considered desirable: safety, efficiency, minimal toxicity, a high level of 
controlled expression, target specificity, and minimal immunogenicity. Other 
features considered include; cost and efficiency of production, environmental and 
ethical factors, and potential limitations on the amount of DNA that can be 
inserted into the vector. 
Gene transfer vectors can be broadly categorised on the basis of the mode of DNA 
delivery, as either viral or non-viral in nature. The most extensively studied viral 
gene transfer vectors are those based on retrovirus, adenovirus, or adeno-
associated virus. The non-viral vectors are classified according to the method by 
which they deliver DNA to the target cell. This is either by a physical or a 
chemical procedure. 
1.2.1 Retroviral vectors 
Retroviruses are single stranded RNA viruses. They have genomes of between 7 
and 10 kilobases (kb) which contain three conserved structural genes (gag, pol 
and env) and are flanked by two direct repeats, the long terminal repeats (LTRs). 
All of these components are essential for the normal retroviral life cycle (Watson 
et al., 1987). The retroviral life cycle can be summarised in five stages. Firstly, 
the viral particle attaches to the host cell surf ace via specific binding of the viral 
envelope surface protein to cell surface receptors. Following attachment, the virus 
enters the cell by receptor-mediated endocytosis. Once within the cell cytoplasm 
the virus sheds its outer envelope coat and the viral reverse transcriptase directs 
synthesis of a double stranded DNA from the single stranded RNA genomic 
template. This DNA intermediate is then transported to the nucleus, in a process 
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that requires cell division, and integrates into a random site in transcriptionally 
active chromatin domains. Following integration the proviral genome can utilise 
host cell machinery to express viral proteins which can be used to produce new 
viral particles (Coffin, 1990). 
Retroviruses have been associated with causing oncogenic activity within cells, 
often eliciting tumorigenic results. This induction of malignancy often results 
from the random insertion of the wild type viral DNA into the host genome, 
which may subsequently function as an oncogene or as a promoter to oncogenes. 
For example, the Moloney murine leukaemia virus (MML V) can induce 
leukaemias and lymphomas in mice after a long latent period. Other members of 
the retrovirus family include Rous sarcoma virus and Human immunodeficiency 
virus (Coffin, 1990). 
A critical factor for insertional mutagenesis to potentially occur, is the presence of 
large quantities of wild type viral DNA. Therefore, to make retroviruses safer for 
use as gene transfer vectors, they must be made replication defective. To achieve 
this, the viral structural genes (gag, pol and env) are removed, consequently 
creating space for up to approximately 8 kb of exogenous DNA to be inserted into 
the viral backbone. Recombinant, replication defective viral particles can then be 
made with the help of packaging cell lines containing the necessary structural 
proteins required to produce an active virion. 
The primary feature of retroviral vectors that make them attractive for gene 
transfer is their potential to integrate into the genome of target cells and hence to 
potentially provide stable, long-term expression of the transgene. On the other 
hand, the fact that retroviruses can only integrate into actively dividing cells 
represents a disadvantage to their use. Recent development of lentiviral vectors, 
which are able to transduce post-mitotic cells, has assisted in expanding the 
potential applications of retroviral vectors. Lentiviruses are a subfamily of 
retroviruses and include the human immunodeficiency virus. A further drawback, 
and a potential risk of retroviral vector use, is the possibility of homologous 
recombination with a replication competent virus in vivo to produce a recombinant 
replication competent virus. Another major disadvantage of retroviral vectors is 
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the low efficiency of gene transfer in vivo. This is due to the low titre achieved in 
recombinant viral production and also to a lack of target cell specificity 
(Anderson, 1998). As a consequence, ex vivo application of retroviral vectors, 
where target cells are infected in vitro and are then transferred back to the target 
tissue in vivo, is a common method of delivery. This aids in avoiding problems 
associated with low titre and target specificity, as viral particles are not diluted by 
non-specific infection, and also allows integration as cells undergo mitosis while 
in vitro. Recently, attempts have been made to improve both the titre and 
specificity of retroviral vectors, in order to target specific cells. For an excellent 
summary of these methods, refer to W.F. Anderson's review (1998). 
Despite these disadvantages, and the fact that they are difficult and expensive to 
produce, retroviral vectors are currently used in nearly 40% of all approved 
clinical human gene therapy trials (www.wiley.co.uk). Retroviral vectors based 
on the Moloney murine leukaemia virus (MML V) are currently the vectors being 
used in several ex vivo human clinical gene therapy trials (Orkin and Motulsky, 
1995). 
Attempts have been made to transduce primary mouse mammary epithelial cells 
in vitro, with a replication defective retroviral vector containing a J3-galactosidase 
reporter gene construct. Up to 30% of cells demonstrated stable J3-galactosidase 
expression (Smith et al., 1991). Also, there have been in vivo attempts to infuse 
retroviral vectors directly to rat mammary epithelial cells via the central mammary 
duct (Wang et al., 1991), and to goat mammary epithelia via the teat canal (Archer 
et al., 1994). The earlier experiments utilised a MMLV vector to drive a 
J3-galactosidase reporter gene construct and achieved J3-galactosidase expression 
in 0.3% of cells. In the later study, delivery of a replication defective Gibbon ape 
leukaemia virus (GaL V) pseudotype retroviral vector expressing human growth 
hormone (hGH) resulted in secretion of hGH into the milk during lactation. The 
level of hGH detected in the milk however was low, only in the ng/ml range. It 
was suggested that the low level of expression was a result of low viral titre, with 
the number of mammary epithelial cells in the lactating gland exceeding the 
number of viral particles infused by at least three orders of magnitude. 
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1.2.2 Adenoviral vectors 
Adenoviruses have a double stranded linear DNA genome of 36 kb (Ginsberg, 
1984). They are non-enveloped viruses, which are commonly associated with 
mild human infections such as respiratory tract infections, conjunctivitis and 
gastroenteritis. The adenoviral life cycle begins with receptor-mediated 
internalisation, nuclear translocation and episomal maintenance of the viral 
genome. Host cell machinery is subsequently utilised for viral gene expression 
which is followed by viral assembly, packaging and lytic release from the cell. 
For use as gene transfer vectors the viral El replication genes are removed which 
allows up to approximately 8 kb of foreign DNA to be accommodated within the 
viral genome, and also renders them replication-defective. Recombinant viral 
particles are assembled by complementing missing replication functions in trans 
using engineered cell lines (Fallaux et al., 1998). 
There are several features of adenoviruses that make them attractive vectors for 
gene transfer. They can be produced at high titres, they have the ability to infect a 
wide variety of cell types, including post-mitotic cells, and the viral genome 
remains episomal which minimises the possibility of insertional mutagenesis 
(Benihoud et al., 1999). Unfortunately there are also several limitations of 
adenoviral vectors that restrict their use, including vector induced inflammation, 
transient expression of transgenes and the development of adenovirus specific 
neutralising antibodies that hinder repeat administration of the vector. Several 
attempts have been made to alleviate the cellular and humoral responses to 
recombinant adenoviral infection. Deletion of additional viral genes such as E2 
has assisted in the reduction of the cellular response to infection. Humoral 
responses can also be decreased by the administration of adenoviral specific 
antibodies (Chen et al., 2000). Further disadvantages of adenoviral vectors 
include episomal maintenance of the introduced recombinant genome, which 
limits the stability of expression. Also, the potential for homologous 
recombination with wild type virus to produce replication competent adenoviral 
particles still exists. Deletion of viral genes reduces the chance of the later 
occurring. 
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Adenoviral vectors have been widely used for gene transfer in vivo with 26% of 
all current human gene therapy trials using this method of delivery 
(www.wiley.co.uk). 
Replication-defective adenoviral vectors have been used to deliver a 
~-galactosidase reporter gene to primary human mammary epithelial cells in vitro 
and to mouse mammary epithelial cells in vitro and in vivo (Yang et al., 1995). A 
high level of expression was detected in all cases. More recently, Jeng et al. 
(1998) have successfully expressed a ~-galactosidase reporter construct in the rat 
mammary gland using a replication-defective adenoviral vector that was delivered 
by the cannulation of the main mammary milk ducts. Up to 70% of epithelial 
cells demonstrated positive staining for ~-galactosidase four days after delivery, 
but ~-galactosidase expression dramatically decreased after this time and was not 
detectable after nine days. 
1.2.3 Adena-associated viral vectors 
Adeno-associated virus (AAV) is a member of the Dependovirus genus of the 
Parvoviridae family. It has a linear, single stranded DNA genome of 4680 
nucleotides (Figure I.I) (Srivastava et al., 1983). At either end are GC rich (over 
80%) inverted terminal repeats (ITRs) of 145 nucleotides. The terminal 125 
nucleotides of these repeats are palindromic and form a T-shaped secondary 
structure when folded. This hairpin structure is thought to be critical for viral 
DNA replication and integration (During, 1997). There are two open reading 
frames between the ITRs, one encoding rep (for replication) genes, and the other 
the cap (for capsid) genes. The DNA molecule possesses three promoters, p5, 
p19 (for the rep genes) and p40 (for the cap genes). The transcripts derived from 
the p5 promoter are Rep78 and Rep68, named from their molecular weight in 
kiloDaltons. Rep68 is a spliced version of Rep78. The p19 promoter directs 
expression of Rep52 and Rep 40 (Green et al., 1980). The four Rep proteins are 
non-structural regulatory proteins. 
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p19 p40 Poly A 
Rep78 4.2 kb An 
Rep68 3.9 kb An 
Rep52 3.6 kb An 
Rep40 3.3 kb An 
VP1 2.3 kb An 
VP2 2.3 kb An 
VP3 2.3 kb An 
Figure 1.1 Schematic representation of the AA V genome. The relative 
positions of the inverted terminal repeats (ITR), common polyadenylation signal 
(PolyA) and the three transcription start sites of the viral promoters, p5, p19 and 
p40 are depicted. Transcripts derived from each of the viral promoters are also 
shown. Both p5 and p19 direct rep gene expression (Rep78, Rep68, Rep52 and 
Rep40), whereas p40 controls cap gene expression (VPl, VP2 and VP3). Coding 
regions are represented by solid boxes. 
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The two larger Rep proteins, Rep78 and Rep68 have been shown to be important 
for DNA replication (Labow and Berns, 1988), targeted integration upon latent 
infection (Weitzman et al., 1994 ), and the regulation of AA V gene expression 
(Beaton et al., 1989). The smaller Rep proteins, Rep52 and Rep40 have been 
implicated to have a role in facilitating packaging of the viral genome 
(Chejanovsky and Carter, 1989). The p40 promoter directs expression of the 
capsid genes, encoding the three structural proteins, VPl, VP2 and VP3. These 
proteins combine to form a non-enveloped icosahedral virion of 20-30 nm in 
diameter (Melnick et al., 1965; Tsao et al., 1991 ). 
The name AA V reflects the viruses' dependence on a helper virus to co-infect a 
cell for lytic infection to proceed. The helper viruses most frequently identified 
and studied are adenoviruses, although herpesvirus is known to also act in this 
capacity (Pattison, 1994). The main role of adenovirus is mediated by the protein 
ElA, which assists in facilitating AAV gene expression (Bueler, 1999). In the 
absence of a helper virus, AA V will demonstrate the converse state of its biphasic 
life cycle and undergo latent infection by integrating into the genome of the host 
cell (Figure 1.2). This integrated provirus may be rescued and stimulated to 
proceed with lytic infection upon infection with a helper virus. Interestingly, 
external genotoxic stimuli such as UV irradiation, chemical carcinogens or heat 
shock may also stimulate lytic infection (Yakinoglu et al., 1988). 
A distinguishing feature of AA V latent infection in human cells is the site-specific 
nature of viral DNA integration. The locus into which AA V preferentially 
integrates, is chromosome 19q13.3qter and is known as AAVSl (Kotin et al., 
1990; Kotin et al., 1991; Samulski et al., 1991; Kotin et al., 1992). AAVSl 
contains two DNA sequence features which are also found in the viral ITRs; a 
Rep Binding Element (RBE), and terminal resolution site (trs) (Linden et al., 
1996a). Recent work by Young et al. (2000) suggests that not just these two 
elements, but the entire AA VS 1 locus is essential for site-specific integration in 
vivo. The mechanism of integration is not well understood, but it is clear that the 
larger Rep proteins (Rep78 and/or Rep68) are essential for site-specific 
integration into AAVSl (Surosky et al., 1997). In the absence of Rep78 and/or 
Rep68, DNA flanked by ITRs will still integrate, but at random sites within the 
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e Helper virus (Adenovirus) 
/ ~/ 








Schematic representation of the AA V life cycle. In latent 
infection, AA V integrates into the host cell genome. In lytic infection, which 
requires the presence of a helper virus or rescue from latent infection, viral 
replication and subsequent progeny release occurs. 
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human genome (Xiao et al., 1997). A model for the integration process was 
proposed by Linden et al. (1996a) which involved binding of the Rep78 and/or 
Rep68 protein to the RBE of AA VS 1 and also to the RBE of the viral ITRs, 
followed by nicking of AA VS 1 and/or ITR sequence at the trs. Subsequent 
integration is likely to occur via a non-homologous recombination process 
involving replication of the viral DNA. 
Production of recombinant AA V (rAA V) virus from packaging cell lines is 
possible because the ITRs are the only cis elements required for viral replication 
and packaging. Thus, all the viral genes may be deleted from the genome and 
replaced with a gene of interest. The rep and cap genes are supplied in trans by a 
helper plasmid (Samulski et al., 1989). Earlier difficulties associated with the 
production of high titre virus, devoid of helper virus contamination, have recently 
been overcome with the development of more efficient packaging cell lines 
(Ferrari et al., 1997; Xiao et al., 1998; Liu et al., 1999b). A potential 
disadvantage of rAA V vectors is that the size of the insert DNA that can be 
successfully packaged is limited to less than 5 kb, although this may be overcome 
by dividing the expression cassette between more than one vector (Nakai et al., 
2000). 
AA V is considered to be the safest of all the viral vectors. Since no viral genes 
are present in rAA V, production of active virus would require infection with both 
wild type AA V as well as a helper virus, and their subsequent recombination. The 
human specific isolate, AA V-2 has never been associated with disease and is 
therefore believed to be non-pathogenic. Approximately 85% of the adult USA 
population are seropositive for this virus (Berns, 1990). To date no adverse 
symptoms or disease have been reported following rAA V infection. Also, the 
absence of a cellular immune response following infection suggests that rAA V 
vectors are not cytotoxic (Chirmule et al., 1999; Hernandez et al., 1999). 
A wide variety of tissues in vanous animal models have been successfully 
transduced by rAAV in vivo. These include mouse skeletal muscle (Xiao et al., 
1996), rat and monkey brain (Kaplitt et al., 1994; During et al., 1998), mouse 
liver (Koeberl et al., 1997; Snyder et al., 1997), rabbit lung (Flotte et al., 1993), 
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and rat retina (Rolling et al., 1999). Expression from these rAA V vectors in vivo 
was not transient, therefore they are suitable for long term delivery of therapeutic 
genes. Nakai et al. (1999) provided the first direct evidence of integration into a 
host genome in vivo by a rAA V vector. They isolated junctions between vector 
and genomic DNA from mouse liver cells transduced in vivo, confirming the 
cellular integration of the virus. The site of rAA V integration was random, as 
expected since these vectors do not express Rep78 and/or Rep68. Also, a locus 
homologous to human AA VS 1 that directs site-specific integration, has not been 
identified in any other species apart from green monkeys (Samulski et al., 1991). 
The efficiency of rAA V integration in vivo is not clearly defined and varies 
depending on the cell type transduced (Carter and Samulski, 2000). 
1.2.4 Naked DNA and physical methods of gene transfer 
Microinjection of DNA directly into the cell nucleus is a very efficient method of 
gene transfer, with normally close to 100% of all the DNA that is delivered being 
successfully expressed (Capecchi, 1980). Unfortunately, as only one cell at a time 
can be injected, this approach is laborious, slow and not practical for in vivo gene 
transfer. Hence its use in animals has been limited to the production of transgenic 
animals by gene transfer to germ line cells in vitro. 
Direct injection of naked plasmid DNA into mouse skeletal muscle to express a 
reporter gene was first demonstrated by Wolff and colleagues (1990). This is the 
simplest approach to in vivo gene transfer, as no other complexes are required, 
however the efficiency is poor. The uptake of the DNA through the cell 
membrane is a limiting factor. 
Several modifications to the basic technique have been developed to enhance the 
efficiency of naked DNA delivery. Biolistic particle bombardment delivery of the 
plasmid DNA with a gene gun has been used. In this method the plasmid DNA is 
complexed with metal particles such as gold or tungsten and blasted into tissues. 
Yang et al. (1990) achieved transient expression of reporter genes in liver, skin 
and muscle tissue of rats and mice in vivo using particle bombardment. Similar 
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results were obtained with rat and human mammary explants and primary cell 
cultures. They found that approximately 3% of mammary tissue stained positive 
for ~-galactosidase expression 48 hours after delivery of a ~-galactosidase 
reporter construct driven by the mouse mammary tumour virus (MMTV) 
promoter. However, 25% of mammary tissue stained positive following delivery 
of a different construct, which had the immediate early cytomegalovirus (CMV) 
promoter driving the ~-galactosidase reporter gene. This suggests that the lower 
percentage may under-represent the transfection efficiency, due to the relative 
weakness of the MMTV promoter. Furth et al. (1992) used a jet propulsion 
injection system to deliver naked plasmid DNA to skin, muscle, fat and mammary 
tissue of mice and sheep in vitro and in vivo, achieving low levels of localised 
~-galactosidase reporter gene expression. This gene gun approach has also been 
utilised to successfully transfect sheep mammary glands in vivo. Expression of a 
hGH transgene was detected by Northern blot analysis 48 hours following 
delivery (Kerr et al., 1996). More recently, pressure-mediated delivery has been 
developed, where controlled non-distending pressure was used to deliver naked 
fluorescently (FITC) labelled oligonucleotides to rat cardiovascular tissue with 
greater than 50% of the label localised in the nucleus (Mann et al., 1999). 
Similarly, hydrodynamic force by rapid injection via the tail vein successfully 
delivered naked plasmid DNA to numerous tissues of mice in vivo, and achieved 
expression in up to 40% of hepatocytes (Liu et al., 1999a; Zhang et al., 1999). 
An alternative approach for gene transfer is electroporation. This method is very 
efficient and widely used in vitro, however, because of the difficulty of 
administration its use to deliver DNA to somatic cells in vivo is limited. Some 
success has been achieved, with skin (Banga and Prausnitz, 1998), corneal 
endothelium (Oshima et al., 1998), and muscle (Aihara and Miyazaki, 1998). A 
disadvantage of electroporation for gene transfer is the resultant high mortality of 
cells. Methods using low voltage, high frequency electric pulses have recently 
improved this, with only transient tissue damage resulting from the procedure 
(Rizzuto et al., 1999b). 
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These physical approaches to improve efficiencies of naked DNA gene transfer all 
assist penetration of the plasmid DNA through the cell membrane, hence reducing 
the extent of DNA degradation as a result of endocytosis. However, they all 
increase cell death as a result of physical damage to the cells. 
1.2.5 Chemical methods of gene transfer 
The general principle of chemical-mediated gene transfer is based on the 
formation of complexes between positively charged chemicals and negatively 
charged DNA molecules, which in tum can be taken up by the cell through 
endocytosis. Several chemicals have been utilised to form these complexes which 
assist in uptake of the DNA into cells. 
Chemical introduction of foreign DNA into cells was first reported in 1965 using 
DEAE-dextran (Vaheri and Pagano, 1965). Since then various chemicals have 
been used. The most common and perhaps the cheapest method is calcium 
phosphate co-precipitation (Graham and van der Eb, 1973). The major drawback 
with calcium phosphate co-precipitation is that the variations from experiment to 
experiment are significant, due to inconsistency in the size of the calcium 
phosphate-DNA complexes. Its use is also limited due to its cytotoxic effect on 
cells and its impracticability for in vivo situations because of gravity dependence 
(Keown et al., 1990). Both the DEAE-dextran and calcium phosphate co-
precipitation methods rely on the formation of a complex between the DNA and 
the chemical, and subsequent internalisation by endocytosis. Various other 
polymers such as poly-L-lysine and polyethylenimine (PEI) have also been used 
to deliver DNA to cells in vitro and in vivo with mixed success (Luo and 
Saltzman, 2000). 
In 1987, Feigner (1987) and co-workers described the first use of a synthetic 
cationic polymer, called lipofectin, to form complexes with plasmid DNA to be 
delivered to cells. They transfected a range of mammalian cells in vitro, yielding 
transfection efficiencies up to 100-fold higher than those obtained with other 
transfection methods such as calcium phosphate co-precipitation. Liposome-
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mediated transfection is often more reproducible than other transfection methods 
because it appears to be less affected by contaminants, salt concentration, and pH 
of various DNA preparations. Subsequently, numerous developments have been 
made to improve these cationic lipids with the goal of enhancing transfection 
efficiency, and also to increase the versatility and simplicity of use for both in 
vitro and in vivo transfections. These improvements have reduced the toxicity of 
many reagents and broadened the range of cell types that are amenable to 
transfection. Numerous commercial liposomes are currently on the market, each 
with specific attributes for various situations. In general, they all have different 
efficiencies and toxicity's across a wide range of cell lines. What is apparent, is 
that no one particular liposome formulation will ubiquitously transfect all cell 
types, and that the requirements for in vivo transfection are very different to those 
in vitro. 
The three basic parts of cationic lipids include; a hydrophobic lipid anchor group 
which helps in the formation of liposomes (or potential micellar structures) and 
can interact with cell membranes, a linker group, and a positively charged 
headgroup which interacts with plasmid DNA leading to its condensation (Mahato 
et al., 1997). 
The biochemical and cellular events required for successful cationic liposome­
mediated delivery of plasmid DNA to the cell nucleus can be divided into five 
main stages; (1) formation of the lipid-DNA complex, (2) entry of this complex 
into the cell, (3) escape of the complex from endosomes, (4) dissociation of the 
DNA from the lipid and (5) transport from the cytoplasm and entry of the DNA 
into the nucleus (Figure 1.3). 
The formation of the lipid-DNA complex involves a charge interaction between 
the multivalent cationic head groups of the lipid and the negative charge of the 
plasmid DNA molecule (Lee and Huang, 1997). Freeze-fracture electron 
microscopy has been utilised to identify the physical structure of the complex 
formed between lipid and DNA. Surprisingly, a heterogeneous population of 










Figure 1.3 Biochemical and cellular events involved in cationic liposome mediated 
delivery of plasmid DNA. (1) formation of the lipid-DNA complex, (2) entry of this 
complex into the cell, (3) escape of the complex from endosomes, ( 4) dissociation of 
the DNA from the lipid and (5) transport from the cytoplasm and entry of the DNA 
into the nucleus. 
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surrounded by lipid, to very large aggregates of both DNA and lipid (Sternberg et 
al., 1994; Zahner, 1997). The overall charge, stability and size of the complex is 
determined by the lipid-DNA ratio. Near neutral complexes usually form large 
aggregates whereas complexes with a net positive or negative charge have greater 
stability and are smaller in size (Lee and Huang, 1997). It remains to be 
determined which type of complex is best for successful transfection, as a 
homogeneous population of lipid complexes is not yet available. However, it is 
clear that the physical characteristics of the complex play an important role in 
determining the efficiency of transfection. 
It is generally accepted that the entry of the lipid-DNA complex into a cell occurs 
mainly by endocytosis. In order to investigate this process, Zahner (1997) 
labelled plasmid DNA with gold particles, complexed them with a cationic lipid 
and transfected COS cells in culture. Electron microscopy at intervals of 5 and 30 
minutes after delivery of the complex to cells showed that the uptake and 
internalisation occurred by endocytosis. An alternate path of entry may be by 
fusion of the complex to the plasma membrane and subsequent internalisation, 
however no conclusive evidence exists to support this hypothesis (Li and Huang, 
2000). 
Once within the cell, the lipid-DNA complex must escape from the endosome to 
avoid the normal endosomal pathway of degradation, so that it can be transported 
to the nucleus. El Ouahabi et al. (1997) observed that the efficiency of DNA 
delivery is correlated not only with the efficiency of uptake, but also with 
destabilisation and escape from endosomes. Using electron microscopy Zhou and 
Huang (1994) demonstrated that the neutral lipid DOPE 
(dioleoylphosphatidylethanolamine) enhances destabilisation of the endosome, 
allowing release of plasmid DNA into the cytoplasm. DOPE is a strong 
destabiliser of lipid bilayers (Litzinger and Huang, 1992). Consequently when 
DOPE is present the efficiency of transfection is enhanced (Farhood et al., 1995). 
DOPE is a component of numerous commercially available cationic liposomes, 
including LipofectAMINE. 
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The adenoviral capsid is also capable of destabilising the endosomal complex. 
Capsid association with the endosomal membrane results in pore formation and 
lysis of the endosome (Greber et al., 1993). Treatment of cells with replication 
deficient adenovirus after they had been transfected using a transferrin-
pol yl ysine/DN A complex was shown to enhance transfection efficiency (Wagner 
et al., 1992). Currently, this method is not a practical option for in vivo gene 
therapy applications because of potential cellular and humoral responses to 
recombinant adenoviral proteins, however the concept has led to the development 
of other fusogenic substances aimed at achieving a similar result (Stayton et al., 
2000). 
The major rate-limiting factor for successful transfection is the transport of the 
plasmid DNA from the cytoplasm to the nucleus. The precise mechanism of this 
nuclear delivery is unknown, however it is likely to involve passive diffusion, 
which is an inherently inefficient process. A recent in vitro study showed that 
only a small portion (0.3%) of radiolabelled DNA delivered to airway epithelial 
cells with the cationic liposome, LipofectAMINE, was detected in the nucleus 24 
hours after delivery (Holmes et al., 1999). This observation is supported by 
Schanbacher and Amstutz (1997), who delivered plasmid DNA complexed with a 
fluorescently labelled polyion to COMMA-ID mouse mammary epithelial cells or 
primary bovine mammary cells in vitro. They observed accumulation of the 
fluorescent label in the perinuclear region of most cells within 6-8 hours after 
delivery, however only a small percentage of cells also demonstrated fluorescent 
signal localised within the nucleus. 
In an attempt to overcome this problem, it has recently been shown that inclusion 
of nuclear localisation signals in the delivery package can enhance the efficiency 
of nuclear targeting and hence increase transfection efficiency (Branden et al., 
1999; Ziemienowicz et al., 1999). An alternative approach is to provide the 
necessary machinery for cytoplasmic expression and therefore avoid the need for 
nuclear delivery of the plasmid DNA. Gao and Huang (1993) used a T7 RNA 
polymerase cytoplasmic expression system to achieve this. More recently, a 
direct comparison was made between cytoplasmic and nuclear expression systems 
within a HEK-293 cell line expressing T7 RNA polymerase. It was shown that 
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once DNA is released into the cytoplasm, the cytoplasmic expression system 
shows immediate expression, proportional to the amount of DNA released. In 
contrast, DNA targeted for nuclear expression requires additional time for nuclear 
entry. The level of nuclear expression is also restricted by the limited amount of 
DNA that is imported into the nucleus (Brisson et al., 1999). 
Once within the nucleus, the plasmid DNA needs to be released from the lipid-
DNA complex for expression to proceed. Naked plasmid DNA injected directly 
into the nucleus will be expressed, whereas plasmid DNA complexed to lipid 
injected into the nucleus will not (Capecchi, 1980; Zahner et al., 1995). There 
must be a balance however, between "coated" plasmid DNA, where it is protected 
from degradation versus "uncoated" plasmid DNA, a state where transcription can 
proceed. The optimum state for maximal transfection efficiency will potentially 
be at an intermediate level of stability. Stable complexes restrict the rate of 
transcription whereas unstable complexes permit rapid plasmid DNA degradation 
(Schaffer et al., 2000). The efficiency of transcription of the "uncoated" plasmid 
DNA may be improved by the presence of stronger promoter and enhancer 
elements. A popular strategy employed to maximise gene expression is to use a 
constitutive viral promoter such as the immediate early cytomegalovirus (CMV) 
promoter. 
Overall, there are low efficiencies of gene transfer using physical or chemical 
methods of delivery compared to viral techniques, and the expression is transient. 
However, the safety aspect of their use makes them attractive and is hence the 
reason for perseverance with their use. Approximately 13% of all current human 
gene therapy clinical trials employ a liposome-based system of gene delivery. 
The first of these was for the treatment of skin cancer (Nabel et al., 1993), and 
other trials include the treatment of cystic fibrosis (Caplen et al., 1995). 
A polyion complex was successful in delivering plasmid DNA containing the 
human growth hormone (hGH) gene to COMMA-ID mouse mammary epithelial 
cells and to primary bovine mammary cells in vitro (Schanbacher and Amstutz, 
1997). A similar polyion complex has also achieved expression of this construct 
in guinea pig mammary glands in vivo (Hens et al., 2000). 
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1.2.6 Hybrid vectors - a composite approach 
The vectors developed for both viral and non-viral mediated gene transfer each 
have novel features which are beneficial for satisfying the wide ranging criteria 
that determine successful gene transfer. One of the more important of these 
criteria is high efficiency of DNA delivery and expression. However, this must be 
counterbalanced with consideration for the safety of the technique, with respect to 
both the microenvironment of the target organism and the macroenvironment 
within which it exists. Both requirements can be addressed somewhat by utilising 
expression features from viral vectors, which in general achieve higher levels and 
greater persistency of expression, and delivery techniques of chemical methods of 
gene transfer, which are generally safer. 
One such composite technique is liposome-mediated delivery of AAV-based 
plasmid DNA. Inclusion of AAV ITRs within the plasmid to be transfected can 
enhance the efficiency and stability of transgene expression. Early studies 
demonstrated that a human interleukin 2 (IL-2) construct expressed up to 10-fold 
more IL-2 protein from AAV-based plasmids containing ITRs compared to 
control plasmid without ITRs, in primary human, and in cultured rat and human 
cell lines. Furthermore, long term expression up to 30 days post transfection was 
observed with AA V-based plasmids (Philip et al., 1994; Vieweg et al., 1995). 
These results suggested that the ITRs stabilise expression by either facilitating 
integration or by maintaining the foreign DNA in an episomal state. The AA V 
Rep78 and/or Rep68 proteins were not present in either of these studies. 
These Rep78 and/or Rep68 proteins are essential for site-specific integration into 
AA VS 1 (Surosky et al., 1997). In their absence, DNA flanked by ITRs will still 
integrate, but at random sites within the human genome (Xiao et al., 1997). 
Shelling and Smith (1994) initially showed by Southern analysis that transfection 
of AA V -based plasmids containing ITRs and rep genes can result in high 
frequency (75%) of site-specific integration at chromosome I9ql3.3qter in human 
HEK-293 and HeLa cell lines. Recent experiments, where AA V-based plasmid 
DNA was delivered with liposomes to several human cell lines in vitro, has 
confirmed this earlier observation. Sequence analysis of AAVSI-plasmid DNA 
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junctions confirmed site-specific integration in the presence of Rep proteins 
(Surosky et al., 1997; Lamartina et al., 1998; Pieroni et al., 1998; Rinaudo et al., 
2000; Tsunoda et al., 2000). Also, Rizzuto and colleagues (1999a) created 
transgenic rats containing a 3.5 kb AAVSl fragment from human chromosome 
19. Subsequent transfection of AAV-based plasmid DNA containing rep genes 
into primary rat fibroblasts derived from these transgenic animals resulted in site-
specific integration into the transgene locus, as observed by Southern blot and 
Fluorescent In Situ Hybridisation (FISH) analysis. 
In vivo gene transfer, using transfection of AAV-based plasmid DNA has also 
been reported in mice (Baudard et al., 1996). Furthermore, a construct expressing 
recombinant aspartoacylase (ASPA) was delivered to two children with Canavan 
disease (Leone et al., 2000). This work is ongoing, but early reports suggest 
positive results for limited in vivo ASPA expression. 
1.3 The mammary gland 
The mammary gland is a structure that lies beneath the skin, exterior to the body 
cavity of mammals. The number, position and relative size of glands may vary 
between species, however the histological structure and resultant function, that of 
milk production, remains conserved. This structure accommodates two primary 
components, the parenchyma and the stroma. 
The parenchyma is made up of secretory and ductal tissue. The secretory tissue 
consists of specialised mammary epithelial cells that synthesise milk. They are 
cuboidal in shape and are polarised with basal and luminal sides. A single layer 
of epithelial cells line pear-shapes structures called alveoli, which exist in clusters. 
Milk is secreted into the hollow lumina of alveoli, from which it drains into the 
ductal system (Figure 1.4). The ductal tissue forms a system of branching ducts 
that leads to a teat from which milk is removed. There are differences between 
species in the structure of the ductal system. 
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Figure 1.4 Schematic representation of a cluster of mammary alveoli. 
Reproduced from Mephan (1987) with permission. 
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The stroma consists of skin, connective tissue, adipose tissue, blood and lymph 
vessels and nerve tissue. It provides the substrate for the parenchyma to develop, 
and creates a network in which the essential supporting features necessary for 
milk production can function. 
Several in vitro mammary epithelial cell models have been developed to study 
mammary function, including whole gland culture, primary explants, primary cell 
culture and cell lines. These models clearly demonstrate that no single in vitro 
system mimics the complex three-dimensional structure encountered in vivo, so 
the choice of model depends on the biological question being examined. For 
example, optimising delivery of plasmid DNA to the vicinity of target cells using 
an in vitro model is not a perfect substitute for the physiological environment 
encountered in vivo. Upon reaching the cell surface however, the cellular and 
molecular barriers to successful expression of foreign DNA are presumed to be 
similar in vitro and in vivo, therefore an in vitro model system is beneficial for 
examining the fate of DNA in vivo. 
The potential use of the mammary gland as a bioreactor has been realised with the 
production of germ line transgenic animals that express proteins in the mammary 
gland (Wall et al., 1997). An alternative to these germ line transgenic animals is 
somatic gene transfer. The mammary glands of domesticated farm animals such 
as goats, sheep and cattle are excellent targets for somatic cell gene transfer with 
the objective to either modify milk composition or express novel proteins. 
The morphology of the mammary gland is such that it is essentially a closed 
system in which each epithelial cell is theoretically accessible from the luminal 
side. This allows for the prospect of direct intramammary infusion through the 
teat canal to deliver foreign DNA to the apical membrane of epithelial cells. 
Patton et al. (1984) demonstrated that such a pathway was successful in achieving 
uniform distribution of a dye marker throughout the mammary gland in a rat 
model. 
Several different modes of delivery have been utilised for in vivo somatic gene 
transfer to the mammary gland, all of which have been discussed earlier in this 
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chapter. They include; recombinant retroviral (Wang et al., 1991; Archer et al., 
1994) and adenoviral vectors (Yang et al., 1995; Jeng et al., 1998), physical 
delivery by direct needle injection (Kerr et al., 1996) or jet injections by gene gun 
(Furth et al., 1992), and chemical-mediated delivery of plasmid DNA 
(Schanbacher and Amstutz, 1997; Hens et al., 2000). 
1.4 Purpose and scope of this investigation 
A diverse range of vectors are presently available for somatic cell gene transfer, 
each having merits for the specific application for which they were intended. The 
perfect vector for ubiquitous use however, has yet to be designed and remains an 
interesting challenge. Development of a vector for the delivery and expression of 
foreign DNA into mammary epithelial cells in vivo is an example of such a 
challenge. A unique set of criteria must be satisfied. These include the two 
essential prerequisites for all gene transfer vectors, which are efficiency and 
safety. 
The focus of the work in this thesis is the somatic transfection of mammary 
epithelial cells. Previously several different approaches, that include retroviral, 
adenoviral, biolistic gene gun and polymer based vectors, have been utilised to 
deliver foreign DNA to mammary epithelial cells, each with varied success. In 
general no one technique has exhibited overwhelming advantages over others. An 
attractive method for somatic cell gene transfer is the use of liposome-mediated 
transfection of AA V-based plasmid DNA. This method encapsulates features of 
AA V to enhance the efficiency and longevity of transgene expression, yet still 
retains a non-viral mode of delivery. It has been used as a gene transfer vector for 
a wide range of target cells both in vitro and in vivo, but has not been used for 
mammary epithelial cells. 
This work therefore investigates the efficacy of gene transfer to mammary 
epithelial cells using liposome-mediated transfection of AA V-based plasmid 
DNA. As yet, sparse knowledge exists about the site of integration resulting from 
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the use of these vectors, therefore characterisation of this event would improve 
knowledge in this area. 
To achieve this goal, two main approaches will be employed. Firstly, several 
plasmid DNA constructs will be created and delivered to mammary epithelial cells 
in vitro. Secondly, the frequency of integration will be examined, and the site of 
integration will be investigated using Southern blots and sequencing. 
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Chapter Two 
Materials and methods 
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2.1 Materials 
Common laboratory chemicals and reagents were obtained from BDH Chemicals 
NZ, Ltd. and Sigma Chemical Co. Restriction enzymes were obtained from 
Roche. Mammalian cell culture medium components were obtained from Life 
Technologies GIBCOBRL. A Perkin-Elmer GeneAmp PCR System 9600 machine 
was used for PCR. Oligonucleotides were purchased from GIBCOBRL. Milli Q 
filtered water was used for all molecular biology and mammalian cell culture 
experiments. Diethylpyrocarbonate (DEPC) treated water and solutions were 
used for all experiments with RNA. 
2.1.1 Solutions 
Solutions used were prepared as described in Ausubel et al.(1987) or Sambrook et 
al. (1989). 
Table 2.1 - Common solutions 
Church and Gilbert 0.5 M Na2HP04 (pH 7.2) 
hybridisation 7%SDS 
buffer 1 mMEDTA 
Crystal Violet 0.04% crystal violet in 1 M citric acid 
DNA loading dye 15% Ficoll (Type 400) 
0.25% bromophenol blue 
0.25% xylene cyanol 
Easyprep lysis lOmM Tris-HCI (pH 8.0) 
buffer lmMEDTA 
15% sucrose 
2 mg/ml I ysozyme 
0.2 mg/ml pancreatic Rnase 
0.1 mg/ml bovine serum albumin 
MOPS 41.8% MOPS 
50 mM sodium acetate 
lOmMEDTA 
PBS OXOID tablets 
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RNA loading dye 10% MOPS (lOx) 
20% deionised formaldehyde 
50% deionised formamide 
0.02% bromophenol blue 
5% glycerol 
1 mM EDT A (pH 8.0) 
40 µg/ml ethidium bromide 
TE 10 mM Tris-Cl, 1 mM EDTA (pH 8.0) 
TAE 40 mM Tris-acetate 
2 mM EDT A (pH 8.0) 
Trypsin-EDT A 0.25% trypsin 
solution lmMEDTA 
in PBS 
2 x HEPES- 0.28 MNaCl 
buffered saline 0.05 MHepes 
1.5 M Na2HP04(pH 7.1) 
2.2 Methods 
2.2.1 General molecular biological methods 
General molecular biology techniques were performed as described by Sambrook 
et al. (1989) and Ausubel et al. (1987). These included: bacterial transformation 
and culture; nucleic acid isolation from bacterial and mammalian cells; restriction 
endonuclease digestions; agarose gel electrophoresis; DNA fragment isolation; 
Northern and Southern blotting and hybridisation; and DNA modifications 
including dephosphorylation, end filling or blunting; and ligation. Modifications 
to these procedures and non-standard protocols are described in more detail where 
appropriate. 
(i) DNA isolation 
For small-scale plasmid DNA preparation, either the "Easyprep" (Berghammer 
and Auer, 1993), or small-scale alkaline lysis (Sambrook et al., 1989) procedures 
were used. QIAGEN plasmid DNA preparation ion exchange columns (QIAGEN 
Pty Ltd) were used for all large-scale plasmid DNA preparation that were 
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intended for use in transfection experiments. Otherwise, large-scale alkaline lysis 
isolation was used (Sambrook et al., 1989). 
Plasmid DNA was quantified by linearising the plasmid, running an aliquot on an 
agarose gel and comparing the amount to known concentrations of lambda DNA 
molecular weight standards. 
Extraction of genomic DNA from mammalian tissues, blood or cells in culture 
was performed either as described by Ausubel et al. (1987), or with DNAzol 
Reagent (GIBCO BRL) following the manufacturers protocol. 
(ii) RNA isolation 
Total RNA was extracted from cells in culture using TRizol Reagent 
(GIBCO BRL) according to the manufacturers protocol. 
(iii) Subcloning 
For ligation reactions either T4 DNA ligase (GIBCO BRL) in 5x pre-mixed buffer, 
or the pGEM-T Easy Vector System I (Promega) were used. Ratios of insert to 
vector, of two-, five- and ten-fold the molecular mass, were commonly used to 
optimise the ligation efficiency. 
(vi) Competent cells 
XLl-Blue (MRF') (Stratagene) competent cells were prepared according to the 
method of Inoue et al. (1990). 
(v) Labelling of DNA 
Oligonucleotides probes were end-labelled with [ a-32P]dCTP using Terminal 
Transferase (Roche). cDNA probes were labelled with [a-32P]dCTP using 
Rediprime II random prime labelling system (Amersham). 
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2.2.2 Mammalian cell culture 
RPMI 1640 Medium, Dulbecco's Modified Eagle Medium (DMEM), OptiMEM I 
and Medium 199 were prepared as described by the manufacturers. All media 
was filter sterilised with 0.22 µm filters. Cells were cultured at 37°C, in 5% CO2 
in sterile plastic dishes. Foetal bovine serum was heat inactivated by incubation at 
56°C for 30 minutes. To passage cells, growth medium was removed and the 
cells were washed with phosphate buffered saline (PBS). A minimal volume of 
trypsin-EDTA solution (0.25 % trypsin, 1 mM EDTA) was added to cover cells, 
which were then incubated for 5-8 minutes at 37°C or until the cells had lifted off 
the plastic. The trypsin-EDTA solution was then inactivated by the addition of 
growth medium containing 10% foetal bovine serum (FBS). 
(i) HCJ 1 cells 
The mouse mammary epithelial cell line HCl 1 was a gift from Dr Jerome 
Demmer (formerly of AgResearch, Ruakura). All experiments were carried out 
with cultures that were between nine and eighteen passages from original isolation 
(Danielson et al., 1984). Cells were cultured in RPMI 1640 Medium containing 
100 U/ml penicillin G, 0.1 mg/ml streptomycin, 10% (v/v) foetal bovine serum, 
and 10 ng/ml epidermal growth factor. 
(ii) HEK-293 cells 
HEK-293 cells (Graham et al., 1977) were a gift from Dr Mike Eccles 
(University of Otago). The passage number of the cells since their original 
isolation was unknown, however for experiments carried out in this thesis the 
cells were passaged less than six times. HEK-293 cells were grown in DMEM 
medium supplemented with 100 U/ml penicillin G, 0.1 mg/ml streptomycin and 
10% (v/v) foetal bovine serum. 
(iii) Neuro-2a cells 
Neuro-2a (ATCC Number CCL-131) were a gift from Dr Ian Garthwaite 
(AgResearch, Ruakura). Neuro-2a cells were cultured in RPMI 1640 Medium 
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containing 100 U/ml penicillin G, 0.1 mg/ml streptomycin, 2 mM glutamine, 
1 mM pyruvate, and 10% (v/v) foetal bovine serum. 
(iv) Primary bovine mammary cells 
A 10 cm3 block of tissue was aseptically removed from the centre of the left rear 
gland of a mid-lactating Holstein-Friesian dairy cow, which had been slaughtered. 
This was cut into smaller pieces of approximately 1 cm3 and washed twice in 
wash solution (Medium 199 media supplemented with 1 % (v/v) foetal bovine 
serum). A collagenase solution (15 ml of Medium 199 containing 1000 U/ml 
collagenase) was infused into the tissue using a 25-gauge needle so that it was 
completely saturated. The block was then diced into smaller pieces and incubated 
at 37°C with shaking (180 rpm) for 2 hours or until the digestion was complete. 
The cell slurry was filtered through 150 µm sterile gauze mesh to remove any 
remaining clumps of tissue. The filtrate was washed in 40 ml of wash solution, 
centrifuged at 180 x g for 5 minutes, re-suspended in 25 ml of wash solution and 
centrifuged at 90 x g for 5 minutes. The resulting pellet was suspended in 25 ml 
of wash solution and filtered through 30 µm gauze mesh to enrich for clumps of 
epithelial cells. These cells were grown in Medium 199, which contained 100 
U/ml penicillin G, 0.1 mg/ml streptomycin, 0.25 µg/ml amphotericin Band 10% 
(v/v) foetal bovine serum. The cultured cells were further enriched for epithelial 
cells by selective trypsinisation as follows. After two, four ~r six minutes of 
exposure to the trypsin-EDTA solution, the cells were washed with growth 
medium and the wash solution (containing fibroblast cells that were more 
sensitive to trypsinisation) was discarded. After rinsing with PBS, fresh trypsin-
EDT A solution was added to dislodge the remaining cells, which were then 
seeded in a new plate. 
2.2.3 Plasmid DNA 
The following plasmids were either supplied as gifts or purchased commercially 
for use in this study: pBiuescript II SK (Stratagene); pGEM-T Easy (Promega); 
pCHl 10 (Pharmacia); pBR322 (Sutcliffe, 1979); pEGFP-Nl (Clontech) (gift from 
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Professor Floyd Schanbacher, Ohio State University); pHIVrep (Antoni et al., 
1991) (gift from Dr Matt During, University of Auckland); pAAV/PLAN (gift 
from Dr Matt During, University of Auckland) was created by digestion of 
psub201 ( +) (Samulski et al., 1987) with Xbal to remove the AA V viral genome, 
leaving the inverted terminal repeats (ITRs). This DNA sequence was replaced 
with a 366 bp HindlII/PvuII fragment consisting of polylinker and bovine growth 
hormone polyadenylation sequence from pcDNA3 (Invitrogen); pCS2-CMVlacZ 
(gift from Dr Russell Snell, AgResearch, Ruakura) consists of a 3.1 kb lacZ gene 
fragment from pMC 1871 (Shapira et al., 1983) inserted immediately downstream 
of the CMV promoter in pCS2+ (www.sitemaker.umich.edu/dltumer.vectors); 
pTK(ES) (gift from Dr Garry Udy, AgResearch, Ruakura) consists of a 1746 bp 
PvuII/BglII herpes simplex virus thymidine kinase (HSV-tk) gene fragment from 
pTK 1 (Cordingley and Preston, 1981) inserted into pSP64 (Promega). 
Furthermore, a 274 bp Xhol/Pstl HSV-tk promoter fragment from pMClneo 
(Stratagene) was inserted immediately upstream of the HSV-tk gene to create 
pTK(ES). 
The plasmids that were made for the experiments described in this thesis are 
described in the following sections. 
pBS-ITR 
pBS-ITR was created by isolating a PvuII/EcoRI fragment from pAAV/PLAN 
which consisted of 190 bp of ITR and 50 bp of pcDNA3 polylinker sequence. 
This was ligated into pBluescript II SK+ backbone digested with SmaI/EcoRI. 
pAAV-GFP 
pEGFP-Nl was digested with Asel/Xhol to release a 607 bp fragment containing 
the CMV promoter and a 4.1 kb vector backbone. pBS-ITR was digested with 
EcoRV/XhoI and the 607 bp fragment from pEGFP-Nl was inserted to create 
pBS-ITR-CMV. pBS-ITR-CMV was digested with Xbal and Xhol to release a 
857 bp fragment containing the ITR and CMV promoter. This 857 bp fragment 
was ligated into the 4.1 kb pEGFP-N 1 vector backbone from the first step to 
create pEGFP-ITR-CMV. pBS-ITR was digested with Xbal and HindlII to 
release a 260 bp fragment containing the ITR. This fragement was ligated into 
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pEGFP-ITR-CMV, which had been linearised by digestion with Bfrl, to create 
pAAV-GFP. 
pCMVlacZ (7 .5 kb) 
pEGFP-Nl was digested with Hindlll and Bfrl to remove the GFP gene, but 
leaving the CMV promoter in the vector backbone. The lacZ gene, isolated from 
pCHl 10 by digestion with Hindlll and BamHI, was ligated into this vector 
backbone to create pCMVlacZ. 
pITR-CMVlacZ (7.9 kb) 
pAAV-GFP was digested with Hindlll and EcoRI to remove the GFP gene, but 
leaving the CMV promoter in the vector backbone. The lacZ gene, isolated from 
pCHllO by digestion with Hindlll and BamHI, was ligated into this vector 
backbone to create pITR-CMVlacZ. 
pITR-neo-tk (5.8 kb) 
A neomycin resistance gene cassette of 1986 bp was isolated from pEGFP-Nl by 
digestion with Dralll and Drall. pITR-neo-tk was created by digesting 
pAA V-GFP with Sad to remove the GFP cassette. The neomycin resistance gene 
cassette was then ligated into this vector backbone to create pITR-2neo. The 
existing copy of the neomycin resistance gene was then removed from the 
pITR-2neo vector backbone by digestion with Dralll and Drall. This was 
replaced a 2.2 kb copy of the herpes simplex virus thymidine kinase (HSV-tk) 
gene isolated as a Hindlll fragment from pTK(ES). 
pneo-tk (5.3 kb) 
pEGFP-Nl was digested with Asel and Bfrl to remove the GFP cassette. This was 
replaced by neomycin resistance gene cassette of 1986 bp was isolated from 
pEGFP-Nl by digestion with Dralll and Drall to create p2neo. The existing copy 
of the neomycin resistance gene was then removed from the p2neo vector 
backbone by digestion with Dralll and Drall. This was replaced a 2.2 kb copy of 
the herpes simplex virus thymidine kinase (HSV-tk) gene isolated as a Hindlll 
fragment from pTK(ES). 
Figure 2.1 
this thesis. 











Schematic representation of the plasmids made for experiments in 
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2.2.4 In vitro transfection 
For the in vitro transfection experiments in this thesis, cells were seeded 16 hours 
prior to transfection. The number of cells that was seeded was determined from 
the surface area of the culture vessel, and calculated so that they would be 70-80% 
confluent at the time of DNA delivery. All DNA for transfection experiments was 
prepared using QIAGEN columns. For each experimental treatment, duplicate 
wells were transfected. Experiments were replicated between one and four times. 
(i) Calcium phosphate co-precipitation 
Calcium phosphate-mediated delivery of plasmid DNA was carried out as 
described in Ausubel et al. (1987). To transfect HCll cells in a 6-well dish, the 
appropriate amount of plasmid DNA was diluted in 0.5 ml of 0.25 M calcium 
chloride. This solution was added dropwise to 0.5 ml 2 x HEPES-buffered saline 
(pH 7 .1) while CO2 was bubbled through the solution. The solution was 
incubated at room temperature for 30 minutes and then added to the cells. Growth 
media (1 ml) was added immediately and a further 1 ml was added 4 hours later. 
This solution was left on the cells overnight, then washed off the cells by rinsing 
them four times with PBS. 
(ii) Cationic liposomes 
Three cationic lipid formulations were utilised for transfection experiments in this 
thesis, DOTAP (Roche), DMRIEC (Life Technologies) and LipofectAMINE (Life 
Technologies). Unless otherwise stated, transfection was carried out using the 
manufacturer instructions. Control, mock-transfections were performed with lipid 
only, or DNA only, in the transfection mixture. DOTAP reagent (1 mg/ml) is N-
[ 1-(2,3-Dioleoyloxy)propyl]-N,N,N-trimethyl-ammonium methyl-sulfate m 
buffered saline. DMRIE-C reagent (2 mg/ml) is a 1: 1 liposome formulation of the 
cationic lipid DMRIE (l,2-dimyristyloxypropyl-3-dimethyl-hydroxy ethyl 
ammonium bromide) and cholesterol m membrane filtered water. 
LipofectAMINE reagent (2 mg/ml) is a 3: 1 (w/w) liposome formulation of the 
polycationic lipid DOSPA (2,3-dioleyloxy-N-[2(sperminecarboxamido )ethyl]-
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N,N-dimethyl-1-propanaminium trifluoroacetate) and the neutral lipid DOPE 
(dioleoyl phosphatidylethanolamine) in membrane filtered water. 
To transfect cells in 6-well culture flasks with LipofectAMINE, a defined amount 
of plasmid DNA was diluted in 100 µl OptiMEM I medium. Likewise, the 
appropriate volume of LipofectAMINE was diluted in 100 µl OptiMEM I 
medium. These two solutions were then mixed and incubated at room 
temperature for 20 minutes. Following incubation, 800 µl OptiMEM I was added 
to this lipid-DNA mix and the resultant solution was added to cells, which were 
pre-washed in OptiMEM I. After 4 hours, the transfection solution was removed 
and replaced with 2 ml of growth medium. To transfect different sized culture 
vessels, the volume of each reagent was adjusted according to surface area of the 
vessel. 
2.2.5 In vivo transfection 
Lactating Sprague-Dawley laboratory rats were used for in vivo transfection 
experiments. On day seven to seventeen of lactation, the pups were removed one 
hour prior to the beginning of manipulations and sacrificed by CO2 inhalation. 
The rats were anaesthetised by a single intra-peritoneal dose of Sagatal (60 mg/kg 
body weight) and the body temperature was maintained using a 37°C heating 
block. Transfection complexes were delivered to either the third or fourth 
mammary glands and milk was clearly present in these glands at this time. The 
delivery route was either by infusion into the mammary gland via the teat canal 
using a blunt 32-gauge needle, or by direct injection into the mammary gland 
through the wall of the gland. Two days after delivery of the transfection 
complex, the rats were sacrificed and mammary tissue was isolated and 
immediately frozen at -80°C. Controls glands were mock-transfected with 
OptiMEM I only. Cryosections of 20 µm, were subsequently prepared and 
mounted on poly-L-lysine coated glass slides. These sections were stained in situ 
for ~-galactosidase expression, counter-stained with eosin and then mounted in 
DPX. 
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All animal procedures were approved by the University of Waikato (Protocol 
number 243), and Ruakura (Protocol number 2414) Animal Ethics Committees 
and the Ruakura Biosafety Supervisory Committee (Application number 23). 
2.2.6 /Jgalactosidase reporter gene assays 
(i) In situ histochemical staining 
Cultured cells and tissue sections were assayed histochemically for 
~-galactosidase expression using a modified method of Sanes et al. (1986). They 
were washed once with PBS and then fixed in situ with fixative solution (2% 
formaldehyde, 0.05% glutaraldehyde in PBS: cells in the culture dishes and tissue 
sections on the glass slides) for five minutes at room temperature. They were 
washed twice with PBS then exposed to the stain solution (5 mM ferricyanide, 5 
mM ferrocyanide, 2 mM MgCb, 1 mg/ml X-gal) and incubated at 37°C for 
between 2 and 16 hours. 
(ii) ONPG /Jgalactosidase assay 
The amount of ~-galactosidase enzyme activity m the cultured cells was 
quantified using the substrate o-nitrophenyl-~-o-galactopyranoside (ONPG) 
(Jagota et al., 1981 ). The cells were harvested 48 hours after liposome-DNA 
complex delivery, resuspended in 0.1 M Tris (pH 7.8) and lysed by repeated 
freeze-thaw cycling (five times alternating between dry ice and 37°C). The cell 
debris was pelleted and an aliquot of the cell lysate (4 µl) was assayed for 
~-galactosidase enzyme activity. Solution Z (150 µl, 36 µl ~-mercaptoethanol/10 
ml PBS) and the ONPG solution (30 µl) were added to the lysate, and the reaction 
was incubated for 30 minutes at 37°C. The colour change was measured at 
405 nm. Units of ~-galactosidase were calculated by comparison to known 
standards, where one unit of ~-galactosidase is defined as the amount of enzyme 
that will hydrolyze 1 µmole of ONPG in one minute at 37°C. The total protein 
concentration was quantified using the method of Bradford (Bradford, 1976), and 
was used to normalise the samples. 
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2.2.7 Selection for integration of plasmid DNA 
HCl 1 or HEK-293 cells were seeded into 60 mm culture plates, at a concentration 
of 1.5 x 106 cells/plate, 16 hours prior to transfection. Plasmid DNA was 
combined with LipofectAMINE and delivered to cells as described in Section 
2.2.4. The cells were then passaged and seeded into plates containing growth 
media with either G418 (at the minimal lethal dose for the cell line which was 
determined as described in the following paragraph), or G418 and FIAU 
(0.2 µM), until discrete colonies were visible (14-24 days post-transfection). 
The minimum lethal dose of G418 (GIBCO BRL), determined for both HCll and 
HEK-293 cells, is the minimum concentration of G418 that gave zero percent 
survival of non-transfected cells. Each cell line was seeded at 30-40% confluence 
(8.0 x 104 cells/well for HCl 1 and 6.0 x 104 cells/well for HEK-293 in 12-well 
plates) in their respective growth medium. This was supplemented with G418 at 
concentrations ranging from O to 1000 µg/ml, initially with increments of 100 
µg/ml. Once the broad range was determined, the experiment was repeated with 
smaller 25 µg/ml increments to more precisely define the minimum lethal dose of 
G418. The media was changed every day for days one to seven and then on days 
nine and twelve. On day fourteen, the media was removed and the plates were 
stained with crystal violet to stain any cells that remaining attached to the plate. 
The lowest G418 concentration where no cells were stained was determined to be 
the minimum lethal dose. 
Following selection with G418, or G418 and FIAU, individual colonies were 
isolated by covering the colony with of 5 µl trypsin-EDT A solution, and scraping 
from the plate with a 200 µl pipette tip. Isolated colonies were placed in 96-well 
tissue culture plates containing growth medium and allowed to grow for 24 hours. 
The cells were then selected with G418. When the cells reached confluence, they 
were expanded by sequentially passaging them into larger culture vessels (Table 
2.2). Control non-transfected cells, cultured in growth medium supplemented 
with G418, had all died before day fourteen. A small aliquot of cells from each 
transfection were seeded separately and stained in situ for ~-galactosidase 
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expression. No significant differences in transfection efficiencies were observed 





Summary of the selection regime for HCl 1 and HEK-293 cells. 
Transfect cells in 60 mm culture plates. 
Supplement growth media with G418. 
Cells were passaged into 4 x 100 mm culture plates (A, B, C and D) at 
dilutions which allowed counting and selection of single colonies. 
Days 4-15 Supplement growth media of all plates (A, B, C and D) with G418. 
Day 15 Isolate and expand 12 colonies from plates A and B. Remaining 
colonies were stained with crystal violet and counted. 
Day 15-24 Supplement growth media of plates C and D with G418 + FIAU. 
Day 24 Isolate and expand 12 colonies from plates C and D. Remaining 
colonies were stained with crystal violet and counted. 
2.2.8 PCR amplification of integration junctions 
Genomic DNA-transgene junction sequences were identified essentially as 
described by the method of Siebert et al. (1995), with the following modifications 
(Figure 2.2). The 'Adaptor' was created by annealing the 'adapt' oligonucleotide 
(5' eta ata cga etc act ata ggg etc gag egg ccg ccc ggg cag gt 3') to the 'link' 
oligonucleotide (5' ace tgc cc 3'), by combining equimolar amounts of each 
oligonucleotide, heating to 95°C for 2 minutes and cooling to room temperature. 
The templates for PCR were prepared by digesting 2.5 µg genomic DNA in 
100 µl reaction volumes with 30 Units of Seal restriction endonuclease and 
incubating overnight at 37°C. Digested DNA was extracted with 
phenol/chlorofonn/isoamyl alcohol (25:24:1), then with chloroform. The DNA 
was precipitated with ethanol, and resuspended in 20 µl TE. Ten µl of this Seal 
digested DNA was ligated to 5 µM 'Adaptor' in a 20 µl reaction with 5 Units T4 
DNA ligase (GIBCO BRL), incubated overnight at 16°C. Ligated DNA was 
diluted 10-fold in TE and stored at -20°C. Primary PCR reactions were conducted 
in 20 µl volumes containing 1 µl of template DNA, 0.4 µM APl primer (5' gga 
tee taa tac gac tea eta tag ggc 3'), 0.4 µM neo primer (neo3341 (5' ace get tee tcg 
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tgc ttt ac 3') or neo3392 (5' cct tct ate gee ttc ttg ac 3')), 0.25 mM dNTPs, 2 U 
Tag DNA polymerase (Roche) in 1 x Roche PCR buffer (lOmM Tris-HCI, 1.5 
mM MgCli, 50mM KCI, pH 8.3). The primary PCR amplification products were 
diluted 100-fold in TE buffer and used as template DNA for the secondary 
amplification. Secondary PCR reactions were conducted in similar conditions as 
for the primary reactions, except with the nested primers AP2 (5' aat agg get cga 
gcg gc 3') and neo3608 (5' aac tga aac acg gaa gga ga 3'). The primary cycle 
parameters were an initial denaturation of 95°C for 2 minutes, followed by 34 
cycles of 95°C for 30 seconds and 68°C for 6 minutes, and a final cycle of 95°C 
for 30 seconds and 68°C for 15 minutes. Secondary cycle parameters were as for 
primary except only 19 rather than 34 cycles were used. 
The specificity of the amplification products was determined by Southern blotting 
then hybridisation with a neomycin gene specific oligonucleotide, neo3685 (5' gtg 
ttg ggt cgt ttg ttc at 3'). Specific products were re-amplified by removing a 'stab' 
with a 2 µI pipette tip, directly from within the DNA band on an agarose gel, and 
using this agarose plug as template DNA for a repeat of the secondary PCR 
amplification reactions. This enabled isolation of unique products, rather than 
mixed pools of products, which could then be subcloned and sequenced. 
Amplification products were subcloned into pGEM-T Easy (Promega) using the 
conditions described in the manufacturer instructions. Sequencing of clones was 
carried out at the University of Waikato DNA sequencing facility (ABI 377, 
Applied Biosystems). 
2.2.9 Probes 
A 703 bp DNA probe specific to the neomycin resistance gene was isolated from 
the plasmid pneo-tk, by digestion with the restriction endonuclease Neal. The 
digested DNA was fractionated by agarose gel electrophoresis, and the desired 
fragment was isolated from the gel using a scalpel blade to cut out a slice of 
agarose. The DNA was then purified from the agarose using a GFX DNA 
purification column (Amersham Pharmacia Biotech Inc.). 
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A 623 bp AAVS I DNA probe was amplified by PCR from HEK-293 genomic 
DNA using primers, AAVSl-1 (cca ttt ccc agg etc ccg eta cct) and AAVSl-4 (acg 
acg ggg egg ate gag ac), that are specific to the human AAVS 1 locus (GenBank 
Accession number SS 1329). The 623 bp product spans a region of human 
genomic DNA that contains the consensus sequence for the terminal resolution 
site and the Rep Binding Element (Linden et al., 1996a). 
A 508 bp DNA probe specific to the AA V Rep78/68 gene was isolated from the 
plasmid pHIVrep, by digestion with the restriction endonucleases Bgll and 
BamHI. The digested DNA was fractionated by agarose gel electrophoresis, and 
the desired fragment was isolated from the gel using a scalpel blade to cut out a 
slice of agarose. The DNA was then purified from the agarose using a GFX DNA 
purification column. 
Figure 2.2 Schematic representation of the Siebert PCR assay. (i) digestion of 
genomic DNA with Seal, (ii) ligation of the Adaptor (shaded box) to digested 
DNA, (iii) primary PCR reactions with APl and neo3341 or neo3392 primers, (iv) 
secondary PCR reactions with AP2 and neo3608 primers, (v) detection of specific 
products with neo3685 oligonucleotide probe. Genomic DNA (open boxes) and 
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Mammary epithelial cell transfection in vitro 
and in vivo 
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3.1 Introduction 
Various techniques have been developed to deliver genes to somatic tissues in 
vivo, as outlined in Chapter One. The objective of this work was to develop an 
efficient system for the delivery of genes directly to the mammary gland. Somatic 
mammary epithelial cell modification has a wide range of potential applications. 
These include the ability to introduce and express novel genes in the mammary 
gland, which may change milk composition or alter mammary gland function. 
The objective of this chapter was to firstly, assess and optimise the efficiency of 
chemical-mediated delivery of plasmid DNA to mammary epithelial cells in vitro. 
Two vehicles for delivery were utilised, calcium phosphate co-precipitation and 
cationic liposomes. 
In order to obtain the highest transfection efficiency with cationic 
liposome-mediated delivery of plasmid DNA to any cell line, optimisation of two 
important parameters is required. It is essential to calibrate both the ratio of lipid 
to plasmid DNA, and the final concentration of these components, to achieve this 
goal of maximal efficiency. Other parameters which may affect transfection 
efficiency, but with much less significance, include the cell density at the time of 
delivery, time of exposure of the lipid-DNA complex to the cells, and DNA 
purity. These were kept constant in all in vitro experiments described in this 
work. For calcium phosphate co-precipitation, the amount of plasmid DNA 
delivered to cells can influence the transfection efficiency; therefore this was also 
optimised in these experiments. 
The second objective of this chapter was to assess the efficacy of cationic 
liposome-mediated delivery of plasmid DNA to rat mammary epithelial cells in 
VlVO. 
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3.2 In vitro transfection 
In order to carry out these in vitro studies, three cell lines were used as models, 
Neuro-2a, HCll and primary bovine mammary cells. The murine neuroblastoma 
cell line Neuro-2a was used as a positive control for transfection (Olmsted et al., 
1970). This cell line was chosen because it has previously been shown to 
efficiently take up DNA following transfection (Hitoshi et al., 1996) and it was 
readily available at Ruakura. HCl 1 is a clonal cell line derived from 
COMMA-ID cells (Ball et al., 1988), which are an epithelial cell line derived 
from the mammary tissue of mid-pregnant BALB/c mice (Danielson et al., 1984). 
HCll cells exhibit typical epithelial-like morphology and provide a cellular 
environment similar to that of in vivo mammary cells. Primary bovine mammary 
cells were isolated for this study from a mid-lactating Holstein-Friesian dairy cow 
(by methods described in Chapter Two). Morphological features, such as a 
cobblestone-like appearance with cells spreading out from organoid-like 
attachments, suggest that they were representative of typical mammary epithelial 
cells. The cell population was not completely homogeneous however, with up to 
10% of cells exhibiting a fibroblast-like morphology. 
Four different chemical reagents were used to deliver plasmid DNA to the HCll 
cell line. These were calcium phosphate co-precipitation, and the commercially 
available cationic liposomes, DOTAP (Roche), DMRIE-C (Life Technologies) 
and LipofectAMINE (Life Technologies). LipofectAMINE was also used to 
deliver plasmid DNA to Neuro-2a and primary bovine mammary cells. 
All in vitro transfection experiments outlined in this chapter were performed with 
the plasmid pCHllO (Pharmacia). This plasmid is a 7.1 kb eukaryotic expression 
vector, which contains the ~-galactosidase gene driven by the SV40 immediate 
early promoter. A large-scale bulk preparation of pCHllO was purified using a 
QIAGEN plasmid purification kit (see Chapter Two) and plasmid DNA from the 
same preparation of pCHl 10 was used for all experiments. 
Following chemical-mediated delivery of pCHl 10, the efficiency of transfection 
was assessed by calculating the percentage of cells that expressed ~-galactosidase 
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48 hours after the plasmid DNA was delivered to cells. To calculate this, cells 
were fixed in situ and histochemically stained with a solution containing X-gal 
(Sanes et al., 1986). Transfection efficiency presented here thus represented the 
number of cells that stained blue compared to the total cell number 48 hours after 
transfection. It does not represent the absolute percentage of cells that have taken 
up plasmid DNA. During the 48-hour period from delivery of the DNA to 
staining, the cells would have divided at least twice. Hence the total cell number 
may have increased by up to 4-fold, consequently diluting the percentage of cells 
staining blue compared to the total cell number by the same amount. 
Furthermore, in experiments with LipofectAMINE-mediated delivery of pCHl 10 
to HC 11 cells, B-galactosidase enzyme activity was also quantified. Cells were 
harvested 48 hours after liposome-DNA complex delivery and lysates were 
assayed for B-galactosidase enzyme activity using the substrate a-nitrophenyl-B-o-
galactopyranoside (ONPG) (Jagota et al., 1981). Units of B-galactosidase were 
calculated from known standards where one unit of B-galactosidase is defined as 
the amount of enzyme that will hydrolyze 1 µmole of ONPG in one minute at 
37°C. The total protein concentration was quantified using the method of 
Bradford (Bradford, 1976), and used to normalise between samples. 
All the in vitro transfection experiments described here were performed in 6-well 
culture dishes with cells seeded at a consistent density. Chapter Two contains 
details on cell growth and maintenance, methods of DNA delivery, and 
B-galactosidase assays. Control mock-transfection of HCl 1, primary bovine 
mammary and Neuro-2a cells with pCHl 10 alone (naked DNA) resulted in no 
detection of reporter gene expression following in situ histochemical staining 
(data not shown). For each experimental treatment, duplicate wells were 
transfected. Experiments were replicated between one and three times. 
3.2.1 Neuro-2a cell line transfection 
The murine neuroblastoma cell line Neuro-2a was transfected with the plasmid 
pCHllO complexed to LipofectAMINE. Over a range of ratios of 
LipofectAMINE (2-10 µl): 1 µg of pCHl 10, a peak transfection efficiency of 75% 
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was achieved using an optimal ratio of 6:1 (µl LipofectAMINE: µg pCHllO) 
(data not shown). These experiments also confirmed that the f3-galactosidase gene 
was expressed by pCHl 10 and the transfection efficiencies were consistent with 
what has been observed previously (Hitoshi et al., 1996). 
3.2.2 HCJ 1 cell line transfection 
A range of DNA amounts (2 µg to 10 µg per well of a 6-well culture flask) were 
used for calcium phosphate co-precipitation delivery of pCHllO to HCll cells. 
At best, 0.9% of HCl 1 cells stained positive for f3-galactosidase activity where 
10 µg of pCHl 10 was delivered per well (data not shown). 
The cationic lipids DOT AP and DMRIE-C were each combined with plasmid 
DNA at a range of ratios of lipid (2-10 µl): 1 µg pCHl 10, and delivered to HCl 1 
cells. At best, a transfection efficiency of 0.3% was obtained with DOT AP at a 
ratio of 6: 1 (µl DOT AP: µg pCHl 10). Higher concentrations of DOT AP were 
toxic causing cell death after 24 hours. The transfection efficiencies achieved 
with DMRIE-C were similar, with the maximal transfection efficiency being 0.2% 
using a ratio of 4: 1 (µl DMRIE-C: µg pCHl 10) (data not shown). As these 
delivery methods were very inefficient at transfecting HCll cells in these initial 
observations, they were not persevered with further. 
In addition, HC 11 cells were transfected with the cationic lipid LipofectAMINE 
complexed to the plasmid pCHl 10. The transfection efficiency was optimised 
firstly by varying the ratio of LipofectAMINE: 1 µg pCHl 10 DNA. Transgene 
expression was quantified by the percentage of cells that stained positive for 
f3-galactosidase in situ (Figure 3.JA and Figure 3.2A), or by the total amount of 
f3-galactosidase enzyme activity (Figure 3.2B). Over a range of 
LipofectAMINE: DNA ratios, from 4 - 14 µ1/µg, a maximal transfection 
efficiency of 0.8% was achieved with a ratio of 10: 1 (µl LipofectAMINE: µg 
pCHllO). At this ratio, f3-galactosidase enzyme activity was also highest at 2.12 
x 10-4 Units per microgram of protein (U/µg). 
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Using this fixed ratio of 10: 1 (µl LipofectAMINE: µg pCHllO), the amount of 
DNA and LipofectAMINE delivered per well (of a 6-well culture flask) was then 
altered. As shown in Figure 3.3A, 15 µl LipofectAMINE complexed with 1.5 µg 
pCHllO produced the greatest transfection efficiency of 2.1 % and also the 
greatest enzyme activity of 3.83 x 10-4 Units ~-galactosidase per microgram of 
protein (U/µg) (Figure 3.3B). 
3.2.3 Primary bovine mammary cell transfection 
Primary bovine mammary epithelial cells were difficult to establish and maintain 
in culture. A particular problem was contamination by fibroblast-like cells, which 
could not be avoided during isolation. Selective seeding and trypsinisation 
(described in Chapter Two) did initially provide a more homogeneous population 
of epithelial cells, but their maintenance proved difficult as fibroblasts 
characteristically grew faster than epithelial cells. Nevertheless, these primary 
bovine mammary cells were grown in 6-well culture flasks and then transfected 
with the plasmid pCHllO complexed to LipofectAMINE. The transfection 
efficiency was optimised by varying the ratio of LipofectAMINE: 1 µg pCHl 10 
and transgene expression was quantified by the percentage of cells that stained 
positive for ~-galactosidase expression in situ. It appears that both epithelial-like 
and fibroblast-like cells were transfected (Figure 3.JB). Over a range of 
LipofectAMINE: 1 µg pCHllO ratios from 2 - 12 µ1/µg pCHllO, maximal 
transfection efficiency of 0.3% was achieved with a ratio of 8: 1 (µl 
LipofectAMINE: µg pCHl 10) (Figure 3.4). Concentrations of LipofectAMINE 





Figure 3.1 In situ histochemical stazmng of cells for [3-galactosidase 
expression. (A) HC 11 cells transfected with 15 µl of LipofectAMINE complexed 
to 1.5 µg pCH 110. (B) Primary bovine mammary cells transfected with 8 µl of 
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Figure 3.2 Effect of cationic liposome amount on transfection of HCJ 1 cells. 
Cells were transfected with 1 µg pCHl 10 DNA and various amounts of 
LipofectAMINE then assayed 48 hours post-transfection. Cells expressing 
~-galactosidase were detected either by staining with X-gal to give the percentage 
of cells expressing the transgene (A), or by quantifying total ~-galactosidase 
















































Figure 3.3 Effect of the DNA quantity on transfection of HCJ l cells. Cells were 
transfected with various amounts of pCHl 10 DNA complexed to LipofectAMINE 
at a set ratio of 10: 1, then assayed 48 hours post-transfection. Cells expressing 
~-galactosidase were detected either by staining with X-gal to give the percentage 
of cells expressing the transgene (A), or by quantifying total ~-galactosidase 
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Figure 3.4 Effect of cationic liposome amount on transfection of bovine 
primary mammary cells. Cells were transfected with 1 µg pCHllO DNA and 
various amounts of LipofectAMINE. Cells were assayed 48 hours post-
transfection to detect the percentage of cells expressing ~-galactosidase by 
staining in situ with X-gal. (n = 1). 
3.3 Rat mammary gland transfection in vivo 
Lactating Sprague-Dawley laboratory rats were used in this work to assess the 
potential of liposome-mediated delivery of plasmid DNA to the mammary gland 
in vivo. LipofectAMINE was chosen because use of this reagent resulted in the 
highest transfection efficiency of HC 11 cells in vitro. However, a different 
eukaryotic expression vector, pCS2-CMVlacZ, which contains the ~-galactosidase 
gene driven by the immediate early cytomegalovirus (CMV) promoter, was used. 
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The optimal range of ratios and concentrations of LipofectAMINE and DNA 
applied in vitro, were utilised as an initial guide for in vivo delivery. Transfection 
complexes were prepared as for in vitro experiments with a range of ratios from 
6: 1 to 24: 1 (µl LipofectAMINE: µg pCS2-CMVlacZ), where the amount of DNA 
was either 0.5 or 1 µg. These preparations were diluted into OptiMEM medium to 
a final volume of either 100 or 200 µl and delivered to the third or fourth 
mammary glands of a total of eleven lactating rats, ranging from day seven to 
seventeen of lactation. The delivery route was either specific infusion into the 
mammary gland via the teat canal using a blunt 32-gauge needle, or non-specific 
direct injection into the mammary gland through the wall of the gland. Two days 
after delivery of the transfection complex, rats were sacrificed and mammary 
tissue was isolated and immediately frozen. Cryosections were subsequently 
prepared, mounted on glass slides and stained in situ for J3-galactosidase 
expression and subsequently counter-stained with eosin. 
Positive staining for J3-galactosidase was detected in a very low number of 
epithelial cells. This was observed in mammary gland tissue sections from only 
three out of the eleven animals utilised. These glands had 200 µl of the 
transfection complex containing 0.5 µg of pCS2-CMVlacZ complexed to 3, 6 or 
12 µl LipofectAMINE, delivered either by teat infusion or direct injection. It was 
not possible to estimate the percentage of cells that had been successfully 
transfected, as positive J3-galactosidase staining was very sparse. Therefore, 
transfection efficiency is best described as extremely low (Figure 3.5). 
Interestingly, all three of these animals, which gave positive J3-galactosidase 
staining, were transfected on day 12 or earlier of lactation. Also, positive 
J3-galactosidase expression from the same or adjacent cells was observed on serial 
cryosections, indicating that this positive signal was not a staining artefact (Figure 
3.5A and B). Furthermore, no J3-galactosidase expression was detected in tissue 





Figure 3.5 In situ histochemical staining for {3-ga/actosidase expression in rat 
mammary glands transfected with 0.5 µg pCS2-CMVlacZ complexed to either 
3 µl (A and B) or 12 µI (C) LipofectAMINE. The transfection complex was 
delivered either by infusion through the teat canal (A and B), or by direct injection 
into the gland (C). (250 x magnification). 
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3.4 Discussion 
Of the chemical-mediated delivery techniques considered in this chapter, the 
cationic liposome, LipofectAMINE gave the highest transfection efficiency. 
Although the efficiency of transfection obtained with calcium phosphate 
co-precipitation was comparable to cationic liposome-mediated delivery, it was 
not subsequently used because, firstly, this method was not considered suitable for 
in vivo experiments involving direct delivery to the mammary gland because it is 
gravity-dependant (Keown et al., 1990). Secondly, combined with its technical 
complexities, reproducible results often prove difficult to obtain, with variable 
results commonly due to slight changes in pH (Graham and van der Eb, 1973). 
Additionally, the amount of plasmid DNA required to achieve this level of 
transfection was high. 
HC 11 cells provided the best in vitro model to assess the potential of chemical-
mediated delivery of plasmid DNA to mammary epithelial cells because they are a 
more homogeneous population of epithelial cells and are stable in culture, as 
opposed to primary bovine mammary cells which prove problematic to grow on a 
continuous basis. 
Two conditions were optimised to attain maximal efficiency of transfection in 
HCl 1 cells: the ratio of LipofectAMINE to DNA and the overall concentrations 
of each respective component. The ratio of LipofectAMINE to DNA determines 
the overall charge and size of the complex. Interaction of the complex with the 
cell membrane, and subsequent uptake by endocytosis, depends on this charge 
normally being near neutral. However, different combinations of cationic 
liposomes and plasmid DNA have different charge ratios which are optimal for 
uptake by certain cell types (Tseng and Huang, 1998). The results in this chapter 
demonstrate that a broad range of both LipofectAMINE and plasmid DNA 
concentrations and ratios were effective at achieving transfection of HCll cells. 
Furthermore, different ratios of LipofectAMINE to plasmid DNA were found to 
be optimal for transfecting the Neuro-2a and primary bovine mammary cell lines. 
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Several studies have shown that cellular entry is not the rate limiting molecular 
event of transfection (Zahner et al., 1995; Tseng et al., 1997). Other crucial 
events include, escape of the lipid-DNA complex from the endosome, dissociation 
of the DNA from the lipid, and entry of the DNA into the nucleus (Zahner, 1997). 
Differences in transfection efficiency between Neuro-2a (75% ), HC 11 (2.1 % ) 
primary bovine mammary cells (0.3% ), and other cell lines reported elsewhere 
may reflect differences in the intracellular environment and also unique features 
of each cell line, which may subsequently impact on any one stage of the 
transfection process (Hawley-Nelson and Shih, 1993). It is unclear what stage of 
the transfection process results in the differences seen between cell lines in these 
experiments. 
The level of transfection achieved with LipofectAMINE-mediated delivery of 
plasmid DNA to the rat mammary gland in vivo was extremely low. The reasons 
for this poor efficiency could be numerous. It may be an incompatibility problem 
with LipofectAMINE and the environment encountered in the mammary gland, 
leading to low transfection efficiency. Indeed, when a human growth hormone 
(hGH) reporter construct complexed to LipofectAMINE was delivered to the 
guinea pig mammary gland in vivo by infusion through the teat canal, no hGH 
expression was detected. However the same construct delivered with 
DEAE-dextran, did express hGH at detectable levels (Hens et al., 2000). 
Overall, the efficiency of transfection of mammary epithelial cells achieved both 
in vitro and particularly in vivo, in this chapter using cationic liposome-mediated 
delivery is low. This efficiency needs to be enhanced before this mode of delivery 
could be effectively used in vivo to modify somatic mammary epithelial cells for 
any chosen application. 
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Chapter Four 
Transfection of mammary epithelial cells 
with AA V-based plasmid DNA 
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4.1 Introduction 
The efficiency of transfection of HCll cells in vitro achieved by delivery of 
plasmid DNA with the cationic liposome LipofectAMINE was poor. 
Furthermore, use of LipofectAMINE to deliver plasmid DNA to the rat mammary 
gland in vivo was also very inefficient. The aim of this chapter was to increase 
this transfection efficiency using HC 11 cells in culture as a model. 
One approach to potentially change cationic liposome-mediated transfection 
efficiency is to incorporate the inverted terminal repeats (ITRs) of 
adeno-associated virus (AA V) into the plasmid construct, so that the ITRs flank 
the expression cassette. This hybrid vector technique has previously been shown 
to enhance liposome-mediated transfection efficiency (Philip et al., 1994; Vieweg 
et al., 1995; Fan et al., 1998). 
To utilise this approach in these experiments, the ITRs of AA V were subcloned 
into a plasmid construct so that they flanked an expression cassette, which 
contained the ~-galactosidase reporter gene driven by the immediate early 
cytomegalovirus (CMV) promoter. This construct (pITR-CMVlacZ) and the 
control construct (pCMVlacZ) which was identical except without ITRs, were 
then delivered to HCll cells in vitro using LipofectAMINE. A detailed 
description of how the plasmids were constructed is outlined in Chapter Two. 
Concurrently, an attempt was made to elucidate the mechanism by which the ITRs 
may enhance transfection efficiency. One hypothesis is that the ITRs may 
stabilise expression from the transfected plasmid by facilitating integration into 
the host genome. When wild type AA V infects human cells this integration 
occurs predominantly in a site-specific manner into the AAVSl locus on 
chromosome 19 (Kotin et al., 1990; Kotin et al., 1991; Samulski et al., 1991; 
Kotin et al., 1992). A prerequisite for this site-specific integration is obviously 
the presence of the AA VS 1 locus. Previously it has been shown by Southern 
analysis that the AA VS 1 locus does not exist in any other species, apart from 
human and the green monkey (Samulski et al., 1991). Mouse, rat, dog, cow, 
rabbit, chicken and yeast, along with human and green monkey genomic DNA 
58 
was screened with a 500 bp AAVSl probe. However, more recently it was 
demonstrated using an in vitro model that a 33 nucleotide region of AA VS 1 locus, 
which contains the terminal resolution site (trs) and Rep Binding Element (RBE), 
was the only requirement for site-specific integration to occur into this locus 
(Linden et al., 1996a; Linden et al., 1996b ). Hence, in the present experiments an 
attempt was made to identify if any other species have sequence identity to this 
33 nucleotide sequence. 
4.2 Transient transfection of HCJ J cells with AA V-based plasmid DNA 
To assess the effect of ITRs on transfection efficiency, the two vectors created for 
this work (pCMVlacZ and plTR-CMVlacZ) were delivered to HCl 1 cells in vitro 
using the cationic liposome LipofectAMINE. The transfection conditions for 
HCl 1 cells as optimised in Chapter Three were used to deliver the plasmid DNA. 
HCl 1 cells, seeded in 6-well culture flasks, were transfected with 15 µl 
LipofectAMINE complexed to 1.5 µg plasmid DNA. Transfection efficiency was 
assessed 48 hours after plasmid DNA delivery to cells by fixing the cells in situ 
and histochemically staining with a solution containing X-gal to determine the 
percentage of cells which had expressed 13-galactosidase. For each experimental 
treatment, duplicate wells were transfected. Data presented in Table 4.1 
represents the percentage of cells expressing 13-galactosidase 48 hours post-
transfection, in four separate experiments. 
The average proportion of HCll cells expressing 13-galactosidase from 
pCMVlacZ 48 hours after delivery was 3.1 %. This is a slight, but not significant, 
increase in transfection efficiency over that obtained with the pCHl 10 reporter 
construct, with the same parameters of DNA delivery, in which expression was 
detected in 2.1 % of cells (Chapter Three). The pCHllO plasmid has the 
13-galactosidase reporter gene driven by the SV40 immediate early promoter, as 
opposed to the CMV promoter that drives the 13-galactosidase reporter gene in 
pCMVlacZ. 
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Table 4.1 Percentage of HCJ I cells expressing ~galactosidase 48 hours 
after LipofectAMINE-mediated transfection of an AA V-based plasmid with ITRs 
(pITR-CMVlacZ), compared to the control plasmid without ITRs (pCMVlacZ) 
(mean ± sem) (n = 4 replicate experiments). 
Experiment pCMVlacZ pITR-CMVlacZ Ratio 
(%) (%) 
1 2.8 3.8 1.36 
2 5.8 8.4 1.45 
3 0.7 1.1 1.54 
4 3.2 4.1 1.28 
mean± sem 3.1 ± 1.0 4.4 ± 1.5 1.41 ± 0.06 
The CMV promoter drives constitutive expression in mammalian cells, and is 
regarded as a stronger promoter than the SV40 immediate early promoter, 
resulting in a greater level of expression. This may account for the observed 
increase in the number of cells in which expression was detected. 
When HCll cells were transfected with pITR-CMVlacZ, which has the 
~-galactosidase reporter cassette flanked by ITRs, the average number of cells 
expressing ~-galactosidase 48 hours after delivery was 4.4%. This was a 1.4-fold 
increase over the control construct without flanking ITRs. 
There was high variability in transfection efficiencies between the four replicates. 
There may be several reasons for this variability, which are discussed below. 
However, when the data from each replicate was converted to a ratio, representing 
the percentage of cells expressing ~-galactosidase from the reporter plasmid with 
flanking ITRs (plTR-CMVlacZ) compared to the reporter plasmid without ITRs 
(pCMVlacZ), the increase was consistently 1.4-fold (1.41 ± 0.06). 
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4.3 AAVSJ 
Southern blot analysis was utilised to elucidate whether any other species had 
DNA sequence that is homologous to the minimal 33 nucleotide sequence of 
human AA VS I. Genomic DNA was isolated from mouse, rat, and sheep tissue, 
and human and cow blood. Ten micrograms of each genomic DNA was digested 
with Haelll, fractionated by electrophoresis on a I% T AE agarose gel, transferred 
overnight to Hybond N+ membrane (Amersham) and hybridised to the AAVSl 
oligonucleotide probe (Figure 4.JA). The sequence of the oligonucleotide probe 
was based on the region of human chromosome 19 that has been shown to be an 
essential requirement for site-specific integration to occur and which contains the 
consensus sequences for the trs and RBE (Figure 4.JB) (Linden et al., 1996a). 
The AA VS I oligonucleotide probe used in this chapter is 37 nucleotides in length 
and was based on the sequence of the human AA VS 1 locus published in the 
GenBank database, accession number S51329 (nucleotides 384 to 420) (Kotin et 
al., 1992). This is different to the oligonucleotide sequence published by Linden 
et al. (1996a), which is only 33 nucleotides. The difference exists in the region 
between the trs and the RBE. The GenBank sequence has seven extra nucleotides 
present between the trs and RBE recognition sites, whereas the 33-mer has three 
extra nucleotides 5' to the trs. The authors do not explain these differences in 
sequence. The probe was end-labelled with [a-32P]dCTP and hybridised 
overnight at 60°C. 
The expected fragment size for human genomic digested with Haelll was 106 bp. 
This band is identified in Figure 4.JA by an arrow. There was also fragments of 
similar size which hybridised to this probe present in rat, sheep and cow genomic 
DNA. Furthermore, there was a fragment of approximately 200 bp present in 
mouse genomic DNA. The resolution of the bands detected is poor because of the 
low percentage of agarose gel used for fractionation. 
A 






(A) Southern blot analysis of 10 µg of genomic DNA from 
human, mouse, rat, sheep and cow, digested with HaellI and hybridised to the 
AA VS I oligonucleotide probe. (BJ Sequence of AA VS 1 oligonucleotide probe. 
The trs is underlined and the RBE is shaded. 
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4.4 Discussion 
Inclusion of AA V ITRs within the plasmid DNA flanking the expression cassette 
enhanced the transfection efficiency into HC 11 cells, albeit at a minimal level of 
1.4-fold. In comparison, others have shown that the level of expression from 
constructs containing ITRs can be enhanced. Philip et al. (1994) transfected a rat 
prostate cell line using cationic liposomes complexed to plasmids containing the 
human interleukin-2 cDNA, either with or without AAV ITRs flanking the 
expression cassette. They recorded an increase of up to 10-fold more 
interleukin-2 protein secreted into the media from cells transfected with the 
construct containing ITRs as compared to the construct without ITRs. Likewise, 
Fan et al. (1998) observed increased levels of human apolipoprotein AI (apoAl) 
and lecithin-cholesterol acyltransferase (LCAT) protein expressed in mouse 
C2C12 muscle, or human embryonic kidney 293 cells, when transfected with a 
plasmid that had ITRs flanking the expression cassette, as opposed to a control 
construct without flanking ITRs. Up to 2.8- or 1.6-fold more apoAl, and up to 
3.1- or 3.5-fold LCAT, was secreted into the culture media during the 48 hours 
following transfection of the C2C12 or 293 cells respectively. Neither of these 
studies quantified transfection efficiency as a percentage of cells that expressed 
detectable levels of the transgene for both the ITR containing plasmid and the 
control plasmid. Therefore, it is possible that the number of cells that had taken 
up and expressed the plasmid DNA was similar for both the ITR and control 
construct. This would suggest that the ITRs have enhanced gene expression from 
the plasmid and hence increased the amount of protein produced per cell. 
Alternatively, the amount of protein detected may have been enhanced by an 
increase in the total number of cells transfected. The authors suggest that this 
enhancement may be due to ITRs potentially facilitating nuclear entry and 
retention of the delivered plasmid DNA. A combination of both enhanced DNA 
delivery and expression is also possible. The mechanism by which the ITRs have 
caused an increase in transfection efficiency, as measured by the number of cells 
expressing detectable levels of the J3-galactosidase reporter gene, in the 
experiments described in this chapter is unknown. The amount of J3-galactosidase 
protein produced per cell was not quantified. 
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Variability in transfection efficiency can be the result of several factors. 
Excessive freeze/thaw cycling can lead to degradation of plasmid DNA, which 
may in tum reduce transfection efficiency. The results presented here, which 
were performed chronologically, are variable rather than just decreasing, 
suggesting that this is not the reason for variability in these experiments. Others 
have also observed large variations in transfection efficiencies. Boussif et al. 
(1995) transfected NIH3T3 or HepG2 cell lines with a luciferase reporter 
construct complexed with polyethylenimine. They noted that absolute values 
varied sometimes within an order of magnitude, depending on plasmid batch and 
the history of the cells, whereas relative values stayed within a factor of two. 
Additionally, NIH3T3 cells have been shown to have variable transfection 
efficiencies with different age of the culture. Cells that had either been freshly 
thawed, or in culture for 8 passages, before transfection with identical conditions 
resulted in a two-fold difference in efficiencies, with older cells being transfected 
less efficiently (Hawley-Nelson et al., 1993). The same batch preparation of each 
plasmid was used for all experiments in this chapter. However, one possible 
reason for the observed variations may be the cell history. The passage number 
was maintained between 9 and 18 for all transfections, however the exact passage 
number for each experiment was not recorded. 
Hybridisation products were identified in mouse, rat, sheep and cow genomic 
DNA as well as human DNA, when probed with the AAVSl oligonucleotide. 
This suggested that sequence with identity to the minimal 33 nucleotide region of 
the human AA VS 1 locus exist in these other species. However, the extent of this 
homology could not be determined from this result alone, and further analysis at 
the sequence level would be required to determine the exact identity of these 
possible homologous sites. 
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Chapter Five 
Analysis of integration frequencies following 
AA V-based plasmid DNA transfection 
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5.1 Introduction 
The results presented in Chapter Four indicated that the presence of AA V ITRs 
flanking a ~-galactosidase expression cassette enhanced transient transfection 
efficiency of liposome-mediated plasmid DNA delivery to HCll cells. It was 
also of interest to investigate whether the mechanism of transgene integration was 
altered due to the inclusion of ITRs in the construct. To assess whether the ITRs 
affect the stability of transgene expression, a selection regime was used whereby 
the neomycin resistance gene was inserted into an expression construct flanked by 
ITRs (plTR-neo-tk). The drug 0418 was then used to identify the cells that 
expressed this selectable marker. 
The frequency of integration was quantified by comparing the number of 0418 
resistant colonies that had formed from cells transfected with this construct 
(plTR-neo-tk) with the number of colonies resulting from cells transfected with a 
control neomycin construct without flanking ITRs (pneo-tk). Moreover, an AA V 
Rep78 and/or Rep68 protein expression construct (pHIVrep) (Antoni et al., 1991) 
was co-transfected together with these neomycin constructs. The Rep78 and 
Rep68 AA V proteins have been extensively characterised and are essential for 
wild type AAV DNA replication (Labow and Berns, 1988). These Rep proteins 
are also essential for site-specific integration into the AA VS 1 locus on human 
chromosome 19 (Surosky et al., 1997). In the absence of Rep78 or Rep68 protein, 
DNA flanked by ITRs will still integrate into the host genome, but the integration 
is at random sites (Xiao et al., 1997). Therefore, pHIVrep was included to assess 
whether Rep78 and/or Rep68 had any effect on integration and whether Rep-
mediated site-specific integration occurred in these experiments. 
The expression vector, plTR-neo-tk, was created for this work as was the control 
plasmid without ITRs, pneo-tk. A full description of their construction is given in 
Chapter Two. The vector pBR322 (which makes up the plasmid backbone of 
pHIVrep) was also co-transfected with the neomycin selection constructs as a 
negative control for pHIVrep (Table 5.1). Furthermore, the 0.5 µg of plasmid 
pCHl 10 was included in all transfections as a control for any variation in 
transfection efficiency. 
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Table 5.1 Plasmid combinations transfected into cell lines for selection. 
Plasmids Summary 
I pneo-tk pBR322 - ITR - rep 
II plTR-neo-tk pBR322 + ITR - rep 
III pITR-neo-tk pHIVrep + ITR + rep 
IV pneo-tk pHIVrep - ITR + rep 
Two cell lines were transfected with these plasmids; the mouse mammary 
epithelial cell line HCll and the human embryonic kidney cell line HEK-293 
(Graham et al., 1977). HCll cells were used as an in vitro model in this study for 
liposome-mediated transfection. HEK-293 cells are a human cell line in which 
site-specific integration into AA VS 1 following AA V-mediated plasmid DNA 
transfection has previously been demonstrated and were included in these 
experiments as a positive control for such an event (Shelling and Smith, 1994; 
Pieroni et al., 1998). LipofectAMINE was used to deliver the DNA using the 
optimised transfection conditions described in Chapter Three for HCl 1 cells, and 
as described by Life Technologies for HEK-293 cells 
(www.lifetechnologies.com). Transfection and selection procedures are outlined 
in Chapter Two. 
The selection constructs created for this study with ITRs flanking the neomycin 
resistance gene also had the Herpes simplex virus thymidine kinase (HSV-tk) gene 
on the plasmid backbone. This allowed investigation into whether excision of the 
neomycin resistance gene from the transfected plasmid had occurred during 
integration. When selected with 0418, colonies that express the neomycin 
resistance gene survive. When these colonies are subsequently selected with the 
drug FIAU, colonies that do not express the HSV-tk will survive. Hence this 
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positive-negative selection assay was aimed to identify colonies which have lost a 
functional copy of the HSV-tk gene from the plasmid backbone. 
When selected with 0418, each individual countable colony represents the 
successful transfection and subsequent stable integration and expression of the 
neomycin resistance gene in to a single cell that maintains its colony forming 
ability. If FIAU is included in the selective medium along with 0418, colonies 
will only develop from single cells where the neomycin resistance gene and not 
the HSV-tk gene has been integrated. Raw colony numbers varied between 
replications due to different seeding dilutions and also because of variation in 
transfection efficiency. However, as these two parameters were constant within 
replicates, data was converted to ratios allowing comparison between 
experimental days. 
For selection with 0418, a value of 1.0 was used to represent the number of 
colonies resulting from transfection of the control plasmid combination pneo-tk + 
pBR322 (- ITR - rep). Ratios for the remaining three plasmid combinations were 
calculated by comparing the colony numbers for each, to the colony numbers for 
control plasmids. For selection with 0418 and FIAU, ratios were calculated for 
each plasmid combination by comparing the number of colonies resulting from 
selection with 0418 and FIAU to the number of colonies resulting from 0418 
selection only. 
The minimum lethal dose of 0418 was determined for both HCll and HEK-293 
cells. The 0418 concentrations that resulted in zero percent cell survival are 
summarised in Table 5.2. At lower concentrations, cell survival was not visibly 
affected (data not shown). The 0418 minimum lethal dose was 175 µg/ml and 
250 µg/ml for HCl 1 and HEK-293 cells respectively. 
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Table 5.2 G418 minimum lethal dose for HCJJ and HEK-293 cells. Survival 
of HCl 1 and HEK-293 cells after 14 days growth in the presence of G418 (µg/ml 
active concentration), expressed as a percentage of the total number of cells that 
survive (representative data from one of several experiments). 
G418 HCll HEK-293 
(µg/ml) (% survival) (% survival) 
125 30 95 
150 5 50 




A FIAU concentration of 0.2 µM was used to select HCll and HEK-293 cells. 
This concentration was not toxic to wild type HCll or HEK-293 cells, with no 
cell death observed over a period of 14 days growth. However, cells expressing 
thymidine kinase were killed at this concentration. 
5.2 Transfection and selection of HCJ 1 cells 
HCll cells were transfected with the four combinations of plasmid DNA as 
summarised in Table 5.1, using LipofectAMINE with conditions that had been 
optimised as described in Chapter Three. Cells were then cultured in selection 
media containing, either G418 (175 µg/ml) or G418 (175 µg/ml) and FIAU (0.2 
µM), until discrete colonies were visible (14-20 days post-transfection). Colonies 
were counted and raw data was converted to ratios as described above. This 
transfection and selection regime was performed on four separate occasions. 
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The data presented in Table 5.3 summarises colony number ratios following 0418 
selection. They suggest that when the neomycin resistance gene was flanked by 
ITRs (pITR-neo-tk + pBR322), the integration frequency was not significantly 
different from the control without ITRs (pneo-tk + pBR322) (P=0.87). Similarly, 
when the rep gene was co-transfected with the neomycin resistance gene, either 
flanked by ITRs (pITR-neo-tk + pHIVrep) or without flanking sequences (pneo-tk 
+ pHIVrep), there was no significant difference in integration frequencies 
compared to the control (P=0.37 and 0.32 respectively). 
The data presented in Table 5.4 summarises colony number ratios following 0418 
and FIAU selection. All the colonies that grew when selected with 0418 and 
FIAU have the neomycin resistance gene integrated into their genome, and only 
those colonies which do not have the HSV-tk gene integrated will grow. With the 
control plasmid combination (pneo-tk + pBR322) approximately 60% of 
integration events were of this kind. When the neomycin resistance gene flanked 
by ITRs (plTR-neo-tk) was co-transfected with the rep gene construct (pHIVrep) 
or its control (pBR322), the percentage of integration events of this type (where 
the HSV-tk gene is lost) was not significantly different from that of the control 
plasmid combination (P=0.57 and 0.70 respectively). Co-transfection of the 
neomycin resistance gene construct without flanking ITRs (pneo-tk), with the rep 
gene construct (pHIVrep) also resulted in no significant change in the percentage 
of integration events where the HSV-tk gene is lost, compared to the control 
plasmid combination (P=0.52). 
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Table 5.3 Effect of ITRs and rep on the frequency of plasmid DNA 
integration into the HCJ J genome. Ratios represent the relative numbers of 
neomycin resistant HCll colonies derived from transfection of plasmids 
containing various combinations of ITR and rep, compared to the control plasmid 
transfection (mean ± sem) (n = 4 replicate experiments). 
Experiment 
1 2 3 4 mean ratio± sem 
pneo-tk + pBR322 1.0 1.0 1.0 1.0 1.0 
plTR-neo-tk + pBR322 0.45 1.16 0.97 1.29 0.97 ± 0.19 
pITR-neo-tk + pHIVrep 1.06 0.91 0.40 1.00 0.84 ± 0.15 
pneo-tk + pHIVrep 1.16 0.77 0.46 0.92 0.83 ± 0.15 
Table 5.4 Effect of ITRs and rep on the nature of plasmid DNA integration 
into the HCJ l genome. Ratios represent the number of neomycin resistant/FIAU 
sensitive colonies relative to the total number of neomycin resistant colonies for 
HCll cells transfected with each plasmid combination (mean ± sem) (n = 4 
replicate experiments). 
Experiment 
1 2 3 4 mean ratio± sem 
pneo-tk + pBR322 0.33 0.86 0.28 0.81 0.57 ± 0.15 
pITR-neo-tk + pBR322 0.69 0.87 0.37 0.65 0.65 ± 0.10 
pITR-neo-tk + pHIVrep 0.70 0.83 0.48 0.69 0.68 ± 0.07 
pneo-tk + pHIVrep 0.45 1.22 0.44 0.83 0.74 ± 0.19 
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5.3 Transfection and selection of HEK-293 cells 
HEK-293 cells were exposed to a similar experimental regime to that used for 
HCl 1 cells. They were transfected with the four combinations of plasmid DNA 
as summarised in Table 5.1, using LipofectAMINE with optimised conditions as 
described previously by Life Technologies GIBCOBRL. Cells were then selected 
with either 0418 (250 µg/ml) alone, or 0418 (250 µg/ml) plus FIAU (0.2 µM) 
until discrete colonies were visible (14-20 days post-transfection). Colonies were 
counted and raw data was converted to ratios as described above. This selection 
of HEK-293 cells was attempted five times but it was only possible to count 
colony numbers twice. Determining a dilution that allowed discrete colony 
formation was difficult. For the unsuccessful attempts, the cell densities reached 
confluence prior to completion of the selection regime hence it was not possible to 
differentiate individual resistant colonies for counting. In contrast, with sparse 
seeding, cell growth and subsequent colony formation was very slow. 
The data presented in Table 5.5 summarises colony number ratios following 0418 
selection and data in Table 5.6 summarises colony number ratios following 0418 
and FIAU selection. There is high variation between the two replicates. Colony 
counts for the first set of recorded data were below 100 colonies per plate for 
0418 selection and less than 40 colonies per plate for 0418 plus FIAU selection. 
Colony numbers were all greater than 200 per plate for the second replicate. 
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Table 5.5 Effect of ITRs and rep on the frequency of plasmid DNA 
integration into the HEK-293 genome. Ratios represent the relative numbers of 
neomycin resistant HEK-293 colonies derived from transfection of plasmids 
containing various combinations of ITR and rep, compared to the control plasmid 
transfection (mean± sem) (n = 2 replicate experiments). 
Experiment 
1 2 mean ratio ± sem 
pneo-tk + pBR322 1.0 1.0 1.0 
pITR-neo-tk + pBR322 1.00 1.18 1.09 ± 0.09 
pITR-neo-tk + pHIVrep 2.50 0.76 1.63 ± 0.87 
pneo-tk + pHIVrep 2.72 0.86 1.79 ± 0.93 
Table 5.6 Effect of ITRs and rep on the nature of plasmid DNA integration 
into the HEK-293 genome. Ratios represent the number of neomycin 
resistant/FIAU sensitive colonies relative to the total number of neomycm 
resistant colonies for HEK-293 cells transfected with each plasmid combination 
(mean ± sem) (n = 2 replicate experiments). 
Experiment 
1 2 mean ratio± sem 
pneo-tk + pBR322 0.31 0.60 0.46 ± 0.15 
pITR-neo-tk + pBR322 0.50 0.51 0.51 ± 0.01 
pITR-neo-tk + pHIVrep 0.19 0.73 0.46 ± 0.27 
pneo-tk + pHIVrep 0.36 0.65 0.51 ± 0.15 
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5.4 Rep expression from transfected HCJ 1 cells 
Northern blot analysis was used to confirm that the pHIVrep construct was 
expressed in the transfected HCll cells used in this study. Forty-eight hours 
following transfection with pHIVrep, total RNA was isolated and 15 µg was 
fractionated by formaldehyde/agarose gel electrophoresis, transferred to Hybond 
membrane and hybridised to a 508 bp probe specific to the rep coding sequence. 
The expected size of rep mRNA transcribed from pHIVrep plasmid is 3 kb. The 
arrow in Figure 5.1 identifies this hybridisation band. There is extensive 
background hybridisation below 3 kb. The 28S and 18S rRNA bands were clearly 
visible on the ethidium bromide stained gel, which suggested that the RNA was 
not degraded. The background smear was attributed to contamination of the RNA 
with degraded plasmid DNA. The pHIVrep construct has been previously 
demonstrated by Northern blot analysis to be transcribed successfully in HEK-293 
cells (Antoni et al., 1991 ). 
5.5 Discussion 
Until the present study, the effect of ITRs and the Rep 78 and/or Rep68 protein on 
integration frequencies of AA V-based plasmid DNA into the mouse genome has 
not been thoroughly characterised. Analysis of the colony number ratios 
following transfection of HCll cells with plasmids containing the neomycin 
resistance gene, with or without flanking ITRs, and selection with 0418, indicated 
that the ITRs had no significant effect on the integration frequency of the 
neomycin resistance gene into mouse genomic DNA. This is in contrast with the 
findings of Vieweg et al. (1995). They transfected a rat prostate tumour cell line 
with constructs containing the neomycin resistance gene either without, or flanked 
by, ITRs and observed a "marked increase" increase in the number of 0418 
resistant colonies when the construct contained ITRs. However, it is difficult to 
make a direct comparison in their study between the ITR containing construct and 
controls without ITRs, as they were driven by different promoters, and exact 





Figure 5.1 Northern blot analysis of pHIVrep expression in HCJ 1 cells. 
Total RNA (15 µg) , isolated from non-transfected (lane 1) or pHIVrep transfected 
(lane 2) HC 11 cells, was fractionated by agarose gel electrophoresis, transferred to 
Hybond membrane and hybridised to a 508 bp rep specific probe. The position of 
the 28S and l 8S rRNA bands are indicated. The arrow identifies the 3 kb rep 
mRNA. 
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Moreover, co-transfection in this study of a Rep78 and/or Rep68 protein 
expression plasmid with the plasmids containing the neomycin resistance gene, 
either with or without flanking ITRs, resulted in no significant change in the 
colony number ratios between those HCll cells which received the rep plasmid 
and their respective controls. This suggests that Rep78 and/or Rep68 protein had 
no effect on the frequency of integration into HCl 1 cell genomic DNA. However, 
although expression from this rep construct was confirmed by Northern analysis, 
the presence of Rep78 and/or Rep68 protein was not confirmed. Therefore a role 
for the Rep78 and/or Rep68 protein for plasmid DNA integration into this mouse 
cell line cannot be excluded based on the data presented here. This could possibly 
be further elucidated by the addition of purified Rep78 and/or Rep68 protein at a 
range of concentrations directly to cells during transfection, followed by analysis 
of integration frequencies. 
Unfortunately, the data presented in this study from transfection and selection of 
HEK-293 cells could not be analysed because of the high variation and low 
number of replicates. This is a limitation of this assay with HEK-293 cells 
because cell growth under selection with 0418 is highly sensitive to seeding 
density. 
Previous studies of liposome-mediated delivery of AAV-based plasmid DNA with 
HEK-293 cells have not attempted to investigate the effect of ITRs and rep on 
integration frequency as compared to a control. Rather, they have focussed on 
achieving long term expression and identifying the site of integration (Shelling 
and Smith, 1994; Pieroni et al., 1998). 
The second objective of the experiments described in this chapter was to assess 
whether ITRs flanking the neomycin resistance gene and/or the presence of rep 
leads to selective excision of this transgene from the plasmid backbone and 
integration into the HCll cell genome. It was of interest to ascertain, firstly 
whether such an event may occur in this in vitro mouse model, and secondly, if 
so, whether there is specificity in the site of integration similar to what has been 
characterised in human cells (Surosky et al., 1997). 
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In all examples of the different vector combinations co-transfected into HCl 1 
cells (+/- ITR and +/- rep), approximately 60% of G418 resistant colonies were 
also FIAU resistant. Thus, in approximately one half of the integration events 
where the neomycin resistance gene is incorporated into the genome, a functional 
copy of the HSV-tk gene has also been integrated. This suggests that the 
integration event is random and not related to the presence of ITRs or rep. 
However, additional evidence, related to the molecular events involved in 
integration, is required before a conclusion can be drawn. 
In a similar experiment, Tsunoda et al. (2000) reported a comparable proportion 
of colonies integrating both a selectable marker, which was flanked by ITRs, and 
a reporter gene cassette on the plasmid backbone. They transfected HeLa cells 
with a construct that contained the neomycin resistance and rep genes flanked by 
ITRs, and the 13-galactosidase gene on the plasmid backbone. HeLa cells, which 
had integrated the neomycin resistance gene, were identified by selection with 
G418. From over four thousand G418 resistant colonies assayed, 51 % also 
expressed 13-galactosidase. 
Tsunoda et al. (2000) also transfected HeLa cells with a plasmid containing the 
rep and neomycin resistance genes flanked by ITRs and a hygromycin resistance 
gene outside of the ITRs. They observed, by Southern analysis, that of the 22 
neomycin resistant clones analysed where site-specific integration into AAVSl 
was observed, 20 (91 % ) also had the plasmid backbone integrated, hence excision 
of DNA flanked by ITRs had not occurred. Furthermore, of these 22 neomycin 
resistant clones, 21 were also hygromycin resistant, confirming that a functional 
hygromycin resistance gene was present. These finding are also supported by the 
work of Surosky et al. (1997). They co-transfected a 13-galactosidase reporter 
construct with flanking ITRs together with a rep expression construct into 
HEK-293 cells. Southern blot analysis determined that both the 13-galactosidase 
gene and plasmid backbone sequences had integrated in six out of seven clones 
analysed where integration into AAVSl was observed. In contrast, evidence also 
exists which suggests that excision of genes flanked by ITRs does occur following 
transfection of human cell lines. These other studies have demonstrated that the 
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plasmid backbone sequences were not integrated along with ITR flanked 
sequences site-specifically into AAVSl (Shelling and Smith, 1994; Balague et al., 
1997; Pieroni et al., 1998). These conflicting data suggests that !TR-mediated 
selective excision from plasmid DNA may be more complicated than initially 
suggested, and requires further investigation. 
This study is the first to analyse the frequency of integration resulting from 
liposome-mediated delivery of AAV-based plasmid DNA versus non-AAV 
plasmid DNA. The results suggest that the ITRs or expression of the rep gene do 
not have any effect on the integration frequency or the nature of integration of the 
transgene into the HCl 1 (mouse) genome. There was high variation in the 
integration frequencies presented in this in vitro assay, with no clear differences or 
trends to indicate that the ITRs and/or rep were having any effect at the molecular 
level. This result may reflect a fundamental difference between the human and 
mouse genomes. Nevertheless, any enhancement of integration frequency would 
be beneficial to achieve longer-term expression from a transgene and further work 
can therefore be justified. Analysis with delivery of purified Rep78 and/or Rep68 
protein could assist in understanding its effect on integration of AA V-based 
plasmid DNA into the genomic DNA of species other than human. 
Since no significant differences were observed in the integration frequencies using 
this positive-negative selection assay, no assumptions about the site of integration 
could be made from this data. Southern blot analysis and sequencing of the 
integration junctions is required in order to determine if ITRs and/or rep have an 
effect on the site of transgene integration in the HCll genome. These 
experiments are described in Chapter Six. 
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Chapter Six 
Analysis of integration sites following 
AA V-based plasmid DNA transfection 
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6.1 Introduction 
The results presented in Chapter Five indicated that the ITRs, or expression of the 
rep gene do not have a detectable effect on the frequency of integration into the 
HCll (mouse) genome. The objective of this chapter was to analyse the effect 
ITRs and expression of the rep gene have on the site of integration into the mouse 
HCl 1 cell genome, and into the human HEK-293 cell genome. 
To obtain information about the site of integration, two approaches were used. 
Firstly, Southern blot analyses were performed to confirm that the neomycin 
transgene was integrated into the genome and to identify any common 
hybridisation patterns amongst the different clones. Secondly, characterisation of 
the integration junctions was attempted by PCR amplification, subcloning and 
sequencing of these regions. 
6.2 Southern blot analysis of plasmid integration into HCJ 1 genomic DNA 
HC 11 cells were co-transfected with two different plasmid combinations, pneo-tk 
and pBR322 (-ITR - rep) or pITR-neo-tk and pHIVrep (+ITR + rep), and were 
then selected with 0418 to identify the presence of the neomycin resistance gene. 
Several individual colonies were isolated and expanded as clonal cell lines. 
Genomic DNA was prepared from each clonal line as described in Chapter Two. 
This DNA was digested with Hindlll, fractionated by agarose gel electrophoresis, 
transferred to Hybond N+ membrane and hybridised at 65°C to a 703 bp 
neomycin resistance gene probe. Digestion of genomic DNA with Hindlll was 
chosen because no sites for this restriction endonuclease are present in either of 
the DNA constructs (pneo-tk or pITR-neo-tk). Thus, the neomycin specific probe 
will detect Hindlll fragments encompassing integrated plasmid plus flanking 
genomic sequence. 
Approximately 10 µg of genomic DNA from each of 12 individual clonal cell 
lines, transfected with pneo-tk and pBR322, was subjected to Southern analysis 
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(Figure 6.1). The neomycin specific probe hybridised to all clones (lanes 1-12). 
Hybridising bands ranged in size from 1.6 kb to greater than 12 kb (summarised 
in Table 6.1). Genomic DNA from non-transfected HCl 1 cells was also included 
(lane 14). No hybridisation to this control was detected. 
Fifteen individual clonal lines transfected with pITR-neo-tk and pHIVrep were 
subjected to Southern analysis as described above (Figure 6.2). Neomycin probe 
hybridisation was detected with all clones, except 3a-15 (lane 15). Hybridisation 
bands ranged in size from 1.5 kb to greater than 12 kb (summarised in Table 6.2). 
No hybridisation to the HCl 1 genomic DNA control was detected (lane 16). 
For bands greater than 12 kb, distinct bands could be resolved, such as in 
Figure 6.2, lanes 3 and 4, however accurate size estimation of these larger 
fragments was not possible on these gels. These bands probably ranged in size 
from 14 to 30 kb. 
The umque pattern of hybridising bands shown by each individual clone in 
Figures 6.1 and 6.2 can be interpreted to mean either that the site of integration is 
different for each clone, or that multiple copies (or part there of) have been 
integrated. The latter possibility would arise as a result of concatemers of head-
to-head, head-to-tail, tail-to-tail or a combination of all three arrangements of all 
or part of the transfected plasmid. It cannot be determined from these results 
whether bands of similar size represent integration of the plasmid DNA into the 
same genomic site. While further Southern analysis with several different 
restriction endonuclease digestions might be expected to elucidate this, such 
experiments still tend to be inconclusive in practice. 
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Figure 6.1 Southern blot analysis of G418 resistant clones derived from 
HCJ l cells co-transfected with the plasmids pneo-tk and pBR322 (lanes 1-12). 
Transfection and selection was carried out as described in Chapter Two. Ten µg 
of genomic DNA was digested with Hindlll, fractionated on a 0.8% agarose gel, 
transferred to Hybond N+ membrane and hybridised at 65°C with a 703 bp 
neomycin gene specific probe. Lane 14 contains Hindlll digested genomic DNA 
from non-transfected HC 11 cells. Molecular size markers (M) are as shown (in 
kb). 
lane 
M 1 2 3 4 s 6 7 8 9 10 11 12 - 14 










Figure 6.2 Southern blot analysis of G418 resistant clones derived from 
HCJ 1 cells co-transfected with the plasmids pITR-neo-tk and pHIVrep (lanes 
1-15). Transfection and selection was carried out as described in Chapter Two. 
Ten µg of genomic DNA was digested with Hindlll, fractionated on a 0.8% 
agarose gel, transferred to Hybond N+ membrane and hybridised at 65°C with a 
703 bp neomycin gene specific probe. Lane 16 contains Hindlll digested genomic 
DNA from non-transfected HC 11 cells. Molecular size markers (M) are as shown 
(in kb). 
lane 
M 1 2 3 4 5 6 7 8 9 to 11 12 13 14 15 16 
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Size estimation of hybridisation products detected by Southern blot 
analysis of HCI I cells co-transfected with pneo-tk and pBR322. 










la-12 5.7, 1.6 
la-14 9.5, 2.6 
la-15 8.5, 2.3 
no DNA 
HCl 1 (non-transfected) 
Size estimation of hybridisation products detected by Southern blot 
analysis of HCI I cells co-transfected with p/TR-neo-tk and 
pH/Vrep. 
Clone Hybridisation band size (kb) 
3-6 >12 
3-10 >12 (2 bands) 
3a-l >12 (3 bands), 7.2, 3 
3a-2 > 12 (3 bands), 8, 2.4 





3a-10 >12, 10 





HCl 1 (non-transfected) 
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6.3 Southern blot analysis of plasmid integration into HEK-293 genomic DNA 
HEK-293 cells were co-transfected with the same two plasmid combinations used 
to transfect HCl 1 cells; pneo-tk and pBR322 (-ITR - rep) or pITR-neo-tk and 
pHIVrep (+ITR + rep). Cells were then selected with 0418 to identify the 
presence of the neomycin resistance gene. Several individual colonies were 
isolated and expanded as clonal cell lines. Genomic DNA was prepared from 
each clonal line as described in Chapter Two. Approximately 10 µg of genomic 
DNA was digested with Hindlll, fractionated by agarose gel electrophoresis and 
transferred to Hybond N+ membrane for Southern hybridisation. Eight clonal 
lines transfected with pneo-tk and pBR322 (lanes 1-8), and seven clonal lines 
transfected with pITR-neo-tk and pHIVrep (lanes 11-17) were analysed. Genomic 
DNA from non-transfected HEK-293 cells was also analysed (lane 10) 
(Figure 6.3). 
This membrane was hybridised at 65°C to a 703 bp neomycin resistance gene 
probe (Figure 6.3A). Hybridisation bands of a range of different sizes were 
detected in lanes 1, 2, 3, 4, 7, 8, 13, 14, 16 and 17. No hybridisation in lanes 5, 6, 
11, 12 and 15, or the HEK-293 genomic DNA control in lane 10, was detected. 
Subsequently, this membrane was stripped then hybridised at 65°C to a 623 bp 
human AA VS 1 probe (Figure 6.3B). As HindITI does not have a restriction site 
within the 4067 bp published region of AA VS 1 (GenBank Accession number 
S51329), the size of the expected hybridisation product was unknown. However, 
a specific band was present in the HEK-293 genomic DNA control (lane 10) 
(highlighted with an arrow in Figure 6.3B). This band was also detected in lanes 
1, 2, 3, 4, 11, 12 and 14. Additionally, secondary hybridisation products, which 
were larger in size compared to the control band, were detected in lanes 1, 2, 3, 4 
and 14. 
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Figure 6.3 Southern blot analysis of G418 resistant clones derived from 
HEK-293 cells co-transfected with the plasmids pneo-tk and pBR322 (lanes l-8) 
or plTR-neo-tk and pHIVrep (lanes 11-17). Transfection and selection was 
carried out as described in Chapter Two. Ten µg of genomic DNA was digested 
with HindIII, fractionated on a 0.8% agarose gel, transferred to Hybond N+ 
membrane and hybridised at 65°C with either a 703 bp neomycin gene specific 
probe (A), or a 623 bp human AA VS I specific probe (8). Lane 10 contains 
HindIH digested genomic DNA from non-transfected HEK-293 cells. Lane 9 had 
no ON A loaded. 
lane 
M - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 - M 
wells -
A 





6.4 Amplification of integration junctions in HCJ I clones by Siebert PCR 
The site of plasmid DNA integration into the HCl 1 genomic DNA was 
determined using a modified PCR technique based on the published method of 
Siebert et al. (1995). In this procedure flanking regions of integrated DNA are 
amplified, subcloned and sequenced. This method allows 'genome walking' into 
unknown regions adjacent to known sequence using a combination of 'vectorette' 
and 'suppression' PCR. It is based on 'adaptor' ligation and subsequent 
amplification using two rounds of PCR, firstly with adaptor specific and gene 
specific primers and, secondly, with nested primers to the same targets. This 
approach has the potential to reveal the specific site of integration. 
Genomic DNA was digested with Seal, and the 'adaptor' was ligated to the DNA 
ends. The Seal restriction endonuclease was chosen because it is a six base cutter 
which generates blunt ends (important for blunt adaptor ligation) and no sites exist 
for it in either of the plasmids pneo-tk or pITR-neo-tk (confirmed by restriction 
endonuclease digestion and sequence analysis; data not shown). 
Genomic DNA, isolated from clonal cell lines from each of the four different 
plasmid combinations transfected into HCll cells described in Table 5.1, was 
used as template DNA for 'Siebert' PCR. In total, 12 clonal cell lines were used 
with three clones per plasmid combination. Two control reactions containing 
non-transfected HCl 1 genomic DNA were also included. (i) Seal digested which 
had the adaptor ligated to it (HA), and (ii) undigested HCl 1 genomic DNA (He). 
PCR amplifications were performed as described in Chapter Two. Primary 
reactions were conducted with the adaptor primer APl and the gene specific 
primers neo3341 or neo3392. A secondary reaction was conducted with products 
from the primary PCR as template DNA using the adaptor primer AP2 and the 
nested gene specific primer neo3608. Products from primary and secondary PCR 
reactions were subjected to agarose gel electrophoresis, transferred to Hybond N+ 
membrane and hybridised to the neomycin specific oligonucleotide, neo3685. 
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6.4.1 Primary PCR amplification 
Four different templates were utilised for the first attempt at 'Siebert' PCR. They 
were HCl 1 clones lb-1, 2b-10, 3b-3 and 4b-5 (designated the names Sample 1, 2, 
3 and 4 respectively). Figure 6.4 shows the result from the primary round of 
amplification. As seen in panel A, a background smear from approximately 
200 bp to greater than 5 kb was visible in all samples. This was produced by non-
specific annealing of the primers to the template DNA. A distinct product of 
approximately 1.8 kb was clearly visible in Samples 2, 3 and 4 amplified with 
AP1-neo3341 and in Samples 3 and 4 amplified with AP1-neo3392 primer pairs 
respectively. This product was present in all four Samples, and HCl 1 DNA 
ligated to the adaptor (HA), but not in the HCl 1 control DNA (He) (not visible in 
photograph). Another product of approximately 1.5 kb could also be seen in the 
same samples. As these bands were present in the control (HA) sample, they were 
interpreted as non-specific artefacts (see discussion). No products were detected 
from amplification of the HCll undigested control DNA (He) or the no DNA(-) 
control. 
When transferred to Hybond N+ membrane and hybridised to the neomycin 
specific oligonucleotide neo3685, several hybridisation products were seen when 
the primary amplification was with APl and neo3341 primers. They ranged in 
size from approximately 400 bp to 1.2 kb in all four templates. Interestingly, the 
neo3685 oligonucleotide did not hybridise to any products from amplification 
with the AP1-neo3392 primer pair. Furthermore, no hybridisation products of 
1.8 kb or 1.5 kb were seen, confirming that the bands seen in panel A were non-
specific artefacts (Figure 6.4B). 
6.4.2 Secondary PCR amplification 
The primary PCR amplification products were diluted 100-fold in TE buffer and 
used as template DNA for the secondary amplification using the nested primers, 
AP2 and neo3608. All conditions were the same as for the primary reactions, 
except that the number of thermocycles was reduced from 35 to 20. 
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Figure 6.4 Siebert primary PCR amplification products - Samples I - 4. 
(A) 1 % agarose gel stained with ethidium bromide. (B) Agarose gel from panel A 
transferred to Hybond N+ membrane and hybridised to the neo3685 
oligonucleotide. Genomic DNA from non-transfected HC 11 cells (HA), and G418 
resistant HC 11 clones 1 b-1 (Sample I), 2b-10 (Sample 2), 3b-3 (Sample 3), 4b-5 
(Sample 4) were prepared for Siebert PCR by digestion with Seal and ligation 
with the adaptor. These templates were then subjected to PCR using the methods 
described in Chapter Two. The primers APl and either neo3341, or neo3392 
were used to amplify template DNA. Control reactions in lane "He" and "-" 
contain undigested HC 11 genomic DNA and no DNA respectively. The DNA 





















AP! + neo3341 AP! + neo3392 
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Following agarose gel electrophoresis, a background smear was detected by 
ethidium bromide staining in all samples (except the negative controls "He" and 
"-"). Several PCR products specific to individual clones could also been seen 
(Figure 6.5A). Products of approximately 950 bp and 550 bp were distinctly 
visible in Sample 1, which was amplified initially with APl and neo3341. These 
two bands also hybridised to the neo3685 oligonucleotide, confirming that they 
contain plasmid sequences (Figure 6.5B). None of the other bands that were 
visible by ethidium bromide staining were detected by Southern hybridisation. 
The 950 bp and 550 bp products from Sample 1 were subjected to further analysis. 
A further eight templates were prepared for a second attempt at 'Siebert' PCR; 
HCl 1 clones la-1, 2a-l, 3a-3, 4a-l, lb-2, 2b-8, 3b-4 and 4b-6 (designated the 
names Sample 5 to Sample 12 respectively). The APl and neo3341 primers were 
used for the primary amplification, and AP2 and neo3608 primers for the 
secondary amplification. A background smear was produced following primary 
amplification. Numerous specific products were produced however, following 
secondary amplification of the diluted primary products. They ranged in size 
from approximately 100 to 650 bp (Figure 6.6A). No products were detected 
from amplification of the HCll undigested control DNA (He) or the no DNA(-) 
control. When transferred to Hybond N+ membrane and hybridised to the 
neomycin specific oligonucleotide neo3685, several of these secondary 
amplification products that were visible by ethidium bromide staining were also 
detected, indicating that they were neomycin specific (Figure 6.6B). Some non-
specific hybridisation to the control HCl 1 DNA (lane HA) was also seen. 
Two specific hybridisation products were present in Sample 11 of approximately 
450 bp and 500 bp, however only the 450 bp product was clearly visible on the 
ethidium bromide stained agarose gel, and was subjected to further analysis. 
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Figure 6.5 Siebert secondary PCR ampl(fication products - Samples I - 4. 
(A) I% agarose gel stained with ethidium bromide. (8) Agarose gel from panel A 
transferred to Hybond N+ membrane and hybridised to the neo3685 
oligonucleotide. Genomic DNA from non-transfected HC 11 cells (HA), and G418 
resistant HC 11 clones I b-1 (Sample 1), 2b-10 (Sample 2), 3b-3 (Sample 3), 4b-5 
(Sample 4) were prepared for Siebert PCR by digestion with Seal and ligation 
with the adaptor. These templates were then subjected to PCR using the methods 
described in Chapter Two. Samples were initially amplified with the primers API 
and neo334 l (lanes 3-6) or with the primers AP 1 and neo3392 (lanes 9-12). 
Secondary amplification was with the primers AP2 and neo3608 (all lanes). 
Control reactions in lane "He" and "-" contain undigested HC 11 genomic DNA 
and no DNA respectively. The DNA marker is the lOObp and 1kb ladder 
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Figure 6.6 Siebert primary and secondary PCR amplification products - Samples 5-12. 
(A) l % agarose gel stained with ethidium bromide. (B) Agarose gel from panel A 
transferred to Hybond N+ membrane and hybridised to the neo3685 oligonucleotide. 
Genomic DNA from non-transfected HCI 1 cells (HA), and G418 resistant HCl 1 clones 
la-I (Sample 5), 2a-l (Sample 6), 3a-3 (Sample 7), 4a-1 (Sample 8), lb-2 (Sample 9), 2b-
8 (Sample 10), 3b-4 (Sample 11), 4b-6 (Sample 12) were prepared for Siebert PCR by 
digestion with Seal and ligation with the adaptor. These templates were then subjected to 
PCR using the methods described in Chapter Two. The primers API and neo3341 were 
used to amplify template DNA for primary reactions. The primers AP2 and neo3608 were 
used for secondary amplification to amplify template DNA from PCR products from the 
primary amplification. Control reactions in lane "He" and "-" contain undigested HCl 1 
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6.5 Subcloning and sequencing of PCR products 
The amplification products from clones lb-1 (Sample J) (950 bp and 550 bp) and 
3b-4 (Sample 11) (450 bp) were subcloned and sequenced. Each product was re-
amplified by taking a 'stab' sample of each template band from the agarose gel 
following secondary amplification (described in Chapter Two). Stab 
amplification of the 450 bp product of clone 3b-4 also produced a secondary 
product of approximately 650 bp as well as the original 450 bp product. All 
products were confirmed as neomycin specific by hybridisation to the neo3685 
oligonucleotide (data not shown) and were subcloned into pGEM-T Easy 
(Promega). Following transformation of XLl-blue cells, positive clones were 
identified for the 950 bp and 550bp 1 b-1 products and the 650 bp 3b-4 product by 
restriction endonuclease digestion and hybridisation to the neo3685 
oligonucleotide. No positive clones were identified however for the 450 bp 3b-4 
product (data not shown). All clones were sequenced utilising either the T7 or the 
SP6 primer, which are external to the cloning site of pGEM-T Easy. 
6.5.1 Clone lb-I 
Sequencing from both ends using the T7 and SP6 primers revealed that the larger 
clone was 939 bp in length. It consists of 30 bp of adaptor, 478 bp of genomic 
DNA and 431 bp of plasmid pneo-tk DNA sequence. Sequencing of the smaller 
clone revealed that it was 369 bp, of which 30 bp was the adaptor sequence and 
the remaining sequence was identical to the plasmid pneo-tk DNA (data not 
shown). This suggests that the adaptor had ligated to a site within the plasmid 
sequence. As there are no Seal restriction sites within the plasmid sequence, 
either a new Seal site has been created during the integration of the plasmid, or 
alternatively, an artificial blunt end was produced during DNA preparation. 
There are three interesting features of the larger 939 bp clone (Figure 6. 7). 
First! y, a rearrangement of 40 bp (nucleotides 5128-5167 of pneo-tk) of the 
plasmid backbone had occurred at the junction between the genomic DNA and 
pneo-tk. This short piece of DNA had recombined in the opposite orientation. 
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AP2 .....>. 
















(iii) cgggcaatggtggcacac gcctttaatcccagcacttgggaggc ggaggcagaggca 
Figure 6.7 (A) Schematic representation of clone lb-I (total length= 939 bp). 
The integration junction is indicated with a vertical arrow between pneo-tk (box) 
and genomic DNA (solid box). Horizontal arrows within pneo-tk show plasmid 
orientation. The location of primers used for Siebert PCR (AP2 and neo3608), 
sequencing (T7 and SP6) and the oligonucleotide probe (neo3685) are as shown. 
Three fragments of this clone are marked with dashed lines (i, ii and iii) and the 
DNA sequence of these fragments is shown in panel B. (B) (i) Sequence flanking 
the integration junction. (ii) Exon 16 of the mouse gene for DNA dependent 
protein kinase catalytic subunit (100% identity). (iii) Mouse Bl repeat consensus 
sequence (81 % identity). Genomic DNA sequence is in lowercase and plasmid 
DNA sequence is in uppercase. The wavy underline in B(i) indicates that the 
plasmid is in an inverted orientation. 
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Downstream from this site, the clone sequence had 100% identity to the pneo-tk 
sequence. Secondly, the 478 bp of genomic DNA was analysed by comparing the 
sequence to the NCBI mouse database using the BLAST search tool. Nucleotides 
15 to 403 (389 bp) of this sequence have 100% identity with the 5' end of exon 16 
of Mus musculus DNA for DNA dependent protein kinase catalytic subunit 
(nucleotides 392 to 4) (Accession number AB005160.l). Thirdly, nucleotides 365 
to 421 of the genomic sequence are 81 % homologous to nucleotides 1 to 57 of the 
mouse B 1 repeat consensus sequence. 
6.5.2 Clone 3b-4 
The complete sequence of this clone was obtained with the T7 primer. This clone 
is 671 bp in length consisting of 30 bp of adaptor, 262 bp of genomic DNA and 
379 bp of plasmid plTR-neo-tk DNA sequence (data not shown). Figure 6.8 
summarises the features of the sequence. The junction between genomic DNA 
and plTR-neo-tk occurs in the middle of the upstream ITR flanking the neomycin 
cassette (nucleotide 95 of plTR-neo-tk). Downstream from this site, the clone 
sequence is 100% homologous to the expected plasmid sequence. Analysis of the 
262 bp of genomic sequence by comparison to the NCBI mouse database using 
the BLAST search tool revealed no overall homology to one particular sequence, 
but rather homology to a specific region within over 60 mouse sequences: again 
this specific sequence contained the mouse B 1 repeat. Alignment of the B 1 
consensus sequence to the cloned sequence gave 73% homology over a 62 bp 
region (nucleotides 51 to 112 of the genomic sequence aligned to nucleotides 74 
to 13 of the complement of mouse Bl repeat consensus sequence). 
6.6 Amplification of integration junctions in HEK-293 clones by Siebert PCR 
Genomic DNA isolated from 12 different HEK-293 clones was used as templates 
for Siebert PCR. The methods for amplification, screening, subcloning and 
sequencing of positive clones were identical to that used for HCll clones. From 
the 12, sequence data was only obtained from two clones. These were clones la-1 









(i) i tagtcttgggtgtctacaaataggttagtttttcctcagtGCCCGGCCTCAGTGAGCGAGCGAGCGCG 
CAGAGAGGGAGT 
(ii) gttcttaggctaagaaatntgcctgcttctgtctcccaggtactggaatgaaaagcatgcgc 
Figure 6.8 (A) Schematic representation of clone 3b-4 (total length= 671 hp). 
The integration junction is indicated with a vertical arrow between pITR-neo-tk 
(box) and genomic DNA (solid box). Horizontal arrow within pITR-neo-tk shows 
plasmid orientation. The region of the plasmid encoding the ITR is labelled. The 
location of primers used for Siebert PCR (AP2 and neo3608), sequencing (T7) 
and the oligonucleotide probe (neo3685) are as shown. Two fragments of this 
clone are marked with dashed lines (i and ii) and the DNA sequence of these 
fragments is shown in panel B. (B) (i) Sequence flanking the integration junction 
(ii) Mouse Bl repeat consensus sequence (73% identity). Genomic DNA sequence 
is in lowercase and plasmid DNA sequence is in uppercase. 
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sequence only. No genomic DNA sequence was obtained (data not shown). This 
suggests that the adaptor had ligated to a site within the plasmid sequence. As 
there are no Seal restriction sites within the plasmid sequence, either a new Seal 
site has been created during the integration of the plasmid, or alternatively, an 
artificial blunt end was produced during DNA preparation. 
6. 7 Discussion 
6. 7.1 Southern blot analysis - HCl 1 cells 
All of the HCl 1 clones analysed by Southern hybridisation in Figures 6.1 and 6.2 
had been selected with 0418 for the presence of the neomycin resistance gene. 
They had not been selected with FIAU for loss of the thymidine kinase gene 
present on the plasmid backbone of pneo-tk and pITR-neo-tk; therefore it is 
possible that a complete copy of the respective plasmids may have integrated. 
The different hybridisation pattern shown by each clone suggests that the site of 
integration for each clone is unique. It is possible however that multiple copies 
have integrated into the same genomic location, as concatemers of head-to-head, 
head-to-tail or tail-to-tail arrangements of all or part of the transfected plasmid. 
An interesting feature of these Southern blots is the presence of hybridisation 
bands smaller than the molecular size of a complete copy of the transfected 
plasmid DNA, suggesting that only part of the plasmid, including the neomycin 
resistance gene has been integrated. This supports the observation made in 
Chapter Five that, in approximately half of the integration events where the 
neomycin resistance gene was incorporated into the genome, a functional copy of 
the HSV-tk gene was not expressed. An alternative possibility is that transfected 
plasmid DNA has been maintained in an episomal state within cells, and that the 
size of the observed restriction fragments correspond to such DNA. Throughout 
the expansion of clones, selective pressure with 0418 was maintained. 
Furthermore, DNA was prepared using a procedure that favours the isolation of 
high molecular weight DNA. These two factors make it unlikely that episomal 
plasmid DNA could either be present in cells, or detected by the procedures 
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described in this thesis, however it cannot be completely discounted. A further 
explanation may be that degradation of chromosomal DNA could have occurred 
during genomic DNA isolation, giving rise to smaller sized fragments than 
expected. 
Four out of twelve clones which were transfected with pneo-tk and pBR322 
(Figure 6.1), and five out of fifteen clones which were transfected with 
pITR-neo-tk and pHIVrep (Figure 6.2) had multiple bands hybridised to the 
neomycin probe, suggesting that these clones have more than one site within the 
genome where the neomycin transgene had integrated. Incomplete digestion of 
genomic DNA could alternatively lead to such a result, however this is unlikely as 
reaction conditions in these experiments were optimised for complete digestion, 
and analysis of ethidium bromide stained gels suggested that this had occurred 
(data not shown). Furthermore, it could not be determined from these results if 
bands of similar size represent the same genomic site where the plasmid DNA has 
integrated. The use of pulse field gel electrophoresis would allow better 
separation of restriction fragment greater than 12 kb and hence better size 
estimation of hybridisation products. 
The higher signal intensity shown by clones la-8, la-10 and la-11 (lanes 7, 8 and 
9 respectively) in Figure 6.1, and clones 3a-1 and 3a-2 (lanes 3 and 4) in 
Figure 6.2, can partly be explained by a greater amount of digested DNA loaded 
onto the agarose gels for these clones (data not shown). However it cannot be 
discounted that the transgene copy number in these clones may be greater than in 
other clones. Furthermore, hybridisation to the neomycin probe was not detected 
for clone 3a-15 (lane 15 of Figure 6.2). It is possible that single or very low copy 
number integration events had occurred in this clone, resulting in signal intensity 
below the detection level. Longer exposure of the hybridisation membrane to 
autoradiographic film did not improve signal intensities (data not shown). 
Although the copy number was not quantified, the sensitivity of the chosen 
method would allow identification of single copy integration events. 
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6. 7.2 Southern blot analysis - HEK-293 cells 
Hybridisation products specific to the neomycin gene probe were not observed in 
all clones analysed. The amount of digested DNA loaded onto the agarose gel 
was similar between samples (as confirmed by ethidium bromide staining). This 
suggested that the number of copies of the transgene, which have integrated into 
HEK-293 genomic DNA of different clones, may have been heterogeneous. 
Furthermore, the range of unique sized hybridisation bands obtained with the 
neomycin gene probe could result from differences in copy numbers of the 
transgene integrating at a single genomic site. Alternatively, the unique size range 
of hybridisation bands could result from integration into different genomic sites. 
To assess if site-specific integration of the neomycin resistance gene into the 
AA VS 1 locus had occurred in any of these clones, the same membrane was 
stripped and re-probed with an AAVSl probe. Upon analysis of the two 
autoradiographs, only one clonal line derived from transfection with AAV-based 
plasmid DNA had hybridisation bands visible with both probes (lane 14). 
Furthermore, these hybridisation bands were of different size. This suggests that 
the neomycin resistance gene did not integrate into the AA VS 1 locus of this 
clone. Site-specific integration into AA VS 1 has been previously observed at 
frequencies of between 40% and 75% following transfection of HEK-293 with 
AA V-based plasmid DNA in the presence of Rep78 and/or Rep68 protein 
(Shelling and Smith, 1994; Balague et al., 1997; Surosky et al., 1997). Analysis 
of a greater number clones would be required to determine if site-specific 
integration into AA VS 1 is occurring in the experiments described in this thesis. 
6. 7.3 Siebert PCR 
The 'Siebert' PCR technique utilised in these experiments used adaptor-specific 
primers. Rather than just the desired adaptor-primed and transgene specific-
primed PCR reaction products, adaptors ligated to both ends of the template DNA 
allowed amplification to proceed via the adaptor primer alone, resulting in 
creation of non-specific products. These products were seen as common bands 
99 
and also as a background smear in all samples, including the control HCll DNA 
(HA). This non-specific amplification can be avoided by attaching an amine group 
to the 3' end of the lower strand of the adaptor. This amine group stops non-
specific amplification by blocking polymerase catalysed extension of the lower 
adaptor strand, preventing the generation of the primer binding site unless a 
defined, distal, gene-specific primer extends a DNA strand opposite the upper 
strand of the adaptor. However, while this modification could be beneficial, it is 
not essential (Siebert et al., 1995). 
In these present experiments, specificity was improved with a second round of 
amplification using the nested primer pair of AP2 (adaptor specific) and neo3608 
(trans gene specific). However non-specific AP2-AP2 amplification can still 
occur. Thus, it was essential to identify specific products by screening for 
hybridisation to the neomycin specific oligonucleotide neo3865 with Southern 
blot analysis. 
Multiple specific products from the same DNA template can result from either 
multiple integration sites of the transgene into the genome or, alternatively, 
incomplete digestion of the genomic DNA with Seal. In the experiments 
described here, when more than one specific product was detected in a single 
clone, the largest product was chosen to be subcloned and sequenced. Smaller 
products were not selected for subcloning because it was thought that larger 
candidates would reveal a greater amount of information about the site of 
integration. 
6. 7.4 Analysis of junctions 
It has been demonstrated with sequence analysis of integration junctions, that 
liposome-mediated transfection of AA V-based plasmid DNA into human cell 
lines can result in site-specific integration into AA VS 1 on human chromosome 19 
(Surosky et al., 1997; Lamartina et al., 1998; Pieroni et al., 1998; Rinaudo et al., 
2000; Tsunoda et al., 2000). Recombinant AA V viral infection of human cell 
lines can also result in site-specific integration; however only a few researchers 
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have carried out detailed analysis of the integration junction at the DNA sequence 
level (Samul ski et al., 1991; Palombo et al., 1998). Other researchers have 
obtained limited information on site-specific integration into AA VS 1 from 
co-localisation of transgene and AAVSl specific probes in Southern blot 
hybridisation (Young et al., 2000). Alternatively, fluorescent in situ hybridisation 
methods have been used to demonstrate that integration sites co-localise to the 
expected chromosomal integration sites (Miao et al., 1998; Palombo et al., 1998). 
Research presented in this thesis identified that genomic DNA from other species, 
including mouse, have homology to a small 37 nucleotide region of the human 
AA VS 1 locus. However, this evidence alone is not conclusive enough to allow 
assumptions about potential AA V-mediated site-specific integration into these 
loci. 
In a study by Nakai et al. (1999), a recombinant AAV (rAAV) vector expressing 
human coagulation factor IX was administered to mice via the portal vein. 
Sustained expression of the transgene was detected in the liver for up to 10 
months. Furthermore, analysis by Southern blot suggested that the rAAV vector 
had integrated into the host genome, forming mainly head-to-tail concatemers. 
They isolated rAAV vector-cellular DNA junctions from 18 clones. Sequencing 
of these junctions revealed homology to four different mouse genes in four 
separate clones, with the remainder of clones having no apparent homology to any 
known mouse sequence (NCBI GenBank database). Of the four known genes, no 
sequence identity to any features of AA VS1 was present. This suggested that the 
integration of recombinant AA V DNA into the mouse genome in this study was 
occurring randomly. 
Given the paucity of published data, the results from this chapter describing 
analysis of integration at the DNA sequence level of AA V-based plasmid DNA 
into mouse cells, do present some interesting new information. 
Clone lb-1 was isolated from a 0418 resistant clone (lb-1), derived from HCll 
cells co-transfected with the pneo-tk and pBR322. These plasmids do not contain 
any AA V sequence and were included as negative controls for analysis of 
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integration frequency (Chapter Five). The integration of the neomycin gene into 
the host genome should therefore be random.- Alignment of clone 1 b-1 genomic 
DNA to the NCBI mouse database using the BLAST search tool revealed that 
nucleotides 15 to 403 (389 bp) had 100% identity with the 5' end of exon 16 of 
Mus musculus DNA for the DNA dependent protein kinase catalytic subunit 
(nucleotides 392 to 4) (Accession number AB005160.l). 
Rep78 and/or Rep68 protein has been shown to be essential for site-specific 
integration into the AAVSl site on human chromosome 19 (Surosky et al., 1997). 
In the absence of Rep78 and/or Rep68, DNA flanked by ITRs will still integrate, 
but randomly into the human genome (Xiao et al., 1997). Linden et al. (1996a) 
showed that a 33 nucleotide region of AA VS 1 containing a Rep Binding Element 
(RBE) and terminal resolution site (trs) was the only sequence required for 
specific targeting for AA V virus integration in vitro. However, it remains to be 
determined whether this sequence alone is sufficient for targeting in a 
chromosomal locus in vivo. Two groups have produced transgenic mice by 
inserting a 2.7 kb or a 3.5 kb AAVSl fragment from human chromosome 19. 
Both transgenic sequences have RBE and trs present. Site-specific integration 
into these loci was observed with AAV-based plasmid transfection (Rizzuto et al., 
1999a) or with rAAV infection (Young et al., 2000). 
In the present experiments, Clone 3b-4 was isolated from a G418 resistant clone 
(3b-4) derived from HCl 1 cells co-transfected with the pITR-neo-tk and pHIVrep. 
No RBE-like sequences were identified in clone 3b-4 genomic sequence 
immediately upstream of the junction. However, it could not be determined from 
these data whether or not any RBE-like sequences exist at a greater distance from 
the junction site in this clone. 
For the human cell lines analysed to date, the location of the junction sites have all 
been observed within the ITR of the AA V vector for both transfected (Surosky et 
al., 1997; Lamartina et al., 1998; Pieroni et al., 1998; Rinaudo et al., 2000; 
Tsunoda et al., 2000) and infected (Samulski et al., 1991; Palombo et al., 1998) 
cells. In contrast, Nakai et al. (1999) infected mice in vivo with a rAAV vector 
and found that in 14 out of 18 integration events analysed, the junction sites were 
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within the ITR. Of the remaining four, the junction was in close proximity, not 
more than 45 bp from the end of the ITR. The exact location of junction sites 
within the ITR was different in all integration events that they analysed. The 
junction site in clone 3b-4 from the experiments described in this work occurs at a 
unique position, 65 bp from the 5' end of the ITR (Figure 6.8). Analysis of 
junction sites from a greater number of clones may help elucidate whether or not 
this location within the ITR is important for integration in these present 
experiments. 
6. 7.5 Bl homology 
A notable feature of both clones lb-1 (Sample 1) and 3b-4 (Sample 11) is 
homology of genomic sequence in the integration region to the sequence of the 
mouse B 1 repeat. The mouse B 1 repeat sequence belongs to the short 
interspersed element (SINE) family of repeats which are present in all higher 
eukaryotes (Jelinek and Schmid, 1982). The 129 bp Bl repeat is estimated to be 
present in between 130,000 and 150,000 copies in the murine genome (Bennett et 
al., 1984) and is frequently located at intron-exon junctions within genes (Krayev 
et al., 1980). The function of B 1 is unknown. The B 1 consensus sequence is 
homologous to the human Alu repeat (Jelinek and Schmid, 1982). 
Clone lb-1 has 81 % homology over 57 bp (nucleotides 365 to 421) and clone 
3b-4 has 73% homology over 62 bp (nucleotides 51 to 112) to B 1. The regions of 
homology overlap, and are predominantly at the 5' end of B 1 consensus sequence 
(Figure 6.9). 
As clone lb-1 was derived from cells initially transfected with plasmids 
containing no AA V features (pneo-tk and pBR322), the integration site of the 
neomycin transgene into the HCll genome is assumed to be random. Kang et al. 
(2000) demonstrated that an increase in the frequency of transgene integration 
could be achieved by homologous recombination of a construct containing 
flanking B 1 repeat sequences with genomic B 1 sequences. However, as neither 
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pneo-tk, nor plTR-neo-tk contain Bl-like sequence, homologous recombination is 
unlikely to be the mode of integration in these present experiments. 
Overall, the PCR technique used in these experiments was successful at 
amplification of junction regions between the transfected plasmid DNA and the 
genomic DNA at the site of integration. However, the efficiency of amplifying 
unknown genomic DNA sequence, and not just plasmid DNA sequence was poor. 
This could possibly be improved by including a 3' amine group on the adaptor, 
reducing the number of non-specific amplification products. 
Figure 6.9 Alignment of the 129 bp mouse Bl consensus sequence to clones lb-1 (nucleotides 365 to 421) and 
3b-4 (nucleotides 112 to 51). An asterisk(*) indicates exact identity to the Bl consensus (Bl cons.) sequence. 
Differences between the 1 b-1 and 3b-4 sequences and the B 1 consensus are as indicated. 
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7.1 Mammary epithelial cell transfection in vitro 
The overall goal of this work was to express foreign genes in mammary epithelial 
cells by chemical-mediated delivery of plasmid DNA. At the commencement of 
this study, cationic liposome-mediated delivery of plasmid DNA was the most 
promising method available to achieve this goal. To assess the efficacy of this 
approach and to identify a suitable cationic liposome, an in vitro model was 
established. Both the mouse mammary epithelial cell line HC 11 and primary 
cultures of bovine mammary cells were employed. 
LipofectAMINE, which consists of a 3: 1 ratio of the polycationic lipid DOSPA 
and the neutral lipid DOPE respectively, was chosen to be used because of 
evidence suggesting that it was the most effective commercial liposome available 
at the time. It was shown to provide higher efficiencies of transfection in several 
different experiments with different cell lines, as compared to earlier generation 
cationic liposomes (Hawley-Nelson and Shih, 1993). In experiments reported in 
this thesis, the efficiency of plasmid DNA delivery to HCl 1 cells with 
LipofectAMINE was greater than that achieved with any of the other cationic 
lipids tested. In comparison, although calcium phosphate co-precipitation attained 
a similar level of efficiency, it was not persevered with as a viable option for 
DNA delivery because of its non-practicality for use in vivo. LipofectAMINE 
was subsequently used for all cell transfections in vitro and in vivo in this study. 
In order to optimise the efficiency of LipofectAMINE-mediated plasmid DNA 
delivery to HCll cells and primary bovine mammary cells, the transfection 
parameters were refined. Specifically, the ratio of LipofectAMINE to DNA, and 
the overall concentrations of each of these respective components was altered to 
achieve the maximal expression of a ~-galactosidase reporter gene. The greatest 
percentage of cells that were detected to express ~-galactosidase 48 hours post-
transfection was 2.1 % for HCll cells, and 0.3% for primary bovine mammary 
cells. In contrast, 75% of Neuro-2a cells stained positive for ~-galactosidase 
expression 48 hours after LipofectAMINE-mediated delivery of the same reporter 
construct. 
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There are two main facets of the transfection process that are crucial for efficient 
delivery of plasmid DNA to the cell nucleus. These are cellular uptake and 
nuclear entry. More specifically, there are several physiological and biochemical 
factors that may contribute to different cells having different efficiencies of 
transfection. Particular attention has been paid to proteoglycans on the cell 
membrane, as these appear to play an important role in the uptake of cationic 
liposome transfection complexes. Cells that are deficient in proteoglycan 
synthesis have been demonstrated to be more difficult to transfect (Mounkes et 
al., 1998). Furthermore, there is evidence to suggest that the role of proteoglycans 
is to protect cells from potential cytotoxicity of cationic lipids (Belting and 
Petersson, 1999). Proteoglycans perform a wide variety of functions ranging from 
the formation of extracellular matrix to mediating cell-cell contact and 
communication. Thus, different cell types may have quite distinct proteoglycan 
composition (Kjellen and Lindahl, 1991). The exact proteoglycan composition of 
HCl 1, primary bovine mammary, or Neuro-2a cells however is not known. 
Previous studies, in which either the plasmid DNA or the chemical utilised for 
delivery was labelled, show that cellular uptake of the transfection complex is an 
efficient process. A high percentage of cells accumulate significant 
concentrations of these foreign molecules within the cytoplasm as a consequence 
of internalisation by endocytosis. In one study, Amstutz and Schanbacher (1995) 
incubated COMMA-ID mouse mammary and primary bovine mammary 
epithelial cells in culture with a plasmid DNA-polyion complex. The plasmid 
DNA was labelled with 33P and the polyion contained fluorescein-labelled 
poly-L-omithine. Within minutes following delivery, a fluorescent signal was 
associated with virtually all cell surfaces and, after 6-8 hours, fluorescence was 
detected within the cytoplasm of most cells. Radiolabelled plasmid DNA 
co-localised with the fluorescent signal indicating that the transfection complex 
was intact in the cytoplasm. However, the majority of signal remained within the 
cytoplasm, with little being detected in the nucleus. This suggested that nuclear 
transport was the limiting step to successful transfection in this model. 
Other researchers have also found that inefficient nuclear entry is a major 
limitation in transfection experiments. Mortimer et al. (1999) found that nuclear 
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transport limited successful transfection, and suggest that mitotic activity 1s 
essential for successful nuclear transport to occur. Furthermore, inclusion of 
nuclear localisation signals (NLS) into the transfection complex can enhance 
nuclear transport of foreign DNA molecules (Branden et al., 1999; Subramanian 
et al., 1999). 
Neither cellular uptake nor nuclear entry of plasmid DNA delivered to HCl 1 cells 
with LipofectAMINE was analysed in this thesis. However, evidence presented in 
these other studies suggests that nuclear entry, rather than cellular uptake, may be 
the main barrier to efficient transfection. Analysis of the fate of transfected DNA, 
using labelled plasmid DNA, may indicate whether poor nuclear transport was 
also a contributing factor to the low transfection efficiencies observed in this 
study using HCl 1 and primary bovine mammary cells. 
What is apparent from the present and other studies, is that a ubiquitous cationic 
lipid ideal for gene transfer to all cell types is not yet available. Several advances 
however have been made during the course of this study in cationic liposome 
production, with several "new and improved" formulations now available. In 
general, these improvements have been aimed at increasing transfection 
efficiency, broadening the range of cell types able to be transfected, and reducing 
the toxicity of cationic liposomes to cells. 
The low efficiency of mammary epithelial cell transfection achieved in these in 
vitro models is not sufficient for high-level expression of foreign genes in the 
mammary gland in vivo. This problem of low transfection efficiency is generally 
recognised as the main limitation of liposome-mediated delivery of DNA to cells 
(Luo and Saltzman, 2000). Despite this, liposome-mediated transfection is a 
popular option for human gene therapy. The Wiley Journal of Gene Medicine 
Clinical Trials Database currently lists 532 gene therapy trials, 68 of which use 
lipofection as the mode of delivery (12.8% ). In comparison, there are 204 
protocols using retroviral (38.3%) and 136 protocols using adenoviral (25.6%) 
vectors (www.wiley.co.uk). 
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7.2 Transfection of the rat mammary gland in vivo 
Despite the low transfection efficiency of cationic liposome-mediated delivery 
achieved in vitro, it was important to assess the efficacy of this approach for in 
vivo gene transfer to the mammary gland. Lactating Sprague-Dawley laboratory 
rats were used as a model. Rats, as opposed to mice, were chosen for these in vivo 
experiments primarily because of the larger size of rat teat canals, which would 
make the successful infusion of transfection complexes technically more feasible. 
Infusion through the teat canal was the preferred route of delivery since this is the 
least invasive approach. However, direct injection into the mammary gland was 
also performed as an alternative approach to assess whether this was a viable route 
for administration. Lactating rats were used for several reasons. The number of 
mammary epithelial cells available to target for gene transfer during lactation is 
greater than at any other developmental stage. Furthermore, these cells are 
actively expressing and secreting milk proteins during lactation. One potential 
application of successful gene transfer to the mammary gland is the production of 
novel proteins; therefore secretion into milk is desirable. 
Based on results from in vitro experiments, LipofectAMINE-mediated 
transfection was chosen as the best available method to deliver a eukaryotic 
expression vector containing a 13-galactosidase reporter gene driven by the CMV 
promoter. The lipid-DNA complex was delivered to the mammary glands of a 
total of eleven animals, at a range of lactational stages from day seven to day 
seventeen. The route of administration was either by infusion through the teat 
canal or by direct injection into the gland. 
Analysis of mammary tissue following infusion or injection revealed 
13-galactosidase expression in only three of the eleven rats, and only in a very 
small number of mammary epithelial cells that were heterogeneously distributed 
throughout the transfected mammary glands. It was not possible to estimate the 
proportion of cells that had been successfully transfected because the number of 
positive cells was very low as compared to the total number of mammary 
epithelial cells that were originally targeted. 
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There have been very few reported attempts at chemical-mediated delivery of 
DNA to the mammary gland. Hens et al. (2000) delivered a human growth 
hormone (hGH) reporter gene construct, complexed with various chemicals, to the 
guinea pig mammary gland by infusion through the teat canal at various 
developmental stages of the mammary gland including pre- and post-parturition. 
Transgene expression was quantified by a hGH radioimmunoassay (RIA) of milk 
samples from the transfected glands collected 2 - 14 days after delivery. No hGH 
was detected in any of the milk samples from glands transfected in late pregnancy 
with the hGH plasmid when delivered with LipofectAMINE. However, the same 
construct delivered at a similar stage of development with DEAE-dextran 
expressed hGH at detectable levels. This interesting observation suggests that 
LipofectAMINE was not as effective as DEAE-dextran for gene transfer in the 
physiological environment encountered within the guinea pig mammary gland at 
this stage of development. Furthermore, DEAE-dextran was also more efficient at 
transfecting the guinea pig mammary gland in vivo than a charge-shifting mixed 
polyion complex that was specifically developed for delivery to mammary 
epithelial cells in vitro. In contrast, this charge-shifting mixed polyion was more 
efficient than DEAE-dextran at transfecting cells in vitro (Schanbacher and 
Amstutz, 1997). These data demonstrate that transfection efficiencies achieved in 
vitro and in vivo with the same delivery vehicle do not always correlate. This lack 
of correlation between in vitro and in vivo has also been observed in human 
airway epithelial cells (Fasbender et al., 1997; Matsui et al., 1997). 
Hens et al. (2000) also observed that the stage of mammary development at which 
the transfection complex was delivered to the guinea pig mammary gland had an 
effect on the efficiency of transgene expression. They detected hGH in milk 
following delivery of the transfection complex within 5 days before parturition at 
levels several fold higher than that obtained at any other stage of development, 
ranging from early pregnancy to involution. In comparison, the transfection 
complex used for rat mammary gland transfection described in the present study 
was only delivered postpartum, during lactation. Interestingly, from eleven rats 
that had the transfection complex delivered, only three showed positive 
J3-galactosidase staining, all of which were transfected on day 12 or earlier of 
lactation. In one other study, an unsuccessful attempt was made to transfect the 
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bovine mammary gland, with a charge-shifting mixed polyion complex, during 
lactation (Schanbacher and Amstutz, 1997). 
These results suggest that delivery of the transfection complex during lactation 
may be especially problematical as compared with prepartum delivery, although 
further studies would be required to confirm this point. There are two main 
physiological differences between the pre- and postpartum mammary gland, 
which may affect transfection efficiency. Firstly, the intramarnrnary environment 
encountered in the lactating gland, specifically the presence of milk, may be 
detrimental to successful delivery of the transfection complex to target cells. 
Secondly, the mammary gland prior to parturition undergoes extensive 
development involving mitosis, and it has been suggested that mitotic activity is 
essential for nuclear transport of foreign DNA to occur (Mortimer et al., 1999). 
Transfection efficiencies may consequently be greatest in these actively dividing 
cells encountered in the prepartum mammary gland. 
As the transfection efficiency attained in this in vivo model was extremely low 
following LipofectAMINE-mediated plasmid DNA transfection, it was obvious 
that this vehicle and method of delivery was not adequate. While a number of 
researchers are currently investigating ways of enhancing DNA delivery using 
different chemicals, further work in this area was outside the scope of the research 
in this thesis. Any potential increase in the efficiency of transfection would be 
beneficial to a chemical-mediated gene transfer approach. Therefore an 
alternative way of enhancing transfection efficiency was sought in this present 
study, to complement advancements made by others in the devopment of new 
chemicals. 
7.3 Enhancement oftransfection efficiency using AA V-based plasmid DNA 
In general, the major problem with liposome-mediated gene transfer of plasmid 
DNA is low transfection efficiency. The use of AAV-based plasmid DNA is an 
attractive alternative to potentially alleviate this problem. This approach 
combines the safety and simplicity of liposome-mediated delivery of plasmid 
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DNA with the features of AA V. The experiments described in this study entailed 
the delivery of a plasmid containing a 13-galactosidase reporter gene construct 
flanked by AAV ITRs (plTR-CMVlacZ) to the mouse mammary epithelial cell 
line HC 11. LipofectAMINE was used to deliver both this construct and a control 
13-galactosidase plasmid without ITRs (pCMVlacZ) to these cells, utilising 
previously optimised transfection conditions. The transfection efficiency, as 
determined by staining for the percentage of cells positive for 13-galactosidase 48 
hours post-transfection, was enhanced by 1.4-fold when the 13-galactosidase gene 
was flanked by ITRs. Although not remarkable, this increase in transfection 
efficiency of HCl 1 cells was statistically significant. 
Other researchers have similarly utilised the ITRs of AAV to enhance transient 
transfection efficiencies. Philip et al. (1994) recorded an increase, of up to 
10-fold, in interleukin 2 (IL-2) protein expressed from a construct with ITRs as 
compared to an ITR minus construct, when they transfected cells from a rat 
prostate cell line using a combination of the cationic lipid DDAB and the neutral 
lipid DOPE. IL-2 protein was quantified by ELISA 48 hours post-transfection. 
Furthermore, Vieweg et al. (1995) transfected cells from the same rat prostate cell 
line with LipofectAMINE and measured expression 48 hours post-transfection 
from constructs with and without ITRs flanking a 13-galactosidase reporter gene. 
They found that up to 78% of cells transfected with plasmids containing ITRs 
were positive for 13-galactosidase, whereas only 5% of cells transfected with 
plasmids without ITRs showed positive staining. However, it must be recognised 
that the 13-galactosidase reporter gene in the control plasmid, without ITRs, was 
driven by the SV40 promoter, as opposed to the CMV promoter for the plasmid 
with ITRs. Hence it is difficult to make a direct comparison between these two 
constructs since expression from the SV40 promoter is generally less than that 
from the CMV promoter. In another study, with mouse C2Cl2 muscle and 
human embryonic kidney 293 cells, between a 1.6- and 3.5-fold increase in 
expression was observed from plasmids containing ITRs, flanking either the 
human apolipoprotein AI (apoAl) or lecithin-cholesterol acyltransferase (LCAT) 
genes (Fan et al., 1998). All three studies described above speculate that the 
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mechanism for this observed enhancement results from the ITRs facilitating 
nuclear accumulation of the transfected plasmid. 
The level of enhancement that was attained in these three reports is greater than 
what was observed with the experiments presented in this thesis. The reason for 
this disparity is not immediately obvious. However, a lack of an appropriate 
control in the second study did not allow an accurate quantification of the effect 
that ITRs may have had on transfection efficiency. Radiolabelling of plasmid 
DNA prior to transfection, and subsequent observation of its intracellular fate 
could assist in elucidating any effect ITRs have on nuclear accumulation of the 
plasmid. 
It should be emphasised that in the liposome-mediated AA V-based plasmid DNA 
transfection experiments described above, DNA was delivered to either mouse or 
rat cell lines. In other studies, several researchers have utilised cationic liposomes 
to deliver AAV-based plasmid DNA to human cell lines in vitro (Shelling and 
Smith, 1994; Surosky et al., 1997; Lamartina et al., 1998; Pieroni et al., 1998; 
Rinaudo et al., 2000; Tsunoda et al., 2000). These experiments were all focussed 
on investigation of the site of integration into the human genome and 
unfortunately none have addressed the question of the effect that AA V ITRs 
might have on the efficiency of plasmid DNA transfection. This would require 
comparisons with transfections using control plasmids without ITRs. 
Furthermore, these studies with human cell lines were all performed in the 
presence of Rep78 and/or Rep68 protein. The AA V Rep78 and/or Rep68 protein 
was shown to be required for site-specific integration to occur at the human 
AA VS 1 locus (Surosky et al., 1997). A model for the integration process was 
proposed by Linden et al. (1996a, 1996b), which involves binding of the Rep78 
and/or Rep68 protein to a sequence motif, known as the Rep Binding Element 
(RBE), which is present in both the human AA VS 1 locus and also the AA V ITR 
sequences. In the absence of Rep78 and/or Rep68, DNA flanked by ITRs will 
still integrate, but at random sites within the human genome (Xiao et al., 1997). 
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In seeking to evaluate what role the Rep78 and/or Rep68 protein may have on 
integration into the genome of cells other than human, an attempt was made in the 
present experiments to identify whether or not a sequence that is homologous to 
human AAVSl exists in other species. Previously, Samulski et al. (1991) 
demonstrated by Southern blot analysis that genomic DNA from only human and 
green monkey, but not mouse, rat, cat, cow, rabbit, chicken, or yeast, hybridised to 
a 500 bp probe based on the human AA VS 1 sequence. This suggested that a 
homologous locus to AA VS 1 does not exist in these other species. However, the 
conditions for hybridisation were stringent, with a hybridisation temperature of 
68°C. Such a temperature would presumably only allow hybridisation, and hence, 
detection of genomic sequences with high sequence identity with the probe 
sequence. Recently, following results using an in vitro model, it was suggested 
that a 33 nucleotide region of AAVSl, which includes the RBE, was the only 
sequence required for integration into AAVSl (Linden et al., 1996a; Linden et al., 
1996b ). Therefore, experiments were performed in this thesis to analyse whether 
or not this 33 nucleotide sequence existed in any other species. 
Mouse, rat, sheep and cow genomic DNA, as well as human genomic DNA, was 
screened by Southern blot analysis with an oligonucleotide probe containing this 
33 nucleotide region. Hybridisation to this probe was observed in all species, 
including the expected size restriction fragment from human genomic DNA, 
suggesting that some degree of identity to this 33 nucleotide sequence exists in all 
of these species analysed. However, the probe has a GC content of approximately 
80% and the hybridisation was at 60°C in this experiment. The binding specificity 
of the probe under these non-stringent hybridisation conditions is difficult to 
determine and binding to divergent target sequences may occur. Hybridisation at 
higher temperatures may provide further information about the conservation of 
AA VS 1 sequences in these other species. 
Subsequent to this observation, Young et al. (2000) demonstrated that, not just the 
33 nucleotide region of AA VS 1, but the entire AA VS 1 locus is essential for site-
specific integration of recombinant AA V in vivo. Therefore, although evidence 
presented in this thesis suggests that other species may have sites within their 
genome that are similar to this 33 nucleotide sequence, it is unlikely that 
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integration will occur specifically into these loci by a mechanism involving the 
Rep78 and/or Rep68 protein. Nonetheless, it cannot be discounted that Rep78 
and/or Rep68 protein may have a role in the integration of plasmid DNA 
containing ITRs into the mouse genome or the genomes of other species besides 
human. This remained to be determined and was investigated further in this 
study. 
7.4 Stability of expression from transfected AA V-based plasmid DNA 
Transient expression, following low transfection efficiency, is a secondary 
disadvantage of liposome-mediated gene transfer. A technique to enhance the 
longevity of gene expression following transfection would be beneficial. One 
potential mechanism, which may lead to greater stability of transgene expression, 
is integration of plasmid DNA into the host genome. AA V-based plasmid DNA 
transfected into human cells has been shown to integrate site-specifically into the 
host cells genome at the AAVSl locus (Shelling and Smith, 1994; Surosky et al., 
1997; Lamartina et al., 1998; Pieroni et al., 1998; Rinaudo et al., 2000; Tsunoda 
et al., 2000). However, very little information exists regarding the fate of AAV-
based plasmid DNA after transfection into mouse, and the genomes of other 
species. 
To further investigate the integration characteristics of AA V-based plasmid DNA, 
the mouse mammary epithelial cell line HCl 1 was transfected with plasmid DNA 
containing the neomycin resistance gene flanked by ITRs. Furthermore, a rep 
expression construct was co-transfected with this neomycin construct to evaluate 
the role Rep78 and/or Rep68 may have on integration into the HC 11 genome. 
Cells were subsequently selected for integration of the neomycin resistance gene 
using the drug 0418. There was no significant difference observed in the number 
of colonies that resulted from transfections with the addition of ITRs, rep or a 
combination of both, as compared to the control transfection without ITRs or rep. 
These results suggested that firstly, the presence of the ITRs in the transfected 
plasmid flanking the neomycin resistance gene does not change the frequency of 
integration of this gene into HCll mouse genomic DNA. Secondly, 
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co-transfection of a rep expression plasmid also does not have an effect on the 
integration frequency of the neomycin resistance gene into HCll genomic DNA. 
It should be noted however that although rep mRNA production was confirmed 
by Northern blot analysis, the presence of Rep78 and/or Rep68 protein was not 
confirmed. The optimal intracellular concentration of Rep78 and/or Rep68 
protein has been demonstrated to be important for efficient integration into the 
AAVSl locus of human cells. Excessive Rep78 and/or Rep68 protein can cause 
non-specific genomic rearrangements at the AAVSl locus (Balague et al., 1997; 
Surosky et al., 1997; Rinaudo et al., 2000). 
To evaluate whether this observation was unique to this mouse cell line, a human 
embryonic kidney cell line, HEK-293 was also co-transfected with plasmid DNA 
containing the neomycin resistance gene flanked by ITRs, and a rep expression 
construct. Cells were similarly selected with 0418 to determine the integration 
frequency of the neomycin resistance gene and the numbers of colonies were 
compared to those generated using control constructs. Unfortunately due to 
technical difficulties with these cells, not enough data was obtained to make any 
inference about what effect the ITRs flanking the neomycin resistance gene, or co-
transfection of a rep expression plasmid had on the frequency of integration. 
Several liposome-mediated AAV-based plasmid DNA transfection studies have 
been performed with a range of human cell lines in vitro, with the aim of 
elucidating the site of AA V integration. Results have demonstrated that AA V-
based plasmid mediated transfection can lead to site-specific integration into the 
AAVSl locus on human chromosome 19. Shelling and Smith (1994) transfected 
AAV-based plasmids containing ITRs and rep genes into human HEK-293 and 
HeLa cell lines. They observed site-specific integration into the AA VS 1 locus in 
75% of cell lines analysed by Southern blot analysis. More recently, site-specific 
integration has been confirmed by isolation and sequencing of AA VS I-plasmid 
DNA junctions (Surosky et al., 1997; Lamartina et al., 1998; Pieroni et al., 1998; 
Rinaudo et al., 2000; Tsunoda et al., 2000). 
In an attempt to recreate an animal model to characterise the molecular aspects of 
site-specific integration and to test the efficacy of targeted integration of 
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AA V-based vectors, Rizzuto et al. (1999a) created transgenic rats containing a 
3.5 kb AAVSl fragment from human chromosome 19. Subsequent transfection 
of a plasmid, which contained the neomycin resistance and the green fluorescent 
protein genes flanked by ITRs and also a rep gene on the plasmid backbone, into 
primary rat fibroblasts derived from these transgenic animals resulted in site-
specific integration into the AA VS 1 transgene locus. However, the frequency was 
low, with Southern blot and fluorescent in situ hybridisation (FISH) analysis only 
demonstrating integration in one of the seven (14%) clones analysed. Thus, this 
data provided evidence that site-specific integration into the AA VS 1 transgene 
locus could occur following AA V-based plasmid DNA transfection, albeit at a 
low frequency. This frequency of site-specific integration was similar to what 
was observed in another study with the same AA V-based plasmid, when it was 
transfected into human cell lines (Pieroni et al., 1998). 
7. 5 Site of integration of AA V-based plasmid DNA 
Experiments were undertaken in this thesis to determine what effect AAV ITRs 
and Rep78 and/or Rep68 protein had on the fate of plasmid DNA transfected into 
mouse cells. Although the frequency of integration was not changed, it was of 
interest to identify and characterise the genomic site at which integration had 
occurred following deli very of these AA V-based plasmids. 
Several clonal HC 11 cell lines were created earlier in this study from cells that 
were co-transfected with an AA V-based plasmid DNA construct containing a 
neomycin resistance gene flanked by ITRs, and a rep expression construct (+ITR 
+rep). In parallel, HCl 1 cells were also co-transfected with a construct 
containing a neomycin resistance gene, without ITRs, and a rep "minus" control 
construct (-ITR -rep). Subsequent selection with the drug 0418 identified 
colonies in which integration had occurred. Individual colonies were expanded so 
that genomic DNA could be isolated for analysis of the integration characteristics. 
Firstly this isolated genmruc DNA was subjected to Southern blot analysis, 
whereby DNA was digested with the restriction endonuclease Hindlll, which does 
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not have any recognition sites in either of the transfected neomycin constructs 
( +ITR or -ITR), and hybridised to a neomycin gene probe. Different patterns of 
hybridisation products were detected for all clones analysed from both +ITR +rep 
(fifteen clones) and -ITR -rep (twelve clones). The differences observed could 
result from either heterogeneous sites of integration, from multi-copy integration, 
or a combination of both. 
Parallel transfection and selection experiments, using the same plasmids, were 
performed with the human embryonic kidney cell line HEK-293. Southern blot 
analysis of seven +ITR +rep and eight -ITR -rep clonal cell lines with the 
neomycin gene probe revealed no common hybridisation products. Hybridisation 
products of different sizes could result from either heterogeneous sites of 
integration, multi-copy integration, or a combination of both, and is similar to 
what was observed in the HCl 1 cells. Furthermore, upon hybridisation of the 
HEK-293 membrane with a probe based on the human AAVSl locus, no co-
localisation of hybridisation products between the neomycin and AA VS 1 probes 
was observed in any of the clones analysed. This suggested that site-specific 
integration of the neomycin transgene into the AA VSl locus had not occurred in 
any of these clones. 
Site-specific integration into AA VS 1 has previously been observed at frequencies 
of between 40% and 75% following transfection of HEK-293 with AA V-based 
plasmid DNA in the presence of Rep78 and/or Rep68 protein (Shelling and Smith, 
1994; Balague et al., 1997; Surosky et al., 1997). In comparison, wild type AAV 
integrates site-specifically into the AA VS 1 locus in approximately 70% of cases 
(Kotin et al., 1990; Kolin et al., 1991; Samulski et al., 1991; Kolin et al., 1992). 
Analysis of a greater number clones would be required to determine whether site-
specific integration into AA VS 1 is occurring in the experiments described in this 
thesis. 
It could not be conclusively determined if different clones had similar integration 
sites within the mouse genome by Southern blot analysis alone. This is because 
no common site of integration has been identified in the mouse genome to date. 
Therefore a novel PCR method was utilised to amplify regions flanking the 
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integration junction between plasmid and genomic DNA (Siebert et al., 1995). 
Amplified DNA was then subcloned and the sequence determined. From twelve 
clonal HC 11 cell lines screened using this method of Siebert, sequence 
information was obtained for two clones: lb-1 and 3b-4. 
Clone 1 b-1 was derived from HC 11 cells co-transfected with pneo-tk and 
pBR322, which do not contain any AAV sequence (- ITR, - rep). Alignment of 
sequence data from this clone to the NCBI mouse database, using the BLAST 
search tool, revealed that nucleotides 15 to 403 (389 bp) had 100% identity with 
the 5' end of exon 16 of the Mus musculus DNA for DNA dependent protein 
kinase catalytic subunit (nucleotides 392 to 4) (Accession number AB005160.1). 
Clone 3b-4 was derived from HCl 1 cells co-transfected with pITR-neo-tk and 
pHIVrep (+ ITR, + rep). No significant matches to the NCBI mouse database 
using the BLAST search tool were detected for the sequence of this clone, hence it 
had integrated into an as yet unknown region of the mouse genome. 
Of particular interest however from alignment of both clones 1 b-1 and 3b-4 to the 
NCBI mouse database was the similarity to the mouse Bl repeat. Clone lb-1 has 
81 % sequence identity over 57 bp (position 365 to 421) and clone 3b-1 has 73% 
sequence identity over 62 bp (position 51 to 112) to B 1. The regions of sequence 
identity overlap and are predominantly at the 5' end of the Bl consensus 
sequence. 
The mouse B 1 repeat sequence belongs to the short interspersed element (SINE) 
family of repeats which are present in all higher eukaryotes, including the human 
Alu repeat (Jelinek and Schmid, 1982). The 129 bp Bl repeat is estimated to be 
present in between 130,000 and 150,000 copies in the murine genome (Bennett et 
al., 1984) and is frequently located at intron-exon junctions within genes (Krayev 
et al., 1980). 
Interestingly, Surosky et al. (1997) reported the presence of a short region of 
sequence, 95% (19/20 nucleotides) homologous to Alu at the integration junction 
in one of their HEK-293 clones which had been transfected with an AAV-based 
plasmid. Adjacent to this Alu sequence was an unknown region of DNA. They 
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demonstrated by inverse PCR that the Alu sequence is not present in this unknown 
genomic DNA of non-transfected cells and suggest that the junction is the result 
of two crossover events; between the unknown DNA and Alu, and between Alu 
and the plasmid. 
As sequence data was only obtained for two clones, it could not be determined 
whether the presence of B 1 repeat sequence identity at the site of integration was 
a function of a targeted integration event or by chance random integration. Wu et 
al. (1998) reported a successful method, using Alu-PCR and Bl-PCR, to identify 
recombinant AAV vector-mediated DNA integration into several human cells 
lines in vitro and into the rat brain in vivo respectively. A similar approach using 
mouse B 1 repeat, and transgene specific primers could possibly elucidate more 
information about the occurrence of B 1 homologous sequences near the site of 
integration in these experiments. 
7.6 Summary 
The aim of the work outlined in this thesis was to develop a method for delivery 
of plasmid DNA to the mammary gland in vivo. Chemical-mediated delivery of 
plasmid DNA is an attractive method for gene transfer. Features, which make it a 
preferential choice over viral-mediated delivery to introduce foreign DNA to cells, 
include safety, simplicity and cost. Unfortunately, one of the main drawbacks of 
this technique is the low transfection efficiency, and in attempting to accomplish 
the original goal of this work, two approaches were explored to overcome this 
problem. 
Firstly, an in vitro mouse mammary epithelial cell culture model was developed 
for assessment of various cationic liposomes to identify an ideal vehicle for 
plasmid DNA delivery. Upon testing several cationic liposomes and optimising 
their efficiencies, LipofectAMINE was chosen as the best available, however the 
level of transfection efficiency achieved was relatively low. Subsequent to these 
in vitro trials, in vivo transfection experiments with rats were undertaken with 
LipofectAMINE as the delivery vehicle. Unfortunately, very low transfection 
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efficiencies were also obtained. These observations suggest that a modified 
approach will be required for in vivo transfection. Specifically, it may be 
necessary to tailor a delivery vehicle for the unique circumstance encountered in 
the mammary gland. This is in agreement with other researchers who have 
addressed a similar question (Hens et al., 2000). Furthermore, the timing of 
delivery to the developing mammary gland appears to be important to the 
efficiency of transfection. Future attempts at in vivo transfection should 
investigate this further. 
The second approach was based on the use of AA V-based plasmid DNA to 
enhance transfection efficiency. Inclusion of ITRs in the transfected plasmid 
flanking the transgene enhanced transient transfection efficiency by 1.4-fold. 
However, the mechanism by which this is occurring is unknown. Other 
researchers have suggested that the mechanism of enhancement may involve the 
ITRs facilitating nuclear accumulation of the transfected plasmid (Philip et al., 
1994; Vieweg et al., 1995). Labelling of AAV plasmid DNA before delivery, so 
that the intracellular location can be determined, may provide further information 
about the effect that ITRs have on nuclear transport of foreign DNA. 
Further investigations in this thesis, on any effects that ITRs and AA V rep 
expression have on the fate of plasmid DNA transfected into HCl 1 cells, revealed 
that the frequency of integration was unchanged in the presence of ITRs and/or 
rep expression. Additional studies with the Rep78 and/or Rep68 protein could 
provide further insight as to their role, if indeed they have any. Specifically, 
analysis of the concentration of Rep78 and/or Rep68 protein, and regulation of 
this concentration may be informative. 
Analysis of the site of integration and the characterisation of integration junctions 
revealed that two unique genomic sites were identified in the clones examined, 
however clearly a greater number of clones need to be evaluated before definitive 
conclusions can be drawn. These new data would also indicate whether the 
presence of B 1 sequences near the integration junction were significant in the two 
clones that were analysed, or whether their occurrence close to the site of 
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integration merely reflects the fact that there are numerous Bl sequences in the 
genome. 
In summary, this project has contributed toward the understanding of cationic 
liposome-mediated transfection of mammary epithelial cells in vitro and in vivo. 
Furthermore, it was demonstrated that the use of AA V-based plasmid DNA could 
enhance transient transfection efficiency in the HCll mouse mammary epithelial 
cell line. Investigation of the integration characteristics of this plasmid DNA into 
the mouse genome has provided insight into the molecular fate of AA V-based 
plasmids in a species other than human. 
123 
References 
Aihara H. and Miyazaki J. (1998) Gene transfer into muscle by electroporation in 
vivo. Nature Biotechnology 16, 867-870. 
Amstutz M. D. and Schanbacher F. L. (1995) Influence of polyion composition 
on cell uptake, nuclear localization, and expression for polyion-mediated 
transfection. Molecular Biology of the Cell 6, 443a. 
Anderson W. F. (1998) Human gene therapy. Nature 392, 25-30. 
Antoni B. A., Rabson A. B., Miller I. L., Trempe J.P., Chejanovsky N. and Carter 
B. J. (1991) Adeno-associated virus Rep protein inhibits human 
immunodeficiency virus type 1 production in human cells. Journal of 
Virology 65, 396-404. 
Archer J. S., Kennan W. S., Gould M. N. and Bremel R. D. (1994) Human 
growth hormone (hGH) secretion in milk of goats after direct transfer of 
the hGH gene into the mammary gland by using replication-defective 
retrovirus vectors. Proceedings of the National Academy of Sciences USA 
91, 6840-6844. 
Ausubel F. M., Brent R., Knigston R. E., Moore D. D., Seidman J. G., Smith J. A. 
and Strohl K. (1987) Current protocols in molecular biology. John Wiley 
& Sons Ltd, USA. 
Balague C., Kalla M. and Zhang W. W. (1997) Adeno-associated virus Rep78 
protein and terminal repeats enhance integration of DNA sequences Into 
the cellular genome. Journal of Virology 71, 3299-3306. 
Ball R. K., Friis R. R., Schoenenberger C. A., Doppler W. and Groner B. (1988) 
Prolactin regulation of beta-casein gene expression and of a cytosolic 120-
kd protein in a cloned mouse mammary epithelial cell line. EMBO 
Journal 7, 2089-2095. 
Banga A. K. and Prausnitz M. R. (1998) Assessing the potential of skin 
electroporation for the delivery of protein- and gene-based drugs. Trends 
in Biotechnology 16, 408-412. 
124 
Baudard M., Flotte T. R., Aran J.M., Thierry A. R., Pastan I., Pang M. G., Keams 
W. G. and Gottesman M. M. (1996) Expression Of the Human Multidrug 
Resistance and Glucocerebrosidase Cdnas From Adeno-Associated 
Vectors - Efficient Promoter Activity Of Aav Sequences and In Vivo 
Delivery Via Liposomes. Human Gene Therapy 1, 1309-1322. 
Beaton A., Palumbo P. and Berns K. I. (1989) Expression from the adeno-
associated virus p5 and p19 promoters is negatively regulated in trans by 
the rep protein. Journal of Virology 63, 4450-4454. 
Belting M. and Petersson P. (1999) Protective role for proteoglycans against 
cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro. 
Biochemical Journal 342, 281-286. 
Benihoud K., Yeh P. and Perricaudet M. (1999) Adenovirus vectors for gene 
delivery. Current Opinions in Biotechnology 10, 440-7. 
Bennett K. L., Hill R. E., Pietras D. F., Woodworth-Gutai M., Kane-Haas C., 
Houston J.M., Heath J. K. and Hastie N. D. (1984) Most highly repeated 
dispersed DNA families in the mouse genome. Molecular and Cellular 
Biology 4, 1561-1571. 
Berghammer H. and Auer B. (1993) "Easypreps": Fast and easy plasmid 
minipreparation for analysis of recombinant clones in E. coli. 
Biotechniques 14, 526-528. 
Berns K. I. (1990) Parvovirus replication. Microbiological Reviews 54, 316-329. 
Boussif 0., Lezoualcb F., Zanta M. A., Mergny M. D., Scherman D., Demeneix 
B. and Behr J. P. (1995) A versatile vector for gene and oligonucleotide 
transfer into cells in culture and in vivo: polyethylenimine. Proceedings of 
the National Academy of Sciences USA. 92, 7297-7301. 
Bradford M. M. (1976) A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye 
binding. Analytical Biochemistry 72, 248-254. 
Branden L. J., Mohamed A. J. and Smith C. I.E. (1999) A peptide nucleic acid-
nuclear localization signal fusion that mediates nuclear transport of DNA. 
Nature Biotechnology 17, 784-787. 
125 
Brisson M., Tseng W. C., Almonte C., Watkins S. and Huang L. (1999) 
Subcellular trafficking of the cytoplasmic expression system. Human 
Gene Therapy 10, 2601-2613. 
Bueler H. ( 1999) Adeno associated viral vectors for gene transfer and gene 
therapy. Biological Chemistry 380, 613-622. 
Capecchi M. R. ( 1980) High efficiency transformation by direct microinjection of 
DNA into cultured mammalian cells. Cell 22, 479-488. 
Caplen N. J., Alton E.W., Middleton P. G., Dorin J. R., Stevenson B. J., Gao X., 
Durham S. R., Jeffery P. K., Hodson M. E., Coutelle C. and et al. (1995) 
Liposome-mediated CFfR gene transfer to the nasal epithelium of patients 
with cystic fibrosis. Nature Medicine 1, 39-46. 
Carter P. J. and Samulski R. J. (2000) Adeno-associated viral vectors as gene 
delivery vehicles. International Journal of Molecular Medicine 6, 17-27. 
Chejanovsky N. and Carter B. J. (1989) Mutagenesis of an AUG codon in the 
adeno-associated virus rep gene: effects on viral DNA replication. 
Virola gy 173, 120-128. 
Chen P., Kovesdi I. and Bruder T. J. (2000) Effective repeat administration with 
adenovirus vectors to the muscle. Gene Therapy 1, 587-595. 
Chirmule N., Propert K. J., Magosin S. A., Qian Y., Qian R. and Wilson J. M. 
( 1999) Immune responses to adenovirus and adeno-associated virus in 
humans. Gene Therapy 6, 1574-1583. 
Coffin J. M. (1990) Retroviradae and their replication. In Virology (Fields B. N. 
and Knipe D. M., Ed.), pp. 1437-1500. Raven Press Ltd, NY. 
Cordingley M. G. and Preston C.M. (1981) Transcription and translation of the 
herpes simplex virus type 1 thymidine kinase gene after microinjection 
into Xenopus laevis oocytes. Journal of General Virology 54, 409-414. 
Danielson K. G., Obom C. J., Durban E. M., Butel J. S. and Medina D. (1984) 
Epithelial mouse mammary cell line exhibiting normal morphogenesis in 
vivo and functional differentiation in vitro. Proceedings of the National 
Academy of Sciences USA 81, 3756-3760. 
126 
During M. J. (1997) Adena-associated virus as a gene delivery system. Advanced 
Drug Delivery Reviews 27, 83-94. 
During M. J., Samulski R. J., Elsworth J. D., Kaplitt M. G., Leone P., Xiao X., Li 
J., Freese A., Taylor J. R., Roth R. H., Sladek J. R., Omalley K. L. and 
Redmond D. E. (1998) In vivo expression of therapeutic human genes for 
dopamine production in the caudates of MPTP-treated monkeys using an 
AA V vector. Gene Therapy 5, 820-827. 
El Ouahabi A., Thiry M., Pector V., Fuks R., Ruysschaert J. M. and 
Vandenbranden M. (1997) The role of endosome destabilizing activity in 
the gene transfer process mediated by cationic lipids. FEBS Letters 414, 
187-192. 
Fallaux F. J., Bout A., van der Velde I., van de Wollenberg D. J., Hehir K. M., 
Keehan J., Auger C., Cramer S. J., van Ormandt H., J. v. d. E. A., Valerio 
D. and Hoeben R. C. (1998) New helper cells and matched early region 1-
deleted adenovirus vectors prevent generation of replication-competent 
adenoviruses. Human Gene Therapy 9, 1909-1917. 
Fan L., Drew J., Dunckley M. G., Owen J. S. and Dickson G. (1998) Efficient 
coexpression and secretion of antiatherogenic human apolipoprotein Al 
and lecithin-cholesterol acyltransferase by cultured muscle cells using 
adeno-associated virus plasmid vectors. Gene Therapy 5, 1434-1440. 
Farhood H., Serbina N. and Huang L. (1995) The role of dioleoyl 
phosphatidylethanolamine in cationic liposome mediated gene transfer. 
Biochemica et Biophysica Acta 1235, 289-295. 
Fasbender A., Zahner J., Zeiher B. G. and Welsh M. J. (1997) A low rate of cell 
proliferation and reduced DNA uptake limit cationic lipid-mediated gene 
transfer to primary cultures of ciliated human airway epithelia. Gene 
Therapy 4, 1173-1180. 
Feigner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz M., Northrop 
J. P., Ringold G. M. and Danielsen M. (1987) Lipofection: a highly 
efficient, lipid-mediated DNA-transfection procedure. Proceedings of the 
National Academy of Sciences USA 84, 7413-7417. 
127 
Ferrari F. K., Xiao X., McCarty D. and Samulski R. J. (1997) New developments 
in the generation of AD-Free, high-titer rAA V gene therapy vectors. 
Nature Medicine 3, 1295-1297. 
Flotte T. R., Afione S. A., Conrad C., McGrath S. A., Solow R., Oka H., Zeitlin P. 
L., Guggino W. B. and Carter B. J. (1993) Stable in vivo expression of the 
cystic fibrosis transmembrane conductance regulator with an adeno-
associated virus vector. Proceedings of the National Academy of Sciences 
of the United States of America 90, 10613-10617. 
Furth P. A., Shamay A., Wall R. J. and Hennighausen L. (1992) Gene transfer 
into somatic tissues by jet injection. Analytical Biochemistry 205, 365-
368. 
Gao X. and Huang L. (1993) Cytoplasmic expression of a reporter gene by co-
delivery of T7 RNA polymerase and T7 promoter sequence with cationic 
liposomes. Nucleic Acids Research 21, 2867-2872. 
Ginsberg H. S. (1984) The Adenoviruses. Plenum, NY. 
Graham F. L., Smiley J., Russell W. C. and Nairn R. (1977) Characteristics of a 
human cell line transformed by DNA from human adenovirus type 5. 
Journal of General Virology 36, 59-74. 
Graham F. L. and van der Eb A. J. (1973) A new technique for the assay of 
infecti vity of human adenovirus 5 DNA. Virology 52, 456-467. 
Greber U. F., Willetts M., Webster P. and Helenius A. (1993) Stepwise 
dismantling of adenovirus 2 during entry into cells. Cell 75, 477-486. 
Green M. R., Straus S. E. and Roeder R. G. (1980) Transcripts of the adenovirus-
associated virus genome: multiple polyadenylated RNAs including a 
potential primary transcript. Journal of Virology 35, 560-565. 
Hawley-Nelson P., Ciccarone V., Gebeyehu n, Jesse J. and Feigner P. L. (1993) 
LipofectAMINE Reagent: A new, higher efficiency polycatioic liposome 
transfection reagent. Focus 15, 73. 
Hawley-Nelson P. and Shih P.-J. (1993) Sensitivity of transfection efficiency to 
culture age. Focus 17, 60-61. 
128 
Hens J. R., Amstutz M. D., Schanbacher F. L. and Mather I. H. (2000) 
Introduction of the human growth hormone gene into the guinea pig 
mammary gland by in vivo transfection promotes sustained expression of 
human growth hormone in the milk throughout lactation. Biochemica et 
Biophysica Acta 1523, 161-171. 
Hernandez Y. J., Wang J.M., Keams W. G., Loiler S., Poirier A. and Flotte T. R. 
(1999) Latent adeno-associated virus infection elicits humoral but not 
cell-mediated immune responses in a nonhuman primate model. Journal 
of Virology 73, 8549-8558. 
Hitoshi S., Kusinoki S., Kanazawa I. and Tsuji S. (1996) Molecular cloning and 
expression of a third type of rabbit GDP-L-Fructose:B-D-Galactosidase 2-
alpha-L-Fucosyltransferase. Journal of Biological Chemistry 271, 16975-
16981. 
Holmes A. R., Dohrman A. F., Ellison A. R., Gonez K. K. and Gruenert D. C. 
(1999) Intracellular compartmentalization of DNA fragments in cultured 
auway epithelial cells mediated by cationic lipids. Pharmaceutical 
Research 16, 1020-1025. 
Inoue H., Nojima H. and Okayama H. (1990) High efficiency transformation of 
Escherichia coli with plasmids. Gene 96, 23-28. 
Jagota S. K., Ramana Rao M. V. and Dutta S. M. (1981) Beta-galactosidase of 
Streptococcus cremoris H. Journal of Food Science 46, 161-163. 
Jelinek W.R. and Schmid C. W. (1982) Repetitive sequences in eukaryotic DNA 
and their expression. Annual Review of Biochemistry 51, 813-844. 
Jeng M. H., Kao C., Sivaraman L., Kmacik S., Chung L. W., Medina D., 
Conneely 0. M. and OMalley B. W. (1998) Reconstitution of estrogen-
dependent transcriptional activation of an adenoviral target gene in select 
regions of the rat mammary gland. Endocrinology 139, 2916-2925. 
Kang Y. K., Park J. S., Lee C. S., Yeom Y. I., Han Y. M., Chung A. S. and Lee K. 
K. (2000) Effect of short interspersed element sequences on the 
integration and expression of a reporter gene in the preimplantation-stage 
mouse embryos. Molecular Reproduction and Development 56, 366-371. 
129 
Kaplitt M. G., Leone P., Samulski R. J., Xiao X., Pfaff D. W., OMalley K. L. and 
During M. J. (1994) Long-term gene expression and phenotypic 
correction using adeno- associated virus vectors in the mammalian brain. 
Nature Genetics 8, 148-154. 
Keown W. A., Campbell C. R. and Kucherlapati R. S. (1990) Methods for 
introducing DNA into mammalian cells. Methods in Enzymology 185, 
527-537. 
Kerr D. E., Furth P.A., Powell A. M. and Wall R. J. (1996) Expression of gene-
gun injected plasmid DNA in the ovine mammary gland and lymph nodes 
draining the injection site. Animal Biotechnology 7, 33-45. 
Kjellen L. and Lindahl U. (1991) Proteoglycans: structures and interactions. 
Annual Review of Biochemistry 60, 443-475. 
Koeberl D. D., Alexander I. E., Halbert C. L., Russell D. W. and Miller A. D. 
(1997) Persistent Expression Of Human Clotting Factor Ix From Mouse 
Liver After Intravenous Injection Of Adena-Associated Virus Vectors. 
Proceedings of the National Academy of Sciences of the United States of 
America 94, 1426-1431. 
Kotin R. M., Siniscalco M., Samulski R. J., Zhu X. D., Hunter L., Laughlin C. A., 
McLaughlin S., Muzyczka N., Rocchi M. and Berns K. I. (1990) Site-
specific integration by adeno-associated virus. Proceedings of the 
National Academy of Sciences USA 87, 2211-2215. 
Kotin R. M., Menninger J.C., Ward D. C. and Berns K. I. (1991) Mapping and 
direct visualization of a region-specific viral DNA integration site on 
chromosome I9q13-qter. Genomics 10, 831-834. 
Kotin R. M., Linden R. M. and Berns K. I. (1992) Characterization of a preferred 
site on human chromosome 19q for integration of adeno-associated virus 
DNA by non-homologous recombination. EMBO Journal 11, 5071-5078. 
Krayev A. S., Kramerov D. A., Skryabin K. G., Ryskov A. P., Bayev A. A. and 
Georgiev G. P. (1980) The nucleotide sequence of the ubiquitous 
repetitive DNA sequence Bl complementary to the most abundant class of 
mouse fold-back RNA. Nucleic Acids Research 8, 1201-1215. 
130 
Labow M.A. and Berns K. I. (1988) The adeno-associated virus rep gene inhibits 
replication of an adeno- associated virus/simian virus 40 hybrid genome in 
cos-7 cells. Journal of Virology 62, 1705-1712. 
Lamartina S., Roscilli G., Rinaudo D., Delmastro P. and Toniatti C. (1998) 
Lipofection of purified adeno-associated virus REP68 protein - toward a 
chromosome-targeting nonviral particle. Journal of Virology 72, 7653-
7658. 
Lee R. J. and Huang L. (1997) Lipidic vector systems for gene transfer. Critical 
Reviews in Therapeutic Drug Carrier Systems 14, 173-206. 
Leone P., Janson C. G., Bilaniuk L., Wang Z., Sorgi F., Huang L., Matalon R., 
Kaul R., Zeng Z., Freese A., McPhee S. W., Mee E., During M. J. and 
Bilianuk L. (2000) Aspartoacylase gene transfer to the mammalian central 
nervous system with therapeutic implications for Canavan disease. Annals 
of Neurology 48, 27-38. 
Li S. and Huang L. (2000) Nonviral gene therapy: promises and challenges. 
Gene Therapy 1, 31-34. 
Linden R. M., Winocour E. and Berns K. I. (1996a) The recombination signals 
for adeno-associated virus site-specific integration. Proceedings of the 
National Academy of Sciences USA 93, 7966-7972. 
Linden R. M., Ward P., Giraud C., Winocour E. and Berns K. I. (1996b) Site-
specific integration by adeno-associated virus. Proceedings of the 
National Academy of Sciences of the United States of America 93, 11288-
11294. 
Litzinger D. C. and Huang L. (1992) Phosphatidylethanolamine liposomes: drug 
delivery, gene transfer and immunodiagnostic applications. Biochemica et 
Biophysica Acta 1113, 201-227. 
Liu F., Song Y. K. and Liu D. (1999a) Hydrodynamics-based transfection in 
animals by systemic administration of plasmid DNA. Gene Therapy 6, 
1258-1266. 
131 
Liu X. L., Clark K. R. and Johnson P. R. (1999b) Production of recombinant 
adeno-associated virus vectors using a packaging cell line and a hybrid 
recombinant adenovirus. Gene Therapy 6, 293-299. 
Luo D. and Saltzman W. M. (2000) Synthetic DNA delivery systems. Nature 
Biotechnology 18, 33-37. 
Mahato R. I., Rolland A. and Tomlinson E. (1997) Cationic lipid-based gene 
delivery systems- pharmaceutical perspectives. Phannaceutical Research 
14, 853-859. 
Mann M. J., Gibbons G. H., Hutchinson H., Poston R. S., Hoyt E.G., Robbins R. 
C. and Dzau V. J. (1999) Pressure-mediated oligonucleotide transfection 
of rat and human cardiovascular tissues. Proceedings of the National 
Academy of Sciences of the United States of America 96, 6411-6416. 
Matsui H., Johnson L. G., Randell S. H. and Boucher R. C. (1997) Loss of 
binding and entry of liposome-DNA complexes decreases transfection 
efficiency in differentiated airway epithelial cells. Journal of Biological 
Chemistry 212, 1117-1126. 
Melnick J. L., Mayour H. D., Smith K. 0. and Rapp F. (1965) Association of 20 
millimicron particles with adeoviruses. Journal of Bacteriology 90, 271-
274. 
Mephan T. B. (1987) Physiology of Lactation. Open University Press, Milton 
Keynes, England. 
Miao C. H., Snyder R. 0., Schowalter D. B., Patijn G. A., Donahue B., Winther 
B. and Kay M. A. (1998) The kinetics of rAA V integration in the liver. 
Nature Genetics 19, 13-15. 
Mortimer I., Tam P., MacLachlan I., Graham R. W., Saravolac E.G. and Joshi P. 
B. (1999) Cationic lipid-mediated transfection of cells in culture requires 
mitotic activity. Gene Therapy 6, 403-411. 
Mounkes L. C., Zhong W., Ciprespalacin G., Heath T. D. and Debs R. J. (1998) 
Proteoglycans mediate cationic liposome-DNA complex-based gene 
delivery in vitro and in vivo. Journal of Biological Chemistry 273, 26164-
26170. 
132 
Nabel G. J., Nabel E. G., Yang Z. Y., Fox B. A., Plautz G. E., Gao X., Huang L., 
Shu S., Gordon D. and Chang A. E. (1993) Direct gene transfer with 
DNA-liposome complexes in melanoma: expression, biologic activity, and 
lack of toxicity in humans. Proceedings of the National Academy of 
Sciences USA 90, 11307-11311. 
Nakai H., Iwaki Y., Kay M.A. and Couto L.B. (1999) Isolation of recombinant 
adeno-associated virus vector-cellular DNA junctions from mouse liver. 
Journal of Virology 73, 5438-5447. 
Nakai H., Storm T. A. and Kay M. A. (2000) Increasing the size of rAAV-
mediated expression cassettes in vivo by intermolecular joining of two 
complementary vectors. Nature Biotechnology 18, 527-532. 
Olmsted J. B., Carlson K., Klebe R., Ruddle F. and Rosenbaum J. (1970) 
Isolation of microtubule protein from cultured mouse neuroblastoma cells. 
Proceedings of the National Academy of Sciences USA 65, 129-136. 
Orkin S. H. and Motulsky A. G. (1995) Report and recommendations of the panel 
to assess the NIH investment in research on gene therapy. 
www .nih.gov/news/panelrep.html 
Oshima Y., Sakamoto T., Yamanaka I., Nishi T., Ishibashi T. and Inomata H. 
( 1998) Targeted gene transfer to corneal endothelium in vivo by electric 
pulse. Gene Therapy 5, 1347-1354. 
Palombo F., Monciotti A., Recchia A., Cortese R., Ciliberto G. and Lamonica N. 
( 1998) Site-specific integration in mammalian cells mediated by a new 
hybrid baculovirus adeno-associated virus vector. Journal of Virology 72, 
5025-5034. 
Pattison J. R. (1994) Parvoviruses: General Features. In Encyclopedia of 
Virology (Webster R. G. and Granoff A., Ed.), pp. 1052-1057. Academic 
Press, London. 
Patton S., Welsch U. and Singh S. (1984) Intramammary infusion technique for 
genetic engineering of the mammary gland. Journal of Dairy Science 67, 
1323-1326. 
133 
Philip R., Brunette E., Kilinski L., Murugesh D., McNally M. A., Ucar K., 
Rosenblatt J., Okarrna T. B. and Lebkowski J. S. (1994) Efficient and 
sustained gene expression in primary T lymphocytes and primary and 
cultured tumor cells mediated by adeno-associated virus plasmid DNA 
complexed to cationic liposomes. Molecular and Cellular Biology 14, 
2411-2418. 
Pieroni L., Fipaldini C., Monciotti A., Cimini D., Sgura A., Fattori E., Epifano 0., 
Cortese R., Palombo F. and Lamonica N. (1998) Targeted integration of 
adeno-associated virus-derived plasmids in transfected human cells. 
Virology 249, 249-259. 
Rinaudo D., Lamartina S., Roscilli G., Ciliberto G. and Toniatti C. (2000) 
Conditional site-specific integration into human chromosome 19 by using 
a ligand-dependent chimeric adeno-associated virus/Rep protein. Journal 
of Virology 74, 281-294. 
Rizzuto G., Gorgoni B., Cappelletti M., Lazzaro D., Gloaguen I., Poli V., Sgura 
A., Cimini D., Ciliberto G., Cortese R., Fattori E. and La Monica N. 
(1999a) Development of animal models for adeno-associated virus site-
specific integration. Journal of Virology 73, 2517-2526. 
Rizzuto G., Cappelletti M., Maione D., Savino R., Lazzaro D., Costa P., 
Mathiesen I., Cortese R., Ciliberto G., Laufer R., La Monica N. and Fattori 
E. (1999b) Efficient and regulated erythropoietin production by naked 
DNA injection and muscle electroporation. Proceedings of the National 
Academy of Sciences of the United States of America 96, 6417-6422. 
Rolling F., Shen W. Y., Tabarias H., Constable I., Kanagasingam Y., Barry C. J. 
and Rakoczy P. E. (1999) Evaluation of adeno-associated virus-mediated 
gene transfer into the rat retina by clinical fluorescence photography. 
Human Gene Therapy 10, 641-648. 
Sambrook J., Fritsch E. F. and Maniatis T. (1989) Molecular cloning, a 
laboratory manual. Cold Spring Habour Press, NY. 
Samulski R. J., Chang L. S. and Shenk T. (1987) A recombinant plasmid from 
which an infectious adeno-associated virus genome can be excised in vitro 
and its use to study viral replication. Journal of Virology 61, 3096-3101. 
134 
Samulski R. J., Chang L. S. and Shenk T. (1989) Helper-free stocks of 
recombinant adeno-associated viruses: normal integration does not require 
viral gene expression. Journal of Virology 63, 3822-3828. 
Samulski R. J., Zhu X., Xiao X., Brook J. D., Housman D. E., Epstein N. and 
Hunter L. A. (1991) Targeted integration of adeno-associated virus 
(AAV) into human chromosome 19. EMBO Journal 10, 3941-3950. 
Sanes J. R., Rubenstein J. L. and Nicolas J. F. (1986) Use of a recombinant 
retrovirus to study post-implantation cell lineage in mouse embryos. 
EMBO Journal 5, 3133-3142. 
Schaffer D. V., Fidelman N. A., Dan N. and Lauffenburger D. A. (2000) Vector 
unpacking as a potential barrier for receptor-mediated polyplex gene 
delivery. Biotechnology & Bioengineering 67, 598-606. 
Schanbacher F. L. and Amstutz M.A. (1997) Direct transfection of the mammary 
gland: Opportunities for modification of mammary function and the 
production, composition and qualities of milk. In Biotechnology in 
Agriculture Series, No 18. Milk composition, Production and 
Biotechnology (Welch R. A. S., Bums D. J. W., Davis S. R., Popay A. I. 
and Prosser C. G., Ed.), pp 243-264. CAB International, New York. 
Shapira S. K., Chou J., Richaud F. V., and Casadaban M. J. (1983) New versatile 
plasmid vectors for expression of hybrid proteins coded by cloned gene 
fused to lacZ gene sequences encoding and enzymatically active carboxy-
terminal portion of beta-galactosidase. Gene 25, 71-82. 
Shelling A. N. and Smith M. G. (1994) Targeted integration of transfected and 
infected adeno-associated virus vectors containing the neomycin resistance 
gene. Gene Therapy 1, 165-169. 
Siebert P. D., Chenchik A., Kellogg D. E., Lukyanov K. A. and Lukyanov S. A. 
(1995) An improved PCR method for walking in uncloned genomic DNA. 
Nucleic Acids Research 23, 1087-1088. 
135 
Smith G. H., Gallahan D., Zwiebel J. A., Freeman S. M., Bassin R. H. and 
Callahan R. ( 1991) Long-term in vivo expression of genes introduced by 
retrovirus-mediated transfer into mammary epithelial cells. Journal of 
Virology 65, 6365-6370. 
Snyder R. 0., Miao C. H., Patijn G. A., Spratt S. K., Danos 0., Nagy D., Gown A. 
M., Winther B., Meuse L., Cohen L. K., Thompson A. R. and Kay M. A. 
( 1997) Persistent and therapeutic concentrations of human factor IX in 
mice after hepatic gene transfer of recombinant AA V vectors. Nature 
Genetics 16, 270-276. 
Srivastava A., Lusby E. W. and Berns K. I. (1983) Nucleotide sequence and 
organization of the adeno-associated virus 2 genome. Journal of Virology 
45, 555-564. 
Stayton P. S., Hoffman A. S., Murthy N., Lackey C., Cheung C., Tan P., Klumb 
L. A., Chilkoti A., Wilbur F. S. and Press 0. W. (2000) Molecular 
engineering of proteins and polymers for targeting and intracellular 
delivery of therapeutics. Journal of Controlled Release 65, 203-220. 
Sternberg B., Sorgi F. L. and Huang L. (1994) New structures in complex 
formation between DNA and cationic liposomes visualized by freeze-
fracture electron microscopy. FEBS Letters 356, 361-6. 
Subramanian A., Ranganathan P. and Diamond S. L. (1999) Nuclear targeting 
peptide scaffolds for lipofection of nondividing mammalian cells. Nature 
Biotechnology 17, 873-877. 
Surosky R. T., Urabe M., Godwin S. G., McQuiston S. A., Kurtzman G. J., Ozawa 
K. and Natsoulis G. (1997) Adeno-associated virus Rep proteins target 
DNA sequences to a unique locus in the human genome. Journal of 
Virology 71, 7951-7959. 
Sutcliffe J. G. (1979) Complete nucleotide sequence of the Escherica coli 
plasmid pBR322. Cold Spring Harbour Symposia on Quantitative Biology 
43, 77-90. 
136 
Tsao J., Chapman M. S., Agbandje M., Keller W., Smith K., Wu H., Luo M., 
Smith T. J., Rossmann M. G., Compans R. W. and et al. (1991) The three-
dimensional structure of canine parvovirus and its functional implications. 
Science 251, 1456-1464. 
Tseng W. C., Haselton F. R. and Giorgio T. D. (1997) Transfection by cationic 
liposomes using simultaneous single cell measurements of plasmid 
delivery and transgene expression. Journal of Biological Chemistry 272, 
25641-25647. 
Tseng W. and Huang L. (1998) Liposome-based gene therapy. Pharmaceutical 
Science and Technologies Today 1, 206-213. 
Tsunoda H., Hayakawa T., Sakuragawa N. and Koyama H. (2000) Site-specific 
integration of adeno-associated virus-based plasmid vectors in lipofected 
HeLa cells. Virology 268, 391-401. 
Vaheri A. and Pagano J. S. (1965) Infectious poliovirus RNA: a sensitive method 
of assay. Virology 27, 434-436. 
Vieweg J., Boczkowski D., Roberson K. M., Edwards D. W., Philip M., Philip R., 
Rudoll T., Smith C., Robertson C. and Gilboa E. (1995) Efficient gene 
transfer with adeno-associated virus-based plasmids complexed to cationic 
liposomes for gene therapy of human prostate cancer. Cancer Research 
55, 2366-2372. 
Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D. T. and 
Birnstiel M. L. ( 1992) Coupling of adenovirus to transferrin-
polylysine/DNA complexes greatly enhances receptor-mediated gene 
delivery and expression of transfected genes. Proceedings of the National 
Academy of Sciences of the United States of America 89, 6099-6103. 
Wall R. J ., Kerr D. E. and Bondioli K. R. (1997) Transgenic dairy cattle: genetic 
engineering on a large scale. Journal of Dairy Science 80, 2213-24. 
137 
Wang B. C., Kennan W. S., Yasukawa-Bames J., Lindstrom M. J. and Gould M. 
N. (1991) Carcinoma induction following direct in situ transfer of v-Ha-
ras into rat mammary epithelial cells using replication-defective retrovirus 
vectors. Cancer Research 51, 2642-2648. 
Watson J. D., Hopkins N. H., Roberts J. W., Steitz J. A. and Weiner A. M. (1987) 
Molecular Biology of the gene. The Benjamin/Cummings Publishing 
Company Inc, Menlo Park, California. 
Weitzman M. D., Kyostio S. R., Kotin R. M. and Owens R. A. (1994) Adeno-
associated virus (AA V) Rep proteins mediate complex formation between 
AA V DNA and its integration site in human DNA. Proceedings of the 
National Academy of Sciences USA 91, 5808-5812. 
Wolff J. A., Malone R. W., Williams P., Chong W., Acsadi G., Jani A. and 
Feigner P. L. (1990) Direct gene transfer into mouse muscle in vivo. 
Science 247, 1465-1468. 
Wu P., Phillips M. I., Bui J. and Terwilliger E. F. (1998) Adeno-associated virus 
vector-mediated transgene integration into neurons and other nondividing 
cell targets. Journal of Virology 72, 5919-5926. 
Xiao X. A., Li J. A. and Samulski R. J. (1996) Efficient long-term gene transfer 
into muscle tissue of immunocompetent mice by adeno-associated virus 
vector. Journal of Virology 70, 8098-8108. 
Xiao X., Xiao W. D., Li J. and Samulski R. J. (1997) A novel 165-basepair 
terminal repeat sequence is the sole cis requirement for the adeno-
associated virus life cycle. Journal of Virology 71, 941-948. 
Xiao X., Li J. and Samulski R. J. (1998) Production of high-titer recombinant 
adeno-asssociated virus vectors in the absence of helper adenovirus. 
Journal of Virology 72, 2224-2232. 
Yakinoglu A. 0., Heilbronn R., Burkle A., Schlehofer J. R. and zur Hausen H. 
(1988) DNA amplification of adeno-associated virus as a response to 
cellular genotoxic stress. Cancer Research 48, 3123-3129. 
138 
Yang J., Tsukamoto T., Popnikolov N., Guzman R. C., Chen X., Yang J. H. and 
Nandi S. (1995) Adenoviral-mediated gene transfer into primary human 
and mouse mammary epithelial cells in vitro and in vivo. Cancer Letters 
98, 9-17. 
Yang N. S., Burkholder J., Roberts B., Martinell B. and McCabe D. (1990) In 
vivo and in vitro gene transfer to mammalian somatic cells by particle 
bombardment. Proceedings of the National Academy of Sciences USA 87, 
9568-9572. 
Young S. M., McCarty D. M., Degtyareva N. and Samulski R. J. (2000) Roles of 
adeno-associated virus Rep protein and human chromosome 19 in site­
specific recombination. Journal of Virology 74, 3953-3966. 
Zahner J., Fasbender A. J., Moninger T., Poellinger K. A. and Welsh M. J. (1995) 
Cellular and molecular barriers to gene transfer by a cationic lipid. 
Journal of Biological Chemistry 270, 18997-9007. 
Zahner J. (1997) Cationic lipids used in gene transfer. Advanced Drug Delivery 
Reviews 27, 17-28. 
Zhang G. F., Budker V. and Wolff J. A. (1999) High levels of foreign gene 
expression in hepatocytes after tail vein injections of naked plasmid DNA. 
Human Gene Therapy 10, 1735-1737. 
Zhou X. and Huang L. (1994) DNA transfection mediated by cationic liposomes 
containing lipopolylysine: characterization and mechanism of action. 
Biochemica et Biophysica Acta 1189, 195-203. 
Ziemienowicz A., Gorlich D., Lanka E., Hohn B. and Rossi L. (1999) Import of 
DNA into mammalian nuclei by proteins originating from a plant 
pathogenic bacterium. Proceedings of the National Academy of Sciences 
of the United States of America 96, 3729-3733. 
